FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1694,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,638813720.0676523,464560416.946384,0.7272236058066907,-0.45952906445942476,0.6211993400464513,0.9043347628664763,Downregulated
Feature1693,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak6,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,2406732617.4431953,2497647362.0529733,1.0377751745045787,0.05349392947694974,0.955916962595581,0.9882637829765163,Upregulated
Feature1692,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,8735036.33354086,6302545.406869555,0.7215248072488253,-0.47087909701135616,0.7713548768113252,0.9502143902366301,Downregulated
Feature1691,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,1767965307.181983,1195315929.342252,0.6760969372456209,-0.5646979832063757,0.5815234034043478,0.8964335502669541,Downregulated
Feature1690,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak13",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,5340601.3819836,4992513.188150799,0.9348222851817647,-0.09723596802165776,0.9411339001948098,0.9882637829765163,Downregulated
Feature1689,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,790967416.9751374,1199925336.8594892,1.5170351029734095,0.60125446877528,0.5933774946378676,0.9015409731649661,Upregulated
Feature1688,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak2,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,3036493607.4865766,1667506951.0347934,0.5491554294478009,-0.8647135566637918,0.4819648608824195,0.8724505635080375,Downregulated
Feature1687,NA,C30 H32 O10,552.19968,NA,NA,Feature1687,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,13188867.89904914,1833398.5497851733,0.13901106325565316,-2.8467283898600018,0.42551308992495585,0.8724505635080375,Downregulated
Feature1686,Phenacetin,C10 H13 N O2,179.09467,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak5,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,90091518.09172681,781067021.4764781,8.669706516447349,3.115983156719034,0.449914805563371,0.8724505635080375,Upregulated
Feature1685,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,503633494.8602187,253856112.55783534,0.5040493040048737,-0.9883632358360553,0.24299944212184232,0.8724505635080375,Downregulated
Feature1684,NA,C30 H32 O10,552.19968,NA,NA,Feature1684,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,5835234.529363762,1104117.9172954103,0.18921568820230378,-2.401896384892108,0.44990139021901976,0.8724505635080375,Downregulated
Feature1683,NA,C9 H16 O7,236.0896,NA,NA,Feature1683,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,548428493.3382387,846568398.0973101,1.5436258480012928,0.6263231071098818,0.29586334712764634,0.8724505635080375,Upregulated
Feature1682,Citric acid,C6 H8 O7,192.02697,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,Citric acid,6,8,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,186640147.5394668,88203166.80510043,0.4725841035163619,-1.081356993218057,0.4455092259376953,0.8724505635080375,Downregulated
Feature1681,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,693818470.0021336,598748945.0953087,0.8629763705965732,-0.2126070377888715,0.8275994429829778,0.9705323413271486,Downregulated
Feature1680,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,973891073.2281893,1061034992.9384587,1.0894801504047167,0.12363991176033662,0.8105460384574305,0.9646810559875049,Upregulated
Feature1679,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak12",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,5701165.280948925,1052725.7396325218,0.18465097708188208,-2.4371271982931657,0.4505153034450524,0.8724505635080375,Downregulated
Feature1678,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,420398766.0956103,210284972.937189,0.5002035921517534,-0.9994126767908857,0.3907525448956958,0.8724505635080375,Downregulated
Feature1677,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak5,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,69779426.42669466,57341708.321685,0.8217566589190032,-0.28321685298183746,0.3937486836410705,0.8724505635080375,Downregulated
Feature1676,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,725472732.6403006,540081659.826396,0.7444548024028573,-0.42574383282093137,0.39124877021565013,0.8724505635080375,Downregulated
Feature1675,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,40546001.36535553,82382659.00750497,2.0318319003929375,1.0227810485169346,0.04071451906315936,0.8724505635080375,Upregulated
Feature1674,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak3,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,7451335.044012327,6728798.96659475,0.9030326682198803,-0.1471499151255142,0.832108059017847,0.9709621554641522,Downregulated
Feature1673,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,649515338.1917224,455173488.8284707,0.7007894380072571,-0.512947063454811,0.2713004173612906,0.8724505635080375,Downregulated
Feature1672,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak3,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,19605220.577863898,77770413.12750827,3.966821633994684,1.9879835289335217,0.009674860773980474,0.8724505635080375,Upregulated
Feature1671,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,7161772.095605956,4504601.031381249,0.6289785504547134,-0.6689172760026023,0.4950284478010397,0.8724505635080375,Downregulated
Feature1670,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak11",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,3729557.006310711,1195369.356733618,0.3205124240522284,-1.6415478136404253,0.4986896436344111,0.8747804400244787,Downregulated
Feature1669,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak4,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,74718031.90133917,45718303.93470083,0.6118777860084591,-0.7086845712616326,0.12608245364144482,0.8724505635080375,Downregulated
Feature1668,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,702862680.9835303,805764420.810668,1.1464037608073674,0.1971152475190807,0.5735554970930932,0.8929340317679025,Upregulated
Feature1667,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak3",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,18763897.616423935,13853096.49383624,0.7382845918808842,-0.43775104533532344,0.6286777600685537,0.9043347628664763,Downregulated
Feature1666,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,68878330.68443577,108855757.85672966,1.5804064467742316,0.6602956364638095,0.27778088815308694,0.8724505635080375,Upregulated
Feature1665,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak3,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,125498399.76561764,94931841.4556662,0.7564386608352145,-0.40270499499221396,0.3567752096329298,0.8724505635080375,Downregulated
Feature1664,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,673111269.6872003,315335840.823823,0.4684750575790565,-1.0939558565331442,0.17026597957744374,0.8724505635080375,Downregulated
Feature1663,NA,C32 H36 O10,580.23111,NA,NA,Feature1663,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,9263256.180983713,1416867.7527581267,0.15295569128993497,-2.708814306114772,0.4203256910367947,0.8724505635080375,Downregulated
Feature1662,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,36834172.804912634,9675188.497114023,0.26266881431971856,-1.9286831700039961,0.21508200359613744,0.8724505635080375,Downregulated
Feature1661,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,451595315.0617203,372017647.09377867,0.8237854439276775,-0.27965946049824214,0.7492312715154901,0.9373691092667948,Downregulated
Feature1660,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak2,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,610501933.558517,437829757.76239836,0.7171635890002175,-0.4796258516647512,0.1533255440691014,0.8724505635080375,Downregulated
Feature1659,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,367318130.9443934,736155650.0846953,2.004136436695902,1.0029807270183242,0.12075299191320565,0.8724505635080375,Upregulated
Feature1658,NA,C6 H11 N O7,209.05352,NA,NA,Feature1658,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,93944112.03684984,46240409.3880831,0.4922118947693621,-1.0226485725699175,0.4559941743907692,0.8724505635080375,Downregulated
Feature1657,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,58950613.74147489,117589971.27783504,1.9947200514912409,0.996186285963807,0.41817522007694335,0.8724505635080375,Upregulated
Feature1656,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,9345987.049863176,8738927.700227013,0.935045988572705,-0.09689077175429564,0.8206519051289733,0.9674212437637306,Downregulated
Feature1655,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,202168213.60857335,261223775.645943,1.2921110147993378,0.3697300279420446,0.19431958342346428,0.8724505635080375,Upregulated
Feature1654,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,36692232.2334362,25523270.3344583,0.6956041859780867,-0.5236614804262204,0.6966052374622171,0.9233562380758966,Downregulated
Feature1653,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,5065355.214374086,1377506.8293820736,0.27194673839913297,-1.878603971983984,0.4823636481196421,0.8724505635080375,Downregulated
Feature1652,L-Pyroglutamic acid,C5 H7 N O3,129.04257,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak2,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,12732712.355706757,23669530.265907865,1.8589542907014047,0.8944912966752829,0.1280785796875845,0.8724505635080375,Upregulated
Feature1651,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak10",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,4008170.840562449,790045.2507764497,0.19710867680120794,-2.3429368091069462,0.43479506802716733,0.8724505635080375,Downregulated
Feature1650,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14748,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak2",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,48190108.552782536,22440656.3587063,0.46566934652423725,-1.1026221774553064,0.49045423915414976,0.8724505635080375,Downregulated
Feature1649,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak3,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,3426594.12994495,7885662.480990906,2.3013120848127975,1.202456643136648,0.48102277477129857,0.8724505635080375,Upregulated
Feature1648,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak8,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3729893.9915680434,3837893.18137416,1.0289550292984906,0.04117993031175727,0.9526871408581694,0.9882637829765163,Upregulated
Feature1647,NA,C16 H29 N O12,427.16894,NA,NA,Feature1647,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,4509180.436277533,6730992.7347543035,1.4927308476284762,0.5779540584417076,0.32836259329511996,0.8724505635080375,Upregulated
Feature1646,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,5756985.322810133,6427951.993874253,1.1165482684844859,0.15904562034800554,0.4236416368380786,0.8724505635080375,Upregulated
Feature1645,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,55820765.85745163,14105151.6965009,0.2526864595967913,-1.984579736484935,0.2488485604144511,0.8724505635080375,Downregulated
Feature1644,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,278020535.3897773,257328770.13955733,0.9255746874193639,-0.11157868467046236,0.8969248923123272,0.983565624317811,Downregulated
Feature1643,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,180477041.91048867,54764180.27367083,0.30344125598441635,-1.7205108466202343,0.19070469767205797,0.8724505635080375,Downregulated
Feature1642,NA,C11 H15 N O7,273.08486,NA,NA,Feature1642,11,15,7,1,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,392613180.4534713,457734007.461678,1.1658651065483632,0.22140087484053259,0.321592833746034,0.8724505635080375,Upregulated
Feature1641,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,197106410.1424992,49802783.52274508,0.25266952752444666,-1.9846764121647935,0.28594629464515753,0.8724505635080375,Downregulated
Feature1640,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,30444561.575508267,50865984.68450387,1.6707740907467699,0.7405166764317703,0.3847509096236437,0.8724505635080375,Upregulated
Feature1639,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,12345950.77253987,14007648.85168343,1.1345945816372072,0.18217687941249908,0.90769757870242,0.983565624317811,Upregulated
Feature1638,NA,C12 H21 N O9,323.12168,NA,NA,Feature1638,12,21,9,1,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,2043832.3916883674,1188030.2360199154,0.5812757645153614,-0.7827053362270555,0.41879375737318464,0.8724505635080375,Downregulated
Feature1637,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,192950386.91660044,39665304.80576243,0.20557255903771313,-2.282280396417664,0.34438431129680913,0.8724505635080375,Downregulated
Feature1636,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,254885124.42493832,233977511.79523867,0.9179724094261265,-0.123477302231158,0.8853032351062797,0.9814814661453127,Downregulated
Feature1635,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,232184780.90601033,106635529.69944523,0.4592701092782299,-1.1225852033366295,0.1258217008738385,0.8724505635080375,Downregulated
Feature1634,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06332,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Υ-Aminobutyric acid (GABA),4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,186852083.8286128,304893886.67052865,1.6317392903693162,0.7064105704606524,0.2999809321283894,0.8724505635080375,Upregulated
Feature1633,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,214055686.65818787,218418832.46893233,1.0203832277425626,0.029111090360847233,0.9741674627386191,0.9914646531164122,Upregulated
Feature1632,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak7,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,170976164.77963647,280356313.58098465,1.639739164475489,0.7134663416446553,0.2955230311953238,0.8724505635080375,Upregulated
Feature1631,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,3408850.469715987,6535495.719057543,1.9172139632167724,0.9390113523667356,0.13528873282385864,0.8724505635080375,Upregulated
Feature1630,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,1391170.8703038492,883211.203368257,0.6348689598247214,-0.6554692518533204,0.48349984841722665,0.8724505635080375,Downregulated
Feature1629,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak9",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,9961279.19268912,1643257.1629113967,0.1649644720446579,-2.59977274631944,0.43559815808485147,0.8724505635080375,Downregulated
Feature1628,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,159707685.12582365,183908020.97611234,1.1515289375788196,0.2035506660824696,0.7362492586908808,0.9321421855174529,Upregulated
Feature1627,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,133982460.78758797,259567596.30248934,1.9373251900037909,0.954066138055256,0.34831567248744766,0.8724505635080375,Upregulated
Feature1626,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,220575313.36269468,210343047.486819,0.9536110105891558,-0.06852720133700821,0.9308805790792369,0.9874405343841273,Downregulated
Feature1625,NA,C9 H17 N O6,235.10555,NA,NA,Feature1625,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,158012533.7586524,213363303.202281,1.35029353765171,0.4332730660026109,0.4230573020264769,0.8724505635080375,Upregulated
Feature1624,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1624,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,1070897.4982396914,141650.53610618468,0.13227273043314183,-2.918412431033183,0.42133759711129326,0.8724505635080375,Downregulated
Feature1623,Homovanillic acid,C9 H10 O4,182.05795,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Other,Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Homovanillic acid,9,10,4,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,41781537.86946376,6011902.369580576,0.14388896809790253,-2.796972109345327,0.42148968363932254,0.8724505635080375,Downregulated
Feature1622,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,248375808.88971168,205999063.63635933,0.8293845707326142,-0.2698868862431897,0.5740097073355738,0.8929340317679025,Downregulated
Feature1621,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,115789016.10492107,171758107.92183214,1.4833713395249446,0.568879799835446,0.6854636771462634,0.9233562380758966,Upregulated
Feature1620,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,3970543.644128999,10385950.802335225,2.6157503186477493,1.3872248377626344,0.35711144339079903,0.8724505635080375,Upregulated
Feature1619,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,2396857.1928644003,1091923.546883103,0.45556470787405706,-1.1342721076025877,0.5937399589647235,0.9015409731649661,Downregulated
Feature1618,NA,C29 H30 O10,538.18407,NA,NA,Feature1618,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,4251650.876200356,515404.5621488307,0.12122457303207383,-3.0442459224943814,0.4161542641938953,0.8724505635080375,Downregulated
Feature1617,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,156021601.26385787,256434942.13375267,1.6435861448446458,0.7168470739924032,0.2863846181227745,0.8724505635080375,Upregulated
Feature1616,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak3,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,21196461.3968052,10413196.49513006,0.49127051445953007,-1.0254104422416446,0.21842718336147704,0.8724505635080375,Downregulated
Feature1615,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak1,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,221914088.00461334,195262578.470938,0.8799016782876746,-0.18458577133250778,0.7211549711736551,0.930298368021698,Downregulated
Feature1614,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,41698798.94546353,51532626.616391204,1.2358299979764167,0.30548029830315154,0.5573418829085723,0.8929340317679025,Upregulated
Feature1613,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,187936623.30709141,200242348.51802334,1.0654780584773207,0.09150088382742665,0.9022264168121138,0.983565624317811,Upregulated
Feature1612,Diethylpyrocarbonate,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Diethylpyrocarbonate,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,255086227.29531333,303127488.96114904,1.1883334203309155,0.24893968156734164,0.43952620076219384,0.8724505635080375,Upregulated
Feature1611,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak7",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,19034223.586797364,20101454.184735,1.0560690375980397,0.0787041499849192,0.8184717828019741,0.9668583758416175,Upregulated
Feature1610,Ectoine,C6 H10 N2 O2,142.07426,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak2,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,5366093.220552864,12752488.882231947,2.376494100659338,1.248834820339983,0.09273807657619716,0.8724505635080375,Upregulated
Feature1609,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak3,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1986298.6127753956,9317833.730707651,4.691053837916204,2.2299120583374137,0.12179294667176493,0.8724505635080375,Upregulated
Feature1608,NA,C9 H19 N O7,253.11617,NA,NA,Feature1608,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,79319437.48531982,132687650.89795099,1.6728264231892513,0.7422877553609263,0.2865824436390933,0.8724505635080375,Upregulated
Feature1607,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak8,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,17215777.956274837,12766121.217890702,0.7415361217084985,-0.4314111239330886,0.6774092999087851,0.9231420067493376,Downregulated
Feature1606,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,176402571.71120533,221378867.43232733,1.2549639457340465,0.32764591711798413,0.19016074271237682,0.8724505635080375,Upregulated
Feature1605,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak2,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,26775093.2137039,27248362.99541707,1.0176757473049969,0.025277961932058727,0.9280824069334569,0.9874405343841273,Upregulated
Feature1604,NA,C6 H14 O4,150.08923,NA,NA,Feature1604,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,112345402.36731066,107838685.87561767,0.959885172007677,-0.05906626372385878,0.844297610665924,0.975607198136477,Downregulated
Feature1603,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1603,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,1183803.7746856813,194796.052433844,0.16455096410345998,-2.603393615655693,0.43820847523556905,0.8724505635080375,Downregulated
Feature1602,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,1,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Lignin,26417951.3979068,22639340.8072209,0.8569680694096025,-0.22268664429826746,0.8270726765198247,0.9705323413271486,Downregulated
Feature1601,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1601,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,167414437.43749782,89606917.63422182,0.5352400844621031,-0.9017419305350635,0.3744610658944747,0.8724505635080375,Downregulated
Feature1600,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,235968830.31028768,169960677.349706,0.7202674909487659,-0.47339530472450003,0.2266185853043723,0.8724505635080375,Downregulated
Feature1599,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,3239048.7754440964,1066004.4311432326,0.32911033610386925,-1.603356758149714,0.28942612840977033,0.8724505635080375,Downregulated
Feature1598,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,83964781.755788,61285594.4287254,0.7298964297552141,-0.4542363307292184,0.5427202497759226,0.8890580920144323,Downregulated
Feature1597,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2425226.699377208,1885906.4594956401,0.7776206900492791,-0.3628614898397753,0.7215655348984676,0.930298368021698,Downregulated
Feature1596,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak4,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,16157445.75498287,21913281.336701244,1.3562342506979053,0.43960638432433863,0.8326820094524656,0.9709621554641522,Upregulated
Feature1595,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,2883218.3894478227,613454.76331016,0.21276735940479533,-2.232651250611769,0.4374359797522882,0.8724505635080375,Downregulated
Feature1594,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,25625375.3627178,14473217.6382873,0.5648002198377275,-0.8241874447365949,0.245268586105898,0.8724505635080375,Downregulated
Feature1593,NA,C6 H15 N O7,213.0849,NA,NA,Feature1593,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,4100806.09840329,5631534.150897114,1.3732749161414473,0.45762046776582094,0.37982606232440286,0.8724505635080375,Upregulated
Feature1592,NA,C6 H15 N O7,213.08492,NA,NA,Feature1592,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,3822012.379708877,4084238.8955533034,1.0686095412031085,0.0957348035993196,0.8492133224008577,0.9789760557739694,Upregulated
Feature1591,NA,C10 H20 O7,252.12091,NA,NA,Feature1591,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,5480303.733095056,7279241.670450437,1.3282551524456132,0.4095323091921745,0.48256369387814857,0.8724505635080375,Upregulated
Feature1590,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,150818316.00759223,112689238.86937754,0.7471853674835139,-0.4204618926043423,0.7323692377769174,0.930298368021698,Downregulated
Feature1589,NA,C12 H18 O9,306.09515,NA,NA,Feature1589,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,2255071.8560710666,2182146.010705593,0.9676614094716566,-0.04742576673430075,0.8693642230959547,0.9807974651872519,Downregulated
Feature1588,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,196208408.85130066,209999578.42722565,1.0702883717199747,0.09799955961589107,0.5448415225215273,0.8890580920144323,Upregulated
Feature1587,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,57348280.8873102,114007467.79137498,1.9879840516126457,0.9913061830814676,0.48480996088014405,0.8724505635080375,Upregulated
Feature1586,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,1190892.7651905427,481123.15671817464,0.4040020821196231,-1.307565366623376,0.4505511033910111,0.8724505635080375,Downregulated
Feature1585,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,403754758.03219366,165755633.63365632,0.41053543106590384,-1.2844213563989504,0.33367547566447586,0.8724505635080375,Downregulated
Feature1584,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,3831778.8908696403,557397.5432229443,0.14546704261853696,-2.7812357653732267,0.41416420792241526,0.8724505635080375,Downregulated
Feature1583,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak6",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,16699370.289871927,7119992.98834286,0.4263629624801538,-1.229845976131271,0.2211488562735216,0.8724505635080375,Downregulated
Feature1582,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,115213749.64487566,78313386.4963408,0.6797225742389847,-0.5569820579902253,0.6513005256597442,0.9089232543643583,Downregulated
Feature1581,Cytarabine,C9 H13 N3 O5,243.08555,Metabolic pathways;ABC transporters;Other,Other,Cytarabine,9,13,5,3,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,7084238.343228183,13237426.384602053,1.8685743961813055,0.9019380049095282,0.151983915112632,0.8724505635080375,Upregulated
Feature1580,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak2,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,149654678.7620286,159339515.0556036,1.0647145573642585,0.09046670568925805,0.8971660318363451,0.983565624317811,Upregulated
Feature1579,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,3187550.515604886,426334.43836469133,0.13374986099123448,-2.9023907027930984,0.41998935354058087,0.8724505635080375,Downregulated
Feature1578,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,4270748.297321083,2912899.237525587,0.6820582798927215,-0.5520330762832075,0.7117506850801165,0.9283104618560314,Downregulated
Feature1577,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,9419534.938851524,13420303.782913677,1.424731037151389,0.5106895908618426,0.6137584207423421,0.9043347628664763,Upregulated
Feature1576,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,13543650.599004459,12987374.522888834,0.9589271687091134,-0.06050684933351312,0.9095649828680026,0.983565624317811,Downregulated
Feature1575,NA,C9 H17 N O6,235.10557,NA,NA,Feature1575,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,83866277.1595889,27452837.950684834,0.32734060555048733,-1.6111355197190107,0.4686744709531571,0.8724505635080375,Downregulated
Feature1574,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,650628.4347356809,111825.48173416736,0.17187303192427592,-2.5405849012134283,0.4243440607926856,0.8724505635080375,Downregulated
Feature1573,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak2,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,7882171.127157353,10885955.740294587,1.3810859425251436,0.46580309873929693,0.18556746472847915,0.8724505635080375,Upregulated
Feature1572,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1572,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,53996831.173355244,17812929.026011236,0.32988841454090795,-1.5999499825737042,0.39676905273690916,0.8724505635080375,Downregulated
Feature1571,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,9422031.320761804,11911878.966745097,1.2642580523476736,0.33829096734798153,0.8141568075485598,0.9660274597293932,Upregulated
Feature1570,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak7,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,52007914.193190835,48143564.90046063,0.9256968991608561,-0.11138820556958555,0.8836808865948405,0.9814814661453127,Downregulated
Feature1569,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Adenine,5,5,0,5,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,5586511.398399807,9068914.831698343,1.6233592281394131,0.6989822847345247,0.6911393906300622,0.9233562380758966,Upregulated
Feature1568,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,96966338.53821209,79114917.0785369,0.8159008401390718,-0.2935342688333002,0.7892360632184263,0.9537107962810556,Downregulated
Feature1567,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak2",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,18309789.206448533,9348696.734305263,0.5105846183642978,-0.9697780184502095,0.5504581921039436,0.8906171704145945,Downregulated
Feature1566,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,113276360.96117489,47473411.981983334,0.4190937242259636,-1.2546551770835166,0.3264301925746388,0.8724505635080375,Downregulated
Feature1565,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,2509329.2541886475,559919.665476785,0.22313519222005257,-2.164010025781504,0.4093980937031127,0.8724505635080375,Downregulated
Feature1564,NA,C22 H33 N O6,407.23081,NA,NA,Feature1564,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,4013370.0664324085,578916.995329309,0.14424710050322465,-2.793385775196227,0.4283452234212207,0.8724505635080375,Downregulated
Feature1563,NA,C8 H19 N O6,225.12125,NA,NA,Feature1563,8,19,6,1,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,78156085.52313027,186750586.205461,2.3894567512620912,1.2566826552996462,0.06947939666055192,0.8724505635080375,Upregulated
Feature1562,NA,C15 H27 N O12,413.15342,NA,NA,Feature1562,15,27,12,1,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,7454811.058546803,4505681.203541493,0.6043991146329339,-0.7264265477459888,0.46604884631030047,0.8724505635080375,Downregulated
Feature1561,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,74312185.6302927,158314313.76470566,2.130395068075756,1.0911209937856088,0.14565233197710317,0.8724505635080375,Upregulated
Feature1560,NA,C21 H31 N O12,489.18471,NA,NA,Feature1560,21,31,12,1,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Lignin,3230622.4035278466,2303302.600084333,0.7129593967927425,-0.48810817770451004,0.36776310468267964,0.8724505635080375,Downregulated
Feature1559,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,7334566.02373676,9231633.930601686,1.2586476010612584,0.3318744106448866,0.6636313141245682,0.9124930569212812,Upregulated
Feature1558,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,9103432.08384998,19158387.33451117,2.1045235640851616,1.073493663443987,0.11312640295195335,0.8724505635080375,Upregulated
Feature1557,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,118229728.84181459,63580320.01962026,0.5377693126970419,-0.894940663371173,0.3972482088443063,0.8724505635080375,Downregulated
Feature1556,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10572,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,9274713.641156826,18125462.880740367,1.9542881410708002,0.9666431945565255,0.05352229273859484,0.8724505635080375,Upregulated
Feature1555,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,16934975.70414906,8526514.827849977,0.5034855069653855,-0.9899778446197518,0.5095729721778461,0.8772526573874708,Downregulated
Feature1554,NA,C10 H15 N O8,277.07983,NA,NA,Feature1554,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,124552562.66600114,59620222.8087439,0.47867519971163397,-1.062881033304069,0.4595158953811254,0.8724505635080375,Downregulated
Feature1553,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1553,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,120698910.81585556,118025625.293478,0.9778516185083388,-0.0323125310217568,0.9303415045963463,0.9874405343841273,Downregulated
Feature1552,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,70049581.70236744,120903918.59534776,1.7259763107373647,0.787412663464572,0.417078505751716,0.8724505635080375,Upregulated
Feature1551,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1300118.9408382643,529170.8318276727,0.40701724681165297,-1.296838166827125,0.5306974717234842,0.8826174436414305,Downregulated
Feature1550,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1550,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,41479392.41707305,8356962.859312869,0.2014726439404912,-2.3113441327130673,0.2189768372774141,0.8724505635080375,Downregulated
Feature1549,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,48030528.445389934,102925304.90821627,2.1429142722266934,1.0995741358253392,0.41530748655678507,0.8724505635080375,Upregulated
Feature1548,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,81737241.42609027,52886623.0147333,0.6470321495074589,-0.628090696761304,0.6876836126153542,0.9233562380758966,Downregulated
Feature1547,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,38928952.63994574,43760633.79052843,1.124115364604616,0.1687901026427087,0.8550979344590492,0.9789760557739694,Upregulated
Feature1546,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,2253659.722047144,398612.38985492865,0.1768733699925397,-2.4992112422899257,0.4387500867843444,0.8724505635080375,Downregulated
Feature1545,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,51667018.69811267,63190349.14080086,1.2230306824943458,0.2904605975915303,0.7976947173012439,0.9586929428349551,Upregulated
Feature1544,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,79448761.84981823,12037206.604907166,0.15150905218209773,-2.722524102191902,0.2775594056330402,0.8724505635080375,Downregulated
Feature1543,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,4641277.528976766,621960.808966728,0.1340063818816385,-2.8996263860718554,0.4172781524042184,0.8724505635080375,Downregulated
Feature1542,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak3,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,11549032.879507385,7544975.621670294,0.6532993455285858,-0.6141839004309261,0.6841431036741039,0.9233562380758966,Downregulated
Feature1541,NA,C10 H17 N O9,295.09039,NA,NA,Feature1541,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,119603018.31279816,71434399.27906293,0.5972625129931112,-0.7435629205983837,0.6268848699529114,0.9043347628664763,Downregulated
Feature1540,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,37112816.99421497,45177776.09498433,1.2173092681707913,0.28369574403649245,0.45901194017794206,0.8724505635080375,Upregulated
Feature1539,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak3,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,8431120.40364383,2738194.528638209,0.3247723194007281,-1.6224994191533169,0.2765075211371076,0.8724505635080375,Downregulated
Feature1538,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak2,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,36674817.57269443,28125065.462135233,0.766876765136938,-0.3829333354254285,0.7792144803902998,0.9502143902366301,Downregulated
Feature1537,triacetic acid,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,triacetic acid,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,18532049.46303202,8520185.077478437,0.45975406521953316,-1.1210657636517123,0.2660616921609053,0.8724505635080375,Downregulated
Feature1536,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,67680987.10317104,32759374.561021067,0.4840262526177932,-1.0468427963660818,0.2542366860611494,0.8724505635080375,Downregulated
Feature1535,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,142521777.569198,147433517.37231335,1.0344630826733168,0.04888216004134287,0.7734664503197042,0.9502143902366301,Upregulated
Feature1534,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,20959904.3561873,23006873.114275333,1.0976611688346647,0.13443278523442878,0.3881418845765388,0.8724505635080375,Upregulated
Feature1533,NA,C12 H25 N O12,375.13771,NA,NA,Feature1533,12,25,12,1,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,3006034.199850848,2941218.56345498,0.9784381573572636,-0.03144742737052099,0.9587799395849961,0.9882637829765163,Downregulated
Feature1532,NA,C7 H15 N O5,193.09509,NA,NA,Feature1532,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,64171572.7432186,125641100.66626966,1.9578934299930637,0.9693022398114934,0.07493741341122001,0.8724505635080375,Upregulated
Feature1531,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,22635378.425933566,17461008.7093844,0.771403436727135,-0.3744425214665137,0.26711339875536094,0.8724505635080375,Downregulated
Feature1530,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,49678282.21114664,72252305.5420932,1.4544042653286728,0.540428335639914,0.633841122521088,0.9043690984397965,Upregulated
Feature1529,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,11746134.775338184,16686461.147064142,1.4205916640849816,0.5064919248426387,0.7118692892504781,0.9283104618560314,Upregulated
Feature1528,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07427,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak2",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,125125528.4171191,145979542.85616633,1.1666647462181192,0.22239004651598274,0.3163776340241531,0.8724505635080375,Upregulated
Feature1527,NA,C6 H14 O4,150.08924,NA,NA,Feature1527,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,100314941.3970299,81808888.17050527,0.8155204701433185,-0.29420700482499174,0.7263441499000075,0.930298368021698,Downregulated
Feature1526,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,94957795.53058687,81693539.65621983,0.8603141974784525,-0.21706444860733126,0.8428964426201306,0.9753186979497959,Downregulated
Feature1525,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Lactamide,3,7,2,1,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,111377189.5016498,120401448.19511066,1.0810242989057215,0.11239895185775553,0.6885355567276472,0.9233562380758966,Upregulated
Feature1524,cis-acetylacrylic acid,C5 H6 O3,114.03168,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak2,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,4563638.85716658,5505115.81205289,1.2062996184301147,0.27058828562698867,0.3814687539074523,0.8724505635080375,Upregulated
Feature1523,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,8272228.161768146,10443975.559533529,1.2625347554849338,0.3363231034094576,0.5533167814906627,0.8929340317679025,Upregulated
Feature1522,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,87279013.959909,111886718.70409927,1.2819429737771055,0.35833208623213475,0.6171867209888313,0.9043347628664763,Upregulated
Feature1521,NA,C8 H9 N,119.07346,NA,NA,Feature1521,8,9,0,1,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,83905946.88042253,72555652.2041702,0.8647259807170992,-0.20968505912129468,0.8285985600603338,0.9707095164192293,Downregulated
Feature1520,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,67116827.68299267,102310621.66024727,1.5243661715282868,0.6082094975779219,0.5274715828456521,0.8826174436414305,Upregulated
Feature1519,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,20126826.768466,19756547.270127866,0.9816026886603767,-0.026788894265028684,0.9596620002358425,0.9882637829765163,Downregulated
Feature1518,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,37078251.19747037,47833222.0991544,1.29006143910093,0.3674397755520238,0.357557146228647,0.8724505635080375,Upregulated
Feature1517,NA,C17 H31 N O12,441.1847,NA,NA,Feature1517,17,31,12,1,0,0,1.8235294117647056,0.7058823529411765,-0.23529411764705888,67.00588235294117,3,-9,-2.5,-0.4,-10,Carbohydrate,1736059.21131225,636085.7907235144,0.36639636861389696,-1.4485228900569933,0.25640752144448137,0.8724505635080375,Downregulated
Feature1516,fructosylglycine,C8 H15 N O7,237.08487,NA,NA,fructosylglycine-peak2,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,23398685.3776976,22304664.5507376,0.9532443464536362,-0.0690820253141408,0.7353308693223695,0.9316757611309602,Downregulated
Feature1515,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,77342500.64029007,58390072.718405135,0.7549545493747324,-0.40553830258930235,0.7088560200452281,0.9283104618560314,Downregulated
Feature1514,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,100918479.16582164,61510531.8256758,0.6095071223240129,-0.7142850154996319,0.3014914178804117,0.8724505635080375,Downregulated
Feature1513,3-Butynoic acid,C4 H4 O2,84.0211,Metabolic pathways;Other,NA,3-Butynoic acid-peak6,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,10307663.678981753,7374201.801694304,0.7154096244652375,-0.4831585677271765,0.7296396597785879,0.930298368021698,Downregulated
Feature1512,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,29224899.17011242,6204845.73174504,0.21231367457002492,-2.235730800426806,0.38971400907453135,0.8724505635080375,Downregulated
Feature1511,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Hordenine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,608653.3995923854,324729.1399981187,0.5335206214498917,-0.9063840602227886,0.34815035607506056,0.8724505635080375,Downregulated
Feature1510,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak3,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,4672840.28633043,4940377.623629874,1.0572536874590122,0.08032159216577169,0.8540839005671342,0.9789760557739694,Upregulated
Feature1509,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak5,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,41871705.95002428,13793849.778150197,0.3294312821792779,-1.6019505376916927,0.3052134055614699,0.8724505635080375,Downregulated
Feature1508,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,85774864.01008417,90871408.19680156,1.0594176889177955,0.08327150238389242,0.930325550350628,0.9874405343841273,Upregulated
Feature1507,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,24276630.36270737,27662213.0372142,1.139458509023872,0.18834839286533853,0.7796918550347791,0.9502143902366301,Upregulated
Feature1506,Thymidine,C10 H14 N2 O5,242.09029,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,5,2,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,36305577.07974527,24849610.772344254,0.6844571212230571,-0.5469679302288755,0.5473952715295471,0.8890580920144323,Downregulated
Feature1505,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,31591050.795431066,23006597.883221865,0.72826314110923,-0.4574682656455726,0.49895733059943465,0.8747804400244787,Downregulated
Feature1504,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,9415227.533356253,1024305.4568522583,0.10879242729114624,-3.200349956403268,0.3880526824571813,0.8724505635080375,Downregulated
Feature1503,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,82269577.73479724,39804902.619606666,0.48383501794455597,-1.0474129055887709,0.3341405144747984,0.8724505635080375,Downregulated
Feature1502,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,769937.8133805563,519246.55410665,0.6744006400033798,-0.5683221894951723,0.7129468186981682,0.9283104618560314,Downregulated
Feature1501,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,10418374.743311353,18293241.3416074,1.7558632504894056,0.8121804897917624,0.4541992873741452,0.8724505635080375,Upregulated
Feature1500,pseudouridine,C9 H12 N2 O6,244.06948,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak2,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,10075329.21361157,12243249.015751967,1.2151711131395668,0.2811594798360813,0.384713180415148,0.8724505635080375,Upregulated
Feature1499,NA,C18 H31 N O11,437.18971,NA,NA,Feature1499,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,1680967.7755278167,1060891.6444589538,0.6311195609480605,-0.6640147558485698,0.18357467710474054,0.8724505635080375,Downregulated
Feature1498,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,58115912.3440734,97069752.67399266,1.6702783929346974,0.7400885833180004,0.04291554781793305,0.8724505635080375,Upregulated
Feature1497,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,6958207.380241867,7180439.773842414,1.0319381676136279,0.04535652894947734,0.9558042012386441,0.9882637829765163,Upregulated
Feature1496,2908,C5 H11 N,85.08916,Other,NA,2908-peak2,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,71363590.5539501,60603522.5164211,0.8492218797568137,-0.23578655288334494,0.7883356874303213,0.9537107962810556,Downregulated
Feature1495,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak2,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,114581231.52287634,116389289.39710633,1.015779703623355,0.022587552748713158,0.8773941264765351,0.9807974651872519,Upregulated
Feature1494,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,60034644.31887669,27754152.855062198,0.4623022784584977,-1.1130916219681148,0.36503190400495955,0.8724505635080375,Downregulated
Feature1493,NA,C17 H31 N O13,457.17959,NA,NA,Feature1493,17,31,13,1,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,2261797.95981734,2008072.7621016977,0.8878214578741008,-0.17165851711594618,0.8698837910442545,0.9807974651872519,Downregulated
Feature1492,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak5,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,89972938.3310516,85056894.68341863,0.9453608636238532,-0.08106295414307703,0.8981714131557985,0.983565624317811,Downregulated
Feature1491,NA,C75 H89 N10 O16 P3 S,1510.53954,NA,NA,Feature1491,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,627995.8862383753,1155446.3820483757,1.8398948263329709,0.879623300051563,0.3494337748960803,0.8724505635080375,Upregulated
Feature1490,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,35983178.4074644,11052543.547908701,0.30715862347546113,-1.702944207367263,0.1870219568552944,0.8724505635080375,Downregulated
Feature1489,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,20060749.088976867,14627776.31780337,0.729173983131126,-0.4556650078346545,0.5635493019868076,0.8929340317679025,Downregulated
Feature1488,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,3325160.8590891333,696478.5929955479,0.20945711275644432,-2.255273218731547,0.45830117333089515,0.8724505635080375,Downregulated
Feature1487,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak1,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,77249847.93946284,111326893.13200366,1.4411276669339912,0.5271981469588973,0.3239127261060313,0.8724505635080375,Upregulated
Feature1486,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak3,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,31503809.92124667,12250563.2308013,0.3888597366929682,-1.3626782318831432,0.00682032033217491,0.8724505635080375,Downregulated
Feature1485,Isoferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Isoferulic acid,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,11940874.79470185,2212858.5048727333,0.1853179555868533,-2.4319254230142535,0.12814251345091948,0.8724505635080375,Downregulated
Feature1484,NA,C11 H19 N5 O2,253.15388,NA,NA,Feature1484,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,1394993.3135270735,1438301.9438999416,1.031045761978147,0.04410836676400603,0.9417300181925627,0.9882637829765163,Upregulated
Feature1483,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak3,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,5315387.024040573,6703942.565468883,1.2612331962184717,0.3348350480085207,0.6336416328174534,0.9043690984397965,Upregulated
Feature1482,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak3,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,14213457.746560333,16570294.6366642,1.165817279097637,0.2213416897418971,0.6347667402862562,0.9043690984397965,Upregulated
Feature1481,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak4,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,51524775.45008433,34126637.208101,0.6623345159681845,-0.5943680521196149,0.5684890313126499,0.8929340317679025,Downregulated
Feature1480,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,29332667.85570057,27072196.347228736,0.9229367229877615,-0.11569635553322744,0.8760630259251115,0.9807974651872519,Downregulated
Feature1479,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,68373583.1978063,41119251.569740735,0.6013909122004302,-0.7336250278108856,0.404040710360217,0.8724505635080375,Downregulated
Feature1478,NA,C2 H5 N2 O5 P S,199.96575,NA,NA,Feature1478,2,5,5,2,1,1,2.5,2.5,4,-53.7,2,-3,1,1,-7,Other,66969188.787663534,65764623.664439,0.9820131444768758,-0.026185759405756508,0.9083366796777739,0.983565624317811,Downregulated
Feature1477,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature1477,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1559266.52478309,734609.0563064041,0.4711247529722962,-1.0858189614545872,0.04084324697753125,0.8724505635080375,Downregulated
Feature1476,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,54611729.245900035,79901736.73003283,1.4630874691819329,0.5490160220962356,0.3146295621321692,0.8724505635080375,Upregulated
Feature1475,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,21567856.745899227,37532639.3703438,1.7402118259840542,0.7992629277386518,0.308159562661752,0.8724505635080375,Upregulated
Feature1474,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak4,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,40620682.542799965,38451208.7033885,0.9465918910366511,-0.079185531580702,0.8592160387461897,0.9789760557739694,Downregulated
Feature1473,NA,C43 H79 N O9,753.57577,NA,NA,Feature1473,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,51710300.74457987,13725434.964043848,0.26542941670055,-1.9135998260021354,0.23969445473782458,0.8724505635080375,Downregulated
Feature1472,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature1472,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,1011156.7095322377,114050.31918719853,0.11279193236027514,-3.1482642147399096,0.41564359382523747,0.8724505635080375,Downregulated
Feature1471,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature1471,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,1627440.2291273107,993056.6985206266,0.6101954964288536,-0.7126565627973022,0.6590688379113658,0.9098405617363219,Downregulated
Feature1470,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak6,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,44510031.782570906,30081375.805600148,0.6758336177459059,-0.5652599791459001,0.5943886190497103,0.9015409731649661,Downregulated
Feature1469,arg-leu,C12 H25 N5 O3,287.19576,NA,NA,arg-leu-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,16766453.238398429,16759958.6013534,0.9996126409710698,-5.589492140839209e-4,0.9993969697814021,0.9994192874260379,Downregulated
Feature1468,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11167,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,1910566.4615663034,3956097.30522976,2.07064102966955,1.050077466835238,0.3086054765207132,0.8724505635080375,Upregulated
Feature1467,NA,C16 H29 N O13,443.16396,NA,NA,Feature1467,16,29,13,1,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,1322893.54370124,833520.312032824,0.6300736109882057,-0.6664077075385026,0.2917037343188744,0.8724505635080375,Downregulated
Feature1466,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,78650730.4548972,65902006.729294896,0.8379071160322771,-0.25513776822601003,0.7135428686869175,0.9283729796894303,Downregulated
Feature1465,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,4289122.024692441,538105.818295371,0.1254582674956553,-2.9947205497522877,0.42005393820169473,0.8724505635080375,Downregulated
Feature1464,NA,C12 H18 N6,246.15928,NA,NA,Feature1464,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,1816623.8326184293,544985.0594115023,0.2999988493082668,-1.7369711278343423,0.3236888320946952,0.8724505635080375,Downregulated
Feature1463,NA,C11 H23 N O7,281.14745,NA,NA,Feature1463,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,16957469.628763046,27613516.222396467,1.6283983888468105,0.7034536991747746,0.3662990236181006,0.8724505635080375,Upregulated
Feature1462,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,NA,4-Guanidinobutyric acid,5,11,2,3,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,14110571.027894856,8614179.806357693,0.6104770522276188,-0.7119910294202098,0.574029020422223,0.8929340317679025,Downregulated
Feature1461,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,63485453.64447493,61330285.6896102,0.9660525706103654,-0.04982639516874367,0.9466336490519226,0.9882637829765163,Downregulated
Feature1460,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak4,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,86357081.38243917,86235709.1384239,0.998594530499731,-0.002029090124548032,0.9947632959321444,0.9974974389355906,Downregulated
Feature1459,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,80207400.55760176,72228973.34101756,0.9005275428312327,-0.15115769293864326,0.7259777757336667,0.930298368021698,Downregulated
Feature1458,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,2005507.9688565384,319122.42143676564,0.15912298848591294,-2.651785818119664,0.4154323620297732,0.8724505635080375,Downregulated
Feature1457,NA,C18 H31 N O14,485.17458,NA,NA,Feature1457,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,1362230.3499550328,461843.8302971543,0.339035046688249,-1.5604936797265738,0.3601982461172199,0.8724505635080375,Downregulated
Feature1456,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,17262362.034758024,3426244.68682124,0.1984806412889757,-2.3329297932035384,0.33351260960297685,0.8724505635080375,Downregulated
Feature1455,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,6358968.565556323,2133079.86292175,0.33544431631187577,-1.5758547956693798,0.22010184098767788,0.8724505635080375,Downregulated
Feature1454,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04228,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak5",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,7277513.6436204435,8424555.843073526,1.1576145721772153,0.21115498789751513,0.5951584237139851,0.9015409731649661,Upregulated
Feature1453,NA,C6 H14 O4,150.08923,NA,NA,Feature1453,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,80343499.3552002,34943649.1658175,0.4349281453541242,-1.2011510224409645,0.4914148254973022,0.8724505635080375,Downregulated
Feature1452,NA,C9 H15 N O7,249.08484,NA,NA,Feature1452,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,42160363.320021465,33636988.84886073,0.7978344160257015,-0.3258387368688032,0.6993801493384775,0.9263095957618301,Downregulated
Feature1451,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,32584575.763132367,32882967.629490435,1.0091574574586202,0.013151293742394035,0.9705894462727105,0.9898726803046187,Upregulated
Feature1450,Furan,C4 H4 O,68.02623,Other,NA,Furan-peak3,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,36630190.1626603,27606324.0946553,0.753649488907004,-0.408034391273605,0.7116137489640498,0.9283104618560314,Downregulated
Feature1449,NA,C23 H35 N O6,421.24649,NA,NA,Feature1449,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,19211569.32332341,2292021.078900623,0.11930420885075964,-3.0672831551148163,0.4195177145571525,0.8724505635080375,Downregulated
Feature1448,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,7772948.583523043,8569555.759770934,1.1024845549520967,0.14075844476229993,0.8470253359488864,0.9780919693915566,Upregulated
Feature1447,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature1447,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,17365591.067188766,23533191.669380467,1.3551621467031438,0.43846548202126695,0.02552659138872945,0.8724505635080375,Upregulated
Feature1446,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak4,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,55614275.872374594,61706116.18764207,1.109537348454329,0.14995823132308034,0.8524811345373966,0.9789760557739694,Upregulated
Feature1445,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,70980240.05135994,74615104.31732143,1.0512095234297796,0.07205025092383056,0.6675833333520506,0.914956445548846,Upregulated
Feature1444,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak3,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,27138014.4034242,61666212.20703024,2.2723185009161675,1.1841650652509317,0.17430105382150723,0.8724505635080375,Upregulated
Feature1443,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,11585594.73589405,15642883.549098266,1.3502011684073565,0.4331743724924829,0.04523979995369543,0.8724505635080375,Upregulated
Feature1442,3-Butynoic acid,C4 H4 O2,84.02112,Metabolic pathways;Other,NA,3-Butynoic acid-peak5,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,13681149.056447104,3563335.696121127,0.260455878480612,-1.9408890958516558,0.4290044500259932,0.8724505635080375,Downregulated
Feature1441,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,19172952.182007052,45941631.807055645,2.396168903512407,1.2607296058192239,0.40625226237153494,0.8724505635080375,Upregulated
Feature1440,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,44045004.10235799,2984945.7310464336,0.06777035879278376,-3.8832017803234624,0.2239401689448822,0.8724505635080375,Downregulated
Feature1439,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature1439,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,3250674.1813857234,3886351.250877803,1.1955523789902247,0.2576773381248805,0.5781006869647165,0.895976728013019,Upregulated
Feature1438,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak2",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,78841666.87127073,32292628.993125066,0.40958835948827765,-1.2877533803970367,0.009737525859349842,0.8724505635080375,Downregulated
Feature1437,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,66584377.45344763,49669390.53865633,0.7459616270105193,-0.4228266761300436,0.46024123637949105,0.8724505635080375,Downregulated
Feature1436,Veronal,C8 H12 N2 O3,184.08481,NA,NA,Veronal-peak2,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,77907145.37545106,79520706.5387706,1.0207113372662218,0.02957492187051258,0.9035162406935611,0.983565624317811,Upregulated
Feature1435,NA,C22 H46 O6,406.32947,NA,NA,Feature1435,22,46,6,0,0,0,2.090909090909091,0.2727272727272727,-1.545454545454546,104.34545454545454,0,-6,-0.375,-0.15789473684210523,-6,Lipid,11982304.023574814,2509797.788572132,0.20945869706144848,-2.255262306424495,0.2870447406001077,0.8724505635080375,Downregulated
Feature1434,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,20599008.89262696,66458261.04691493,3.2262844000568616,1.689873619047446,0.016379213110374498,0.8724505635080375,Upregulated
Feature1433,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature1433,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,494377.40697256866,709983.8911410486,1.4361171872493017,0.5221734779669248,0.44063475513301925,0.8724505635080375,Upregulated
Feature1432,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,48689205.60657346,57597171.4251924,1.182955661478615,0.242396000842803,0.7235848313320317,0.930298368021698,Upregulated
Feature1431,NA,C15 H18 O11,374.08496,NA,NA,Feature1431,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,624955.7909839479,104993.7787266861,0.1680019294826934,-2.573450292602802,0.4170443616137163,0.8724505635080375,Downregulated
Feature1430,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,53132043.3143314,63963017.879130505,1.2038501418197416,0.26765581310304254,0.6860070645293679,0.9233562380758966,Upregulated
Feature1429,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,58919696.5235876,60567025.33635647,1.0279588814940583,0.03978255767281381,0.9533708508179257,0.9882637829765163,Upregulated
Feature1428,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak3,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,69202834.86146104,63229356.29212763,0.9136815914941653,-0.13023660619618724,0.7454966700509875,0.9351636436381646,Downregulated
Feature1427,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10574,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,2656010.163904223,3182423.1541707064,1.1981969035437268,0.26086501031666254,0.6722431397401436,0.9205981234598247,Upregulated
Feature1426,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04716,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Inosine-5'-monophosphate (IMP),10,13,8,4,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Tannin,478629.56803885003,112534.06779489534,0.235117249976836,-2.0885477050113357,0.4337288017499541,0.8724505635080375,Downregulated
Feature1425,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.111,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak3,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,10313485.221200656,18202786.2558828,1.7649500499079303,0.8196273541651014,0.04532908033732086,0.8724505635080375,Upregulated
Feature1424,NA,C10 H21 N O9,299.12162,NA,NA,Feature1424,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,17188508.52607315,16575122.197722066,0.964314162137998,-0.05242485888817638,0.9402818796204606,0.9882637829765163,Downregulated
Feature1423,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature1423,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,855925.8449627867,457736.960665257,0.5347857683689388,-0.9029670217088064,0.43165502759490604,0.8724505635080375,Downregulated
Feature1422,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak4,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,5459789.055033838,891577.291758452,0.16329885326548138,-2.614413434998238,0.3995028739392719,0.8724505635080375,Downregulated
Feature1421,NA,C16 H27 N O14,457.14329,NA,NA,Feature1421,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,8574122.023436591,4373137.5672451435,0.5100391101609664,-0.9713202166818532,0.285493645834381,0.8724505635080375,Downregulated
Feature1420,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak2,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,70736364.987432,80480038.9495626,1.137746319928396,0.1861789198770631,0.37511291039757294,0.8724505635080375,Upregulated
Feature1419,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10 H15 N3 O3,225.11134,Other,NA,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",10,15,3,3,0,0,1.5,0.3,0,60.3,5,2,-0.25,0.09090909090909093,-1,Lipid,77608184.10720317,77112940.93860413,0.9936186734131681,-0.0092358080163413,0.9608444218195529,0.9882637829765163,Downregulated
Feature1418,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak4",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,21553468.2438594,7198525.46655335,0.3339845534420761,-1.5821467143072956,0.41461297665393665,0.8724505635080375,Downregulated
Feature1417,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak3,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,21035804.0200085,20268736.829307433,0.9635351617665072,-0.05359077991741086,0.9104078506082218,0.983565624317811,Downregulated
Feature1416,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak2,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,31020275.6778579,18777183.443163075,0.6053196831053995,-0.7242308311399984,0.40592472773426463,0.8724505635080375,Downregulated
Feature1415,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,80612480.4007358,48353467.468742765,0.5998260719478049,-0.7373838633570459,0.664560193251541,0.9130291706148503,Downregulated
Feature1414,NA,C14 H25 N O12,399.13775,NA,NA,Feature1414,14,25,12,1,0,0,1.7857142857142858,0.8571428571428571,0.1428571428571428,56.22857142857143,3,-9,-10,-0.5714285714285714,-10,Carbohydrate,6594752.180620583,2664912.4594703466,0.40409592149671525,-1.3072303042819926,0.02024382029810207,0.8724505635080375,Downregulated
Feature1413,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,44297041.54398782,28489473.923494134,0.6431461996215602,-0.636781367452468,0.5738852693181898,0.8929340317679025,Downregulated
Feature1412,NA,C23 H41 N,331.32396,NA,NA,Feature1412,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,645917367.9299812,80241645.0929891,0.1242289634510764,-3.0089265239391967,0.42079449564692967,0.8724505635080375,Downregulated
Feature1411,NA,C21 H31 N O13,505.17965,NA,NA,Feature1411,21,31,13,1,0,0,1.4761904761904765,0.6190476190476191,-0.0952380952380949,63.014285714285705,7,-6,-1,-0.03703703703703703,-7,Lignin,1122921.1730418166,453499.002277666,0.403856488919172,-1.308085374946818,0.3753230207006433,0.8724505635080375,Downregulated
Feature1410,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak3,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,29185482.5335071,27494566.955748267,0.942063127590317,-0.08610435690705485,0.8598220108864754,0.9789760557739694,Downregulated
Feature1409,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,4606188.546413187,17152196.09818478,3.7237286153952813,1.8967479333988024,0.15620928331224365,0.8724505635080375,Upregulated
Feature1408,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,18233775.46466988,57727442.406315766,3.165962118935247,1.6626439935827337,0.01192803360588303,0.8724505635080375,Upregulated
Feature1407,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,NA,4-guanidinobutanal,5,11,1,3,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,9033134.161625756,9292611.150810916,1.0287250232911918,0.040857403466955426,0.9696310363670433,0.9898726803046187,Upregulated
Feature1406,NA,C9 H15 N O7,249.08488,NA,NA,Feature1406,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,8498319.807983037,7387740.229593997,0.8693177470979853,-0.20204449739375546,0.5393961601904904,0.8890580920144323,Downregulated
Feature1405,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,49172712.893907495,24503059.546141416,0.4983060340601494,-1.0048960509563307,0.4269690347397484,0.8724505635080375,Downregulated
Feature1404,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,13686473.234748447,6688234.039672207,0.488674761200827,-1.0330534998805925,0.5597215586165406,0.8929340317679025,Downregulated
Feature1403,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak2",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,67810060.51342574,73080020.52020264,1.0777164917251991,0.10797770705511822,0.5643078711575245,0.8929340317679025,Upregulated
Feature1402,NP-016455,C11 H18 N2 O4,242.12665,NA,NA,NP-016455-peak3,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,3850409.897954461,5761649.670596964,1.496373067620113,0.5814699049758711,0.5908070656728028,0.9015409731649661,Upregulated
Feature1401,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak3,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,2444773.7605108134,2935590.2272690944,1.200761507950629,0.26394963525343984,0.8543195017634583,0.9789760557739694,Upregulated
Feature1400,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,67017004.87854747,73255639.91833864,1.0930903291052358,0.12841262513382642,0.5118857790412427,0.8780428973934686,Upregulated
Feature1399,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,28684079.491458,27790764.49776393,0.968856766208583,-0.04564469855002642,0.8784721891673335,0.9807974651872519,Downregulated
Feature1398,2908,C5 H11 N,85.08916,Other,NA,2908-peak1,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,40718036.058811866,42930523.63383937,1.0543367949237987,0.07633579178720117,0.9342024648329754,0.9882637829765163,Upregulated
Feature1397,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak4,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,34594607.791810304,25594449.890937567,0.7398392849245317,-0.43471618634077525,0.6962686591264999,0.9233562380758966,Downregulated
Feature1396,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature1396,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,45668420.907666706,68989422.93870267,1.510659260108573,0.5951782871158959,0.03992918457848315,0.8724505635080375,Upregulated
Feature1395,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak3,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,76572247.4708387,10916549.0641279,0.14256534742937108,-2.810304738400655,0.28669794455205433,0.8724505635080375,Downregulated
Feature1394,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,2439818.47121382,283183.57526999933,0.11606747740093726,-3.106964315322893,0.42158132346440036,0.8724505635080375,Downregulated
Feature1393,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak6,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,21312070.407546766,15236643.881292334,0.7149302526654999,-0.48412559291493024,0.23538062559829653,0.8724505635080375,Downregulated
Feature1392,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,4900492.47096265,5232236.251707407,1.067696008658409,0.09450094550037136,0.8773338400683086,0.9807974651872519,Upregulated
Feature1391,3-Buten-1-amine,C4 H9 N,71.07352,NA,NA,3-Buten-1-amine-peak2,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,43126559.41329507,45948640.4849616,1.0654371948529828,0.09144555197122066,0.9041307628454215,0.983565624317811,Upregulated
Feature1390,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak4,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,6116752.212204463,6204752.044683883,1.0143866923861715,0.020607724175910745,0.8823228880337074,0.9813886883316483,Upregulated
Feature1389,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,42112104.916309,51477665.6436828,1.2223959297685627,0.2897116447293572,0.6549365002720827,0.9089232543643583,Upregulated
Feature1388,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak4,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,17318880.47765296,17630589.3131854,1.0179982092915676,0.025735023644995955,0.9751128787306921,0.991501330474065,Upregulated
Feature1387,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,31223965.67987797,2737461.1369672013,0.08767179560190638,-3.5117433937374383,0.42076478738894174,0.8724505635080375,Downregulated
Feature1386,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,2738944.281021968,4731951.190560507,1.7276551492295777,0.7888152752869523,0.5016869822920258,0.8747804400244787,Upregulated
Feature1385,Ne-Acetyllysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,14828016.976517597,16339646.4460444,1.1019441420872862,0.1400510950741378,0.7027945162529672,0.9272348854064458,Upregulated
Feature1384,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak2,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,28497025.499640968,24292943.019796565,0.8524729368720476,-0.23027406070390838,0.6943876890217923,0.9233562380758966,Downregulated
Feature1383,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,2,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Tannin,5237506.374456679,1363918.6825380726,0.2604137513206484,-1.9411224619049692,0.17326012542792196,0.8724505635080375,Downregulated
Feature1382,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak7,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,24023120.939805802,19229826.2056416,0.8004716062423924,-0.32107786548724004,0.6530986132540708,0.9089232543643583,Downregulated
Feature1381,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,8759646.40440786,976114.284879919,0.11143306930616943,-3.1657506589403512,0.4023031058018021,0.8724505635080375,Downregulated
Feature1380,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,15892406.514899934,25518434.72217539,1.605699847801563,0.6832022362185687,0.3835302770306703,0.8724505635080375,Upregulated
Feature1379,NA,C5 H13 O6 P,200.04503,NA,NA,Feature1379,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,25445628.9821568,66325176.75854237,2.6065449906957094,1.3821387620223224,0.06877139884816362,0.8724505635080375,Upregulated
Feature1378,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,16954524.9956155,20776107.11257057,1.2254018981919779,0.29325499121654625,0.21372954816563441,0.8724505635080375,Upregulated
Feature1377,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,15499527.719832946,2123450.24940178,0.1370009646606617,-2.867742043261757,0.41293349532861134,0.8724505635080375,Downregulated
Feature1376,Acetonedicarboxylic Acid,C5 H6 O5,146.02149,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Acetonedicarboxylic Acid,5,6,5,0,0,0,1.2,1,0.7999999999999998,37.5,3,-2,-Inf,0.2,-2,Tannin,9882090.400729217,4561157.2168901935,0.461557932778435,-1.1154163547374973,0.41895063702067337,0.8724505635080375,Downregulated
Feature1375,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak6",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,12958046.24991978,12822769.31244715,0.9895603909058847,-0.015140340113991377,0.9856974206978966,0.9951332564369114,Downregulated
Feature1374,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,3491024.11307342,557826.459526765,0.15978877299580355,-2.6457620490262475,0.4229880296116578,0.8724505635080375,Downregulated
Feature1373,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733-peak2,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,1525797.8244329002,229248.362298873,0.1502481905714335,-2.7345804781228713,0.40029233915998597,0.8724505635080375,Downregulated
Feature1372,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak6,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,30111847.586138565,33751052.41245247,1.120856244901729,0.1646012575666332,0.6499628524586558,0.9089232543643583,Upregulated
Feature1371,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak2,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,65079189.1698355,57708372.1389106,0.8867407980193258,-0.17341564093723666,0.4112821358012697,0.8724505635080375,Downregulated
Feature1370,NA,C16 H28 N2 O13,456.15926,NA,NA,Feature1370,16,28,13,2,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,3633803.344507277,1655909.067319666,0.45569583995861446,-1.1338568946103251,0.17608610074425957,0.8724505635080375,Downregulated
Feature1369,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,45720582.2391375,34843338.2534967,0.7620930562793726,-0.3919609244181732,0.7653483930420468,0.9486064407934096,Downregulated
Feature1368,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,16366303.675310733,15777744.2824786,0.9640383433847681,-0.05283756595189316,0.7803785470546329,0.9503675475992438,Downregulated
Feature1367,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak2,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,6962284.219661233,6673639.265109289,0.9585416300965104,-0.06108700443414952,0.9279001726181844,0.9874405343841273,Downregulated
Feature1366,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,15510360.056423353,4042693.02995659,0.2606446926602698,-1.9398436113227617,0.4545619002597511,0.8724505635080375,Downregulated
Feature1365,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak1,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,15968788.302934464,27784084.80090083,1.7398993758214678,0.7990038726250878,0.29876808546586686,0.8724505635080375,Upregulated
Feature1364,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,1253220.1469577956,179746.67881128166,0.1434278560296198,-2.8016028487207683,0.4287670427115296,0.8724505635080375,Downregulated
Feature1363,Zalcitabine,C9 H13 N3 O3,211.0957,Other,NA,Zalcitabine-peak2,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,60341622.590887204,63103164.1465857,1.0457651192846038,0.0645588560830624,0.7717649459493846,0.9502143902366301,Upregulated
Feature1362,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak3,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,37833241.51755653,21817668.416957945,0.5766798598749051,-0.7941574566885703,0.41165779575015476,0.8724505635080375,Downregulated
Feature1361,ile-his,C12 H20 N4 O3,268.15355,NA,NA,ile-his-peak4,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,18274281.964912195,17908594.39609783,0.979988950071116,-0.029162612769188453,0.9726917058978033,0.990823661930775,Downregulated
Feature1360,glu-thr,C9 H16 N2 O6,248.10093,NA,NA,glu-thr,9,16,6,2,0,0,1.7777777777777777,0.6666666666666666,0.22222222222222232,53.96666666666666,3,-3,-5,-0.5,-5,Amino Sugar,4855887.11096119,674805.1053975667,0.13896639068777558,-2.847192088564924,0.2673707650953338,0.8724505635080375,Downregulated
Feature1359,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature1359,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,49686373.1054335,51421556.693915464,1.0349227258910594,0.0495230506852975,0.8728455088234912,0.9807974651872519,Upregulated
Feature1358,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak2,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,1538611.5877440497,797799.9729449659,0.5185194101616769,-0.9475300992531834,0.3741229425941958,0.8724505635080375,Downregulated
Feature1357,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,26095049.2134372,30299400.514719,1.1611168182475333,0.2155131269219841,0.624888237221317,0.9043347628664763,Upregulated
Feature1356,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,5623010.505868809,890452.2096036507,0.1583586245613936,-2.6587326530146593,0.36268973717060465,0.8724505635080375,Downregulated
Feature1355,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16304,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,23732962.310952365,22568998.527651936,0.9509558154582634,-0.0725497846113256,0.9187992884952546,0.9838470257338569,Downregulated
Feature1354,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",C12 H18 O8,290.10021,NA,NA,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",12,18,8,0,0,0,1.5,0.6666666666666666,-0.16666666666666696,65.05000000000001,4,-4,-1,0,-4,Amino Sugar,2296527.036811467,5092173.30639145,2.2173365367653153,1.1488277521969132,0.13688379012105115,0.8724505635080375,Upregulated
Feature1353,NA,C12 H18 O9,306.09516,NA,NA,Feature1353,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,5032651.40130317,6599743.436235064,1.311384975825289,0.39109127151147577,0.2408329272017795,0.8724505635080375,Upregulated
Feature1352,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Other,Other,Asparagine,4,8,3,2,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,6848486.137495027,6921880.42352105,1.0107168627566017,0.015378904356174831,0.9875075827593702,0.9956526818674369,Upregulated
Feature1351,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,27281462.817164466,46090086.176881164,1.6894286969056154,0.7565354621966265,0.15883918219239515,0.8724505635080375,Upregulated
Feature1350,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1637146.1574685243,461803.223722156,0.2820781893024323,-1.8258329759390415,0.37289431071481505,0.8724505635080375,Downregulated
Feature1349,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal-peak1,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,9846042.83495843,8606378.394905575,0.8740951607836378,-0.19413774363145203,0.3365673561831363,0.8724505635080375,Downregulated
Feature1348,NA,C10 H15 N O5,229.09503,NA,NA,Feature1348,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,29837357.5402963,37269079.80554514,1.2490744113386065,0.32085942544183027,0.2292218863619582,0.8724505635080375,Upregulated
Feature1347,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,34065011.2685344,57097958.7437548,1.6761467739919922,0.7451484860533861,0.19158484566363876,0.8724505635080375,Upregulated
Feature1346,2-Methylhippuric Acid,C10 H11 N O3,193.07391,Phenylalanine metabolism;Other,NA,2-Methylhippuric Acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,28400835.1355047,44958043.1705357,1.582983139616636,0.6626458893847555,0.06772301630458057,0.8724505635080375,Upregulated
Feature1345,NA,C14 H27 N O11,385.1585,NA,NA,Feature1345,14,27,11,1,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,1486748.6684227977,3084845.25939569,2.0748935747615076,1.0530373397841941,0.269165102593179,0.8724505635080375,Upregulated
Feature1344,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,24158869.436836354,14622473.09732667,0.6052631368184384,-0.7243656076236826,0.5520678523548563,0.8923692193598536,Downregulated
Feature1343,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,36800083.599434435,43270573.668836735,1.1758281350616753,0.23367720403987818,0.3395964297702618,0.8724505635080375,Upregulated
Feature1342,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak2,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,40820355.707656965,42151862.9551792,1.03261870761387,0.046307640280743086,0.9459339994192475,0.9882637829765163,Upregulated
Feature1341,L-(+)-Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-(+)-Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,7938389.104095734,7352144.287702717,0.9261506574311721,-0.11068119832471991,0.9391033379620883,0.9882637829765163,Downregulated
Feature1340,NA,C37 H71 N O5,609.53331,NA,NA,Feature1340,37,71,5,1,0,0,1.9189189189189189,0.13513513513513514,-1.5675675675675675,104.97567567567567,3,-2,-0.0967741935483871,-0.01492537313432835,-3,Lipid,11077379.004828677,1335254.7042922867,0.12053886607204137,-3.0524296965763345,0.40750396007690975,0.8724505635080375,Downregulated
Feature1339,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,4481228.8711937135,620727.9650521943,0.13851735380943492,-2.8518613627540996,0.43012152777551166,0.8724505635080375,Downregulated
Feature1338,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak6,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,22314543.93576187,18213284.632921133,0.8162068956171696,-0.2929931958195637,0.7014793401349295,0.9272348854064458,Downregulated
Feature1337,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak2,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,8219348.007664164,1644990.6446713842,0.20013639076207823,-2.3209445788251557,0.34126155828441274,0.8724505635080375,Downregulated
Feature1336,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak4,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,23294948.418355435,23667593.930642433,1.015996837837742,0.022895911910366686,0.9652113859700513,0.988553862051552,Upregulated
Feature1335,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1510682.165890411,721164.487811493,0.47737671370895646,-1.0667999009770428,0.44567870092462714,0.8724505635080375,Downregulated
Feature1334,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,27770692.323365346,17675994.170737196,0.6364981457759769,-0.6517717835630847,0.6243001736021099,0.9043347628664763,Downregulated
Feature1333,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,20546571.076458618,22377549.29672643,1.0891135661251852,0.12315439734511857,0.8358837960760013,0.972310750246385,Upregulated
Feature1332,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,13853036.39353741,1348963.4942225732,0.09737673791515333,-3.36027901811057,0.15832863006880882,0.8724505635080375,Downregulated
Feature1331,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak2,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,15596877.389602274,17337599.48915016,1.1116070900646013,0.15264694149387892,0.9049187915236878,0.983565624317811,Upregulated
Feature1330,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,16432092.437249754,16835063.261909466,1.0245234029809998,0.034952939916756055,0.9492402480200339,0.9882637829765163,Upregulated
Feature1329,NA,C6 H15 N O6,197.08997,NA,NA,Feature1329,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,22881498.6378882,19220986.518308666,0.8400230606609701,-0.25149916099054426,0.5995295756526317,0.9015641283557303,Downregulated
Feature1328,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak3",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,496272.524761591,666797.862521352,1.3436122881106127,0.4261168950250136,0.6423144169418016,0.9052251433439367,Upregulated
Feature1327,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak3,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,13360519.632093584,8285001.289215534,0.6201107080681173,-0.6894022927381345,0.4699044755532901,0.8724505635080375,Downregulated
Feature1326,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,38935552.47893557,45402647.0880834,1.1660974147637067,0.22168831506161635,0.3645628510557087,0.8724505635080375,Upregulated
Feature1325,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,36752300.62454617,27563090.14262457,0.749969108715216,-0.4150969227737836,0.515602023721862,0.8801268903348092,Downregulated
Feature1324,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak1,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,23464232.662007302,21556083.9234513,0.9186784087064723,-0.12236817283025407,0.7940451610524388,0.9578562748101455,Downregulated
Feature1323,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,7166259.613122096,10585726.58301314,1.4771620279608175,0.5628280821046268,0.13826610501672643,0.8724505635080375,Upregulated
Feature1322,NA,C14 H25 N O9,351.15307,Biosynthesis of secondary metabolites;Other,NA,Feature1322,14,25,9,1,0,0,1.7857142857142858,0.6428571428571429,-0.2857142857142856,68.44285714285714,3,-6,-1.75,-0.29411764705882354,-7,Amino Sugar,2168886.08514669,718284.4097745573,0.3311766416381325,-1.5943271738050175,0.13688885545668322,0.8724505635080375,Downregulated
Feature1321,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11612,NA,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,2,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Lignin,46492637.3902664,49707795.65389517,1.0691541380335177,0.0964698588078469,0.6032469023806678,0.9031677924568101,Upregulated
Feature1320,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,28219012.9130208,39003896.76795466,1.382185014343911,0.46695074265180575,0.14066785610191535,0.8724505635080375,Upregulated
Feature1319,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak4,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,15636641.830926856,44073743.158264466,2.8186194730823484,1.4949887204223158,0.10139829423377723,0.8724505635080375,Upregulated
Feature1318,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,654646.0239440684,133046.70021694934,0.2032345654761306,-2.298782303012949,0.42057181306605607,0.8724505635080375,Downregulated
Feature1317,Nojirimycin,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,42572995.17866614,49975209.62616053,1.1738711222085623,0.23127402552054127,0.4372270882706029,0.8724505635080375,Upregulated
Feature1316,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature1316,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,2159667.4769735048,2827496.5124014034,1.309227713316207,0.38871604632871887,0.6117714170950002,0.9043347628664763,Upregulated
Feature1315,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,4241677.189806234,680377.2270713587,0.16040287759437896,-2.64022807121235,0.36504077437147425,0.8724505635080375,Downregulated
Feature1314,NA,C30 H46 O11,582.30426,NA,NA,Feature1314,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,32104234.3086204,40178950.0052368,1.251515598191614,0.3236762720837379,0.6058032583460111,0.9031677924568101,Upregulated
Feature1313,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak2,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,2742396.0427000895,5826403.898019988,2.1245669142242005,1.087168782718823,0.4092479844545323,0.8724505635080375,Upregulated
Feature1312,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,17766193.079233203,17039110.21383147,0.9590749204312309,-0.06028457566821295,0.9323334825097501,0.987788959559877,Downregulated
Feature1311,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature1311,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,32834114.949137934,41640214.2909737,1.2681996866818843,0.3427819255276878,0.38228469440792606,0.8724505635080375,Upregulated
Feature1310,Guanosine monophosphate,C10 H14 N5 O8 P,363.05806,Metabolic pathways;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Guanosine monophosphate,10,14,8,5,0,1,1.4,0.8,1.2000000000000002,26.09999999999999,7,-1,1.75,-Inf,-7,Tannin,600734.176094128,250413.30479626867,0.41684544472634066,-1.2624155252667542,0.3638117421883938,0.8724505635080375,Downregulated
Feature1309,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,23334944.144124907,3243695.1849125135,0.13900591168670898,-2.846781855249811,0.30383839698012116,0.8724505635080375,Downregulated
Feature1308,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,29515507.896830894,17165465.647084564,0.5815744627226163,-0.7819641738284718,0.5199859517323286,0.8823277748748858,Downregulated
Feature1307,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,4713274.004583386,589943.3856774683,0.12516636739213177,-2.9980811373688665,0.41203974664240517,0.8724505635080375,Downregulated
Feature1306,NA,C18 H34 N2 O12,470.2114,NA,NA,Feature1306,18,34,12,2,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,5017674.361862023,8416269.3218603,1.6773247355049725,0.7461620263791165,0.546924694647652,0.8890580920144323,Upregulated
Feature1305,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,125757062.9394438,48376302.3602553,0.38468059947893424,-1.378267022573612,0.46117544107320585,0.8724505635080375,Downregulated
Feature1304,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak2,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,489200.4866697378,86533.94013413851,0.1768884996889999,-2.4990878398549135,0.41605493623402884,0.8724505635080375,Downregulated
Feature1303,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2688511.9494062266,2438312.4436358903,0.9069375511514485,-0.14092488012679427,0.4224193979655953,0.8724505635080375,Downregulated
Feature1302,(+)-castanospermine,C8 H15 N O4,189.10013,NA,NA,(+)-castanospermine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,31924915.132052332,35366768.27139873,1.107810878278289,0.14771161039585906,0.8201495945468965,0.9674212437637306,Upregulated
Feature1301,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Other,Other,Agmatine,5,14,0,4,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,21434573.579278722,26362941.765501928,1.2299261129686092,0.2985716491778757,0.7971973963556032,0.9586929428349551,Upregulated
Feature1300,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak5,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,36797514.81341818,41667742.66582663,1.1323520861966616,0.1793226101414381,0.7795839318091877,0.9502143902366301,Upregulated
Feature1299,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,12670405.601091653,11707877.34867622,0.9240333512028609,-0.1139831710094013,0.9080960713758826,0.983565624317811,Downregulated
Feature1298,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,251199.84728302775,143023.26540926629,0.5693604791412212,-0.812585739716848,0.45898689239267876,0.8724505635080375,Downregulated
Feature1297,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,32785081.17154557,11075367.83549586,0.33781730713261915,-1.5656848523762927,0.4241179246057581,0.8724505635080375,Downregulated
Feature1296,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,1412941.9180483576,234042.965307615,0.16564231149068714,-2.5938568545332252,0.43189176257840256,0.8724505635080375,Downregulated
Feature1295,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,4727803.490562355,6087049.322136297,1.2875004924141347,0.364572984065405,0.5780098942574113,0.895976728013019,Upregulated
Feature1294,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak3,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12416905.112102037,10134599.284808813,0.8161936644688704,-0.2930165828637778,0.7605896425363537,0.945990348352851,Downregulated
Feature1293,NA,C15 H22 N4 O6,354.15406,NA,NA,Feature1293,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,27200196.314768534,37149591.53113383,1.3657839488078696,0.44972928404124574,0.14820169071760778,0.8724505635080375,Upregulated
Feature1292,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,7458059.414138923,6218566.7681907965,0.8338049381051715,-0.2622181785353201,0.7833876473578736,0.952064465859151,Downregulated
Feature1291,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,18078252.154542025,7607511.36021734,0.4208101145611032,-1.2487587133280262,0.2428973445980072,0.8724505635080375,Downregulated
Feature1290,NA,C15 H22 N4 O6,354.15401,NA,NA,Feature1290,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,510438.12947263865,339360.54471076734,0.6648416823041396,-0.5889172600589546,0.5950466021645674,0.9015409731649661,Downregulated
Feature1289,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,1450032.6687005751,754612.0216641751,0.5204103589889525,-0.942278415089057,0.46725118473193616,0.8724505635080375,Downregulated
Feature1288,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-D-galactosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,27268238.626746334,20124594.61383097,0.7380232690970935,-0.4382617912280318,0.5324724852260783,0.8826174436414305,Downregulated
Feature1287,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,23237651.578078534,27379113.676865168,1.1782220584929297,0.23661146828161722,0.5025694980963494,0.8747804400244787,Upregulated
Feature1286,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature1286,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,19524298.73601934,3586961.860615327,0.18371783330675698,-2.44443642067281,0.43198054114071033,0.8724505635080375,Downregulated
Feature1285,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak2,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,24610630.8478262,39546943.3013764,1.6069048999964781,0.68428454981992,0.2353150988735333,0.8724505635080375,Upregulated
Feature1284,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12666,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak2,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,26600987.137786068,36988816.2064662,1.390505397971659,0.47560934526843845,0.01710272188233307,0.8724505635080375,Upregulated
Feature1283,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak1,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,3315466.5960154664,3693722.272148077,1.1140882181069773,0.15586347575367665,0.7602349929694201,0.945990348352851,Upregulated
Feature1282,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature1282,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,1299058.665231795,184401.195764481,0.14194986007931962,-2.8165466678960067,0.4248672026955136,0.8724505635080375,Downregulated
Feature1281,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak1",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,1795863.0786181968,1825737.3681787134,1.0166350597193095,0.023801889598594056,0.957110641087516,0.9882637829765163,Upregulated
Feature1280,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,26729150.89942203,25849164.794425733,0.96707766332318,-0.04829634169806978,0.9631657289752272,0.988553862051552,Downregulated
Feature1279,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,35655244.6909943,44338635.85965837,1.243537556505882,0.31445007954242493,0.2455959774863409,0.8724505635080375,Upregulated
Feature1278,N-Methyltyramine,C9 H13 N O,151.09973,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,N-Methyltyramine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,253329.56503804808,97623.9926616321,0.3853635979952429,-1.3757077958849662,0.5397472335011967,0.8890580920144323,Downregulated
Feature1277,NP-013538,C12 H16 O8,288.08462,NA,NA,NP-013538-peak2,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,4746512.691547274,6898376.332215981,1.4533567653786763,0.5393888946180383,0.1353934311962034,0.8724505635080375,Upregulated
Feature1276,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11608,NA,Other,N1-Acetyl-5-methoxykynuramine-peak2,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,11741187.298293784,11882732.795174627,1.0120554670737099,0.017288361059174296,0.9793415215922696,0.9946070369168493,Upregulated
Feature1275,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak5,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,34545011.23022863,30357757.138482865,0.8787884576490829,-0.1864121739220143,0.704932835211149,0.9283104618560314,Downregulated
Feature1274,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,12713523.45239361,27250417.67600577,2.1434197827255557,1.0999144254452602,0.08320939287652768,0.8724505635080375,Upregulated
Feature1273,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,282158.17232330557,191904.35884701533,0.6801304292087822,-0.5561166550996475,0.6548530870906827,0.9089232543643583,Downregulated
Feature1272,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,38250061.26398448,24233812.57931408,0.6335627128036045,-0.6584406641988069,0.7056030811162268,0.9283104618560314,Downregulated
Feature1271,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,13946046.686979908,3676876.8685777904,0.2636501189982778,-1.9233034470101764,0.27882747773905164,0.8724505635080375,Downregulated
Feature1270,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak2,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,9095124.56200614,5251231.90620265,0.5773677831900269,-0.7924374866704292,0.40355195815684874,0.8724505635080375,Downregulated
Feature1269,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,18157037.40939586,20317152.43196736,1.1189684734280323,0.16216938942443596,0.8851995367460366,0.9814814661453127,Upregulated
Feature1268,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,7309618.906363407,6719894.626614763,0.9193221579260092,-0.12135758136315795,0.7104954546772757,0.9283104618560314,Downregulated
Feature1267,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak2,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,13065028.40962236,16298369.577289281,1.2474806074884288,0.31901738855032524,0.5193078959035416,0.8823277748748858,Upregulated
Feature1266,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,1017188.777429104,270696.33822544664,0.2661220259523691,-1.9098401729631738,0.4200607735240336,0.8724505635080375,Downregulated
Feature1265,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13723,NA,NA,L-gamma-Glutamyl-L-leucine-peak3,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,15663268.184524372,14256648.340855211,0.9101962740407566,-0.13575041435353535,0.9134743193506325,0.9838470257338569,Downregulated
Feature1264,NA,C18 H33 N O15,503.18514,NA,NA,Feature1264,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,2422143.4917313554,2778240.78005384,1.1470174205360333,0.19788730271388746,0.7375894420736149,0.932761626098252,Upregulated
Feature1263,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,15885321.351015266,12189031.514954085,0.7673141289127938,-0.38211077472580235,0.5151828349703974,0.8801268903348092,Downregulated
Feature1262,NA,C11 H23 N O7,281.14745,NA,NA,Feature1262,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,15876129.13735363,27613516.222396467,1.7393103812330997,0.7985154056229797,0.3567889289050449,0.8724505635080375,Upregulated
Feature1261,NA,C5 H16 N5 O7 P,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,Feature1261,5,16,7,5,0,1,3.2,1.4,1.6,14.699999999999996,1,-6,1.5,1.8888888888888888,-12,Other,26996208.363178436,13827093.197466584,0.5121864897266867,-0.9652588963474787,0.44142047244350185,0.8724505635080375,Downregulated
Feature1260,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,6084507.891221804,2814708.179697047,0.46260243720907357,-1.1121552280914222,0.4248665721473451,0.8724505635080375,Downregulated
Feature1259,Pipecolic acid,C6 H11 N O2,129.07898,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak2,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,5009706.905825357,5125737.2540312465,1.023161105107959,0.03303332713671177,0.9629878023654899,0.988553862051552,Upregulated
Feature1258,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak4,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,16697534.77074831,17108752.106717933,1.0246274280374619,0.035099416624027456,0.9418914156456274,0.9882637829765163,Upregulated
Feature1257,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,7370672.641999159,5921142.005936531,0.8033380796478475,-0.3159208304515826,0.8643219206393944,0.9789760557739694,Downregulated
Feature1256,NA,C7 H11 N O6,205.0586,NA,NA,Feature1256,7,11,6,1,0,0,1.5714285714285714,0.8571428571428571,0.5714285714285716,44.014285714285705,3,-3,-Inf,-0.3333333333333333,-4,Carbohydrate,14427527.326283554,16655376.035338996,1.1544165301975777,0.20716386317401517,0.7065782983629565,0.9283104618560314,Upregulated
Feature1255,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,7983662.691043212,25794770.393341262,3.230944416311594,1.69195593135184,0.28920227881109006,0.8724505635080375,Upregulated
Feature1254,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature1254,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,2709893.530198213,371632.8193075607,0.13713926955660796,-2.8662863517613055,0.4213591534359118,0.8724505635080375,Downregulated
Feature1253,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak3,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,11370076.773916613,9647691.050796054,0.8485159108976488,-0.23698638225210847,0.641114268010656,0.9050396416750427,Downregulated
Feature1252,NA,C14 H31 N O,229.24056,NA,NA,Feature1252,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,200821014.02805638,13853729.3050511,0.0689854563881229,-3.857563946844838,0.40240807520086397,0.8724505635080375,Downregulated
Feature1251,11-Aminoundecanoic acid,C11 H23 N O2,201.1728,NA,NA,11-Aminoundecanoic acid,11,23,2,1,0,0,2.090909090909091,0.18181818181818185,-1.454545454545454,101.75454545454544,1,-1,-0.25,-0.1111111111111111,-2,Lipid,4652568.22784509,5256088.858063083,1.1297177388191733,0.17596235877023791,0.7149741197076769,0.9288084039760771,Upregulated
Feature1250,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak1,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,14179631.134395786,24821835.15392484,1.750527564409914,0.807789779118256,0.5657390324383522,0.8929340317679025,Upregulated
Feature1249,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak3,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,4893317.452629506,1613857.558728371,0.329808473362205,-1.6002996302520756,0.47486062195351725,0.8724505635080375,Downregulated
Feature1248,NA,C12 H19 N O7,289.11624,NA,NA,Feature1248,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,2167252.0698202667,1133571.417788297,0.5230454886045192,-0.9349916735960999,0.330477790446535,0.8724505635080375,Downregulated
Feature1247,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,11470865.03051,14002860.975845415,1.2207327815819344,0.28774742892639454,0.8604549606787127,0.9789760557739694,Upregulated
Feature1246,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak4,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,6709571.238677493,7038629.893089927,1.0490431717179731,0.06907405097696961,0.752906925110166,0.9391931746219596,Upregulated
Feature1245,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature1245,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,1551899.1867649634,1234258.7652936566,0.7953214846813282,-0.33038995071251764,0.2095065366424968,0.8724505635080375,Downregulated
Feature1244,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak3,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,699213.3872636746,24483200.869987413,35.015349127969074,5.129915567133846,0.1663786873850201,0.8724505635080375,Upregulated
Feature1243,Etilevodopa,C11 H15 N O4,225.1001,NA,NA,Etilevodopa-peak2,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,34380163.893068366,35687614.00827417,1.0380291996068525,0.053847027063323206,0.7323025894048708,0.930298368021698,Upregulated
Feature1242,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature1242,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,19814118.4341787,12386310.828077435,0.6251255068058672,-0.6777822253228165,0.620618283873486,0.9043347628664763,Downregulated
Feature1241,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak2,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,7379741.843941013,4710613.071234827,0.6383167827343961,-0.6476555150094011,0.20633180936146156,0.8724505635080375,Downregulated
Feature1240,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,30619873.912407033,14570019.299213333,0.4758353787116552,-1.0714655536952387,0.5087469792521839,0.8772526573874708,Downregulated
Feature1239,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,20801960.283287633,21004464.52946277,1.009734863609841,0.013976519540684436,0.9852017671153219,0.9951332564369114,Upregulated
Feature1238,Leucylasparagine,C10 H19 N3 O4,245.13753,NA,NA,Leucylasparagine-peak4,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,5802185.424862104,4096750.187020037,0.7060701937352168,-0.5021164792099408,0.5303808748497734,0.8826174436414305,Downregulated
Feature1237,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,678995.8223825314,299772.638570271,0.44149408389347305,-1.1795339892780237,0.12361626377117495,0.8724505635080375,Downregulated
Feature1236,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature1236,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,16117502.360641947,2052830.3188835233,0.12736652819709968,-2.9729419063726565,0.4232172317286915,0.8724505635080375,Downregulated
Feature1235,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak2,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,6536477.569221933,6709838.524743933,1.0265220761007883,0.03776465398198322,0.9514857760747659,0.9882637829765163,Upregulated
Feature1234,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe-peak2,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,15656244.765993252,12278165.75987007,0.784234402526673,-0.35064316399182244,0.7301546896004172,0.930298368021698,Downregulated
Feature1233,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,15484190.518302873,12246995.112325886,0.7909354446297658,-0.33836814672929144,0.7893167275006139,0.9537107962810556,Downregulated
Feature1232,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,2499805.5073946617,1403101.3074386367,0.5612841892251738,-0.8331966741902168,0.5025371117666129,0.8747804400244787,Downregulated
Feature1231,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,3422196.243411541,21170512.60575104,6.186235709453776,2.629061804390887,0.23726535865785547,0.8724505635080375,Upregulated
Feature1230,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,3061315.18400157,1230783.155422395,0.4020439195070362,-1.3145749840453522,0.4041147637202162,0.8724505635080375,Downregulated
Feature1229,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,19849798.367678203,10418688.85506369,0.5248763066545117,-0.9299506203021589,0.5208546486864734,0.8823277748748858,Downregulated
Feature1228,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,C14 H16 N2 O4,276.11103,NA,NA,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,14,16,4,2,0,0,1.1428571428571428,0.2857142857142857,-0.14285714285714324,64.37142857142858,8,4,0.25,0.4,2,Lignin,10657667.63802535,21008518.50529182,1.971211640184369,0.97908268041629265,0.502972933048313,0.8747804400244787,Upregulated
Feature1227,NA,C21 H35 N O16,557.19585,NA,NA,Feature1227,21,35,16,1,0,0,1.6666666666666667,0.7619047619047619,0,60.3,5,-11,-3,-0.3333333333333333,-12,Carbohydrate,639959.0929359787,692567.5944243453,1.0822060379625382,0.11397519569775023,0.7762904122614157,0.9502143902366301,Upregulated
Feature1226,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,20854766.296702642,26453941.87000513,1.2684842157251974,0.3431055674612442,0.656669939558566,0.9089232543643583,Upregulated
Feature1225,NA,C12 H19 N O8,305.11113,NA,NA,Feature1225,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,15251157.588443616,18299979.347963292,1.1999075638579648,0.26292327058359727,0.8579495561278104,0.9789760557739694,Upregulated
Feature1224,NA,C18 H33 N O15,503.18519,NA,NA,Feature1224,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,7810383.031840123,10481437.148054134,1.3419875959124006,0.4243713366659877,0.4337806586706472,0.8724505635080375,Upregulated
Feature1223,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak1",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,1795152.8199685032,2977891.0026950333,1.6588509733379033,0.7301842843145194,0.21457607901059342,0.8724505635080375,Upregulated
Feature1222,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577-peak2,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,4153150.5143077862,4156417.940196969,1.000786734282306,0.0011345714029683351,0.9994192874260379,0.9994192874260379,Upregulated
Feature1221,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,24847373.890824813,26021584.727574036,1.0472569391803137,0.06661544361036537,0.9356835433945322,0.9882637829765163,Upregulated
Feature1220,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,2101368.6048149196,2469084.1197805633,1.1749885832133817,0.23264673889967347,0.6058103565517265,0.9031677924568101,Upregulated
Feature1219,NA,C7 H17 N O6,211.10558,NA,NA,Feature1219,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,5686699.171524073,5400109.949745174,0.9496035902138126,-0.07460270542789678,0.9040640048255988,0.983565624317811,Downregulated
Feature1218,NA,C20 H42 O5,362.30324,NA,NA,Feature1218,20,42,5,0,0,0,2.1,0.25,-1.5999999999999996,105.89999999999998,0,-5,-0.3333333333333333,-0.14285714285714285,-5,Lipid,6098328.239922505,713012.1657075757,0.11691928306513007,-3.0964152070347333,0.4194288430883231,0.8724505635080375,Downregulated
Feature1217,leu-phe,C15 H22 N2 O3,278.16307,NA,NA,leu-phe-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,18458805.012098342,22263746.21076006,1.2061315018045788,0.2703872096084364,0.7257339540202274,0.930298368021698,Upregulated
Feature1216,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak2,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,28502488.523829635,20395571.326482967,0.7155716003334641,-0.482831964164834,0.4010540390990829,0.8724505635080375,Downregulated
Feature1215,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,23810856.942699034,29812944.7461291,1.252073573743025,0.324319339711055,0.49400698942727256,0.8724505635080375,Upregulated
Feature1214,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak1,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,3003620.024691523,7764550.950137444,2.5850643178259127,1.3702001760350377,0.4251154687374076,0.8724505635080375,Upregulated
Feature1213,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,19512770.56389116,24226361.6022225,1.2415644166417836,0.31215911544850594,0.7440829881555705,0.9351636436381646,Upregulated
Feature1212,NA,C32 H36 O10,580.23105,NA,NA,Feature1212,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,1612219.7276558238,194929.76684711268,0.12090769235936694,-3.0480220605925057,0.41791854945307255,0.8724505635080375,Downregulated
Feature1211,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,6271451.22892456,2024267.32382514,0.32277494473512236,-1.631399500501231,0.4605030514330322,0.8724505635080375,Downregulated
Feature1210,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,1212658.5631032253,5789162.608758587,4.773942793875935,2.255181278718395,0.4949132913559732,0.8724505635080375,Upregulated
Feature1209,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,17961047.1463977,16020425.129459767,0.8919538487305209,-0.1649590304033509,0.6387911114752789,0.9050396416750427,Downregulated
Feature1208,NA,C12 H22 N4 O7,334.14893,NA,NA,Feature1208,12,22,7,4,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,4,-3,-7,-0.7777777777777778,-7,Amino Sugar,7803055.96455086,12020197.902396854,1.5404474807055584,0.6233494966471447,0.4081562982763902,0.8724505635080375,Upregulated
Feature1207,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature1207,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,2322112.3513975656,285042.0106858203,0.12275117115425853,-3.0261913057007086,0.41914832466576024,0.8724505635080375,Downregulated
Feature1206,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,1354455.7410738566,1474152.1303415864,1.0883723148995852,0.12217216410277844,0.8220453254814934,0.9680535986412692,Upregulated
Feature1205,NA,C9 H19 N O3,189.13649,NA,NA,Feature1205,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,863589.0202417793,1073801.843019301,1.2434176649428317,0.31431098016331327,0.3585990251602635,0.8724505635080375,Upregulated
Feature1204,NA,C16 H5 O13 P3,497.89406,NA,NA,Feature1204,16,5,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,20530056.495400533,29819149.790595368,1.4524631141310265,0.5385015262900796,0.14403300723442894,0.8724505635080375,Upregulated
Feature1203,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,567994.0950885563,193395.75663553269,0.3404890267483859,-1.5543197909548156,0.19680657747306968,0.8724505635080375,Downregulated
Feature1202,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,1681426.5750556653,1031618.2022939856,0.6135374672901389,-0.704776646315932,0.4868754427846852,0.8724505635080375,Downregulated
Feature1201,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Nicotinamide,6,6,1,2,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Lignin,13342301.882509397,20313679.895411793,1.522501894672408,0.6064440234897597,0.6155051891966563,0.9043347628664763,Upregulated
Feature1200,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak2,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,20866244.045805644,17945355.80306212,0.8600184951191224,-0.21756040887527445,0.8812522107493155,0.9808471485893633,Downregulated
Feature1199,NA,C11 H17 N O5,243.11065,NA,NA,Feature1199,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,1146470.0847216668,1047726.5265881413,0.9138716662131678,-0.1299365111326528,0.7712641986742256,0.9502143902366301,Downregulated
Feature1198,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,11492718.147758476,7206876.20774083,0.6270819587746045,-0.67327408122155,0.6586427982204569,0.9098405617363219,Downregulated
Feature1197,Fluoranthene,C16 H10,202.07833,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak4,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,9196693.666123606,11755637.204839367,1.2782460340221762,0.35416554982269316,0.6081010683032295,0.904145091526307,Upregulated
Feature1196,Nicotinic acid,C6 H5 N O2,123.03199,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Aminobenzoate degradation;Other,Other,Nicotinic acid,6,5,2,1,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Lignin,14685362.566155257,8711093.405577414,0.5931820454779583,-0.7534531641412173,0.6066064162759682,0.9031677924568101,Downregulated
Feature1195,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",C11 H15 N O2,193.11027,NA,NA,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,14068879.066705199,28973799.437954232,2.0594248696417026,1.0422414958723918,0.003508572915175959,0.8724505635080375,Upregulated
Feature1194,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,1716632.577639627,188288.87530102534,0.10968501807178965,-3.18856161408356,0.35381495483011793,0.8724505635080375,Downregulated
Feature1193,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,28511994.0179335,29085942.3897486,1.0201300677691676,0.02875310921870431,0.8770841639623121,0.9807974651872519,Upregulated
Feature1192,"2,5-Furandicarboxylic acid",C6 H4 O5,156.00587,Microbial metabolism in diverse environments;Other,NA,"2,5-Furandicarboxylic acid",6,4,5,0,0,0,0.6666666666666666,0.8333333333333334,1,31.799999999999997,5,0,0,0.7142857142857143,0,Condensed HC,5184611.003120843,1822490.9866219326,0.35151933009533326,-1.5083240694134599,0.16140768718476756,0.8724505635080375,Downregulated
Feature1191,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak5",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,13303991.517399667,8555379.561909184,0.6430686272401785,-0.6369553870450395,0.6197233394602482,0.9043347628664763,Downregulated
Feature1190,MFCD00025555,C9 H18 N2 O3,202.13171,NA,NA,MFCD00025555-peak1,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,11152449.44667572,10301506.87931433,0.9236990428488303,-0.11450522172551489,0.870687040265246,0.9807974651872519,Downregulated
Feature1189,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,13137477.876154155,26028524.0369875,1.9812420833249806,0.9864051705223997,0.20586836577213885,0.8724505635080375,Upregulated
Feature1188,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,27211453.07960677,17910769.33610349,0.6582070161305152,-0.6033866899949087,0.7264885123552296,0.930298368021698,Downregulated
Feature1187,Meglutol,C6 H10 O5,162.05283,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak1,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,6298216.53473295,10486412.290303642,1.664981226427185,0.735505910213597,0.26727623908515163,0.8724505635080375,Upregulated
Feature1186,NA,C7 H17 N O6,211.10569,NA,NA,Feature1186,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,4442827.053640453,5419130.7734412765,1.2197483062053562,0.28658347987732036,0.6962608481592101,0.9233562380758966,Upregulated
Feature1185,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,1886323.7414689057,3619471.5837075934,1.918796601101496,0.9402017891077616,0.25966725476354796,0.8724505635080375,Upregulated
Feature1184,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak2,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,13278091.191183297,17786092.609709166,1.33950673734785,0.42170183755497476,0.42985968154700155,0.8724505635080375,Upregulated
Feature1183,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,14287754.10339278,14500081.68895987,1.0148608090558244,0.021281871395578383,0.9639091663201715,0.988553862051552,Upregulated
Feature1182,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Other,Thymine,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,7458193.858941278,4770397.256455577,0.6396182972284331,-0.6447168850510566,0.650233539786494,0.9089232543643583,Downregulated
Feature1181,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak2,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,17894469.83039894,2284273.84850118,0.12765250215017152,-2.9697062782213353,0.42209573020974356,0.8724505635080375,Downregulated
Feature1180,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak1,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,14399725.357376797,18419563.42094288,1.2791607453476028,0.3551975714470645,0.7422210797051414,0.9351636436381646,Upregulated
Feature1179,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Other,NA,pyroglutamine,5,8,2,2,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,6734151.318995417,7884903.261612906,1.1708829944719976,0.22759691552407854,0.5810067566774884,0.8964335502669541,Upregulated
Feature1178,pyr-gln-OH,C10 H15 N3 O5,257.10118,NA,NA,pyr-gln-OH,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,1367157.2195765958,1582487.9135664117,1.157502510250067,0.21101532222969824,0.7789397579250809,0.9502143902366301,Upregulated
Feature1177,NA,C9 H17 N5 O2,227.1382,NA,NA,Feature1177,9,17,2,5,0,0,1.8888888888888888,0.2222222222222222,0.22222222222222232,53.96666666666666,4,2,-1.5,-0.6666666666666666,-3,Lipid,1117549.6813268473,480704.3581098767,0.43014137638976796,-1.2171171804353023,0.3983561231188631,0.8724505635080375,Downregulated
Feature1176,NA,C5 H10 N6 O,170.09157,NA,NA,Feature1176,5,10,1,6,0,0,2,0.2,2,3.299999999999997,4,3,1.5,1.6666666666666667,-3,Lipid,270475754.85004675,21733609.252534967,0.08035326221599493,-3.6374995935370684,0.41526637264298677,0.8724505635080375,Downregulated
Feature1175,NA,C15 H27 N O5,301.18898,NA,NA,Feature1175,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,5644386.19976562,1725688.5473661833,0.30573537782333915,-1.7096445931787008,0.4248040476644182,0.8724505635080375,Downregulated
Feature1174,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak4",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,12191839.022632103,3547193.50653088,0.290948190830449,-1.7811658197142781,0.4120982926790505,0.8724505635080375,Downregulated
Feature1173,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,31488660.055848632,4481825.116454997,0.14233140147932566,-2.8126741072272323,0.40522973318098154,0.8724505635080375,Downregulated
Feature1172,NA,C31 H40 O6,508.28264,NA,NA,Feature1172,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,838638.476164045,126373.761421138,0.1506892004277874,-2.7303520691100305,0.4290844057140458,0.8724505635080375,Downregulated
Feature1171,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,C14 H20 N2 O3,264.14741,Metabolic pathways;Other,NA,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,14885063.495235765,18765491.709920175,1.260692755252701,0.3342167177893553,0.5683165305342708,0.8929340317679025,Upregulated
Feature1170,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak4,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,13459741.278413156,14090048.80120908,1.0468290964705849,0.06602592956587394,0.9085917215254466,0.983565624317811,Upregulated
Feature1169,N6-Acetyl-L-lysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,N6-Acetyl-L-lysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12319659.088157054,21741585.90774466,1.764787950069572,0.8194948453879093,0.2631523617357175,0.8724505635080375,Upregulated
Feature1168,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,6872840.180606899,872284.770333395,0.12691765666175708,-2.978035305405968,0.4180454250406454,0.8724505635080375,Downregulated
Feature1167,NA,C6 H9 O7 P,224.00856,NA,NA,Feature1167,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,7561421.14130635,8616894.333038466,1.1395866163261694,0.1885105833966843,0.9042709833855048,0.983565624317811,Upregulated
Feature1166,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,8854826.891967747,1407892.7166395993,0.15899720387721017,-2.6529267003711463,0.15267252551924515,0.8724505635080375,Downregulated
Feature1165,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,9363066.66265121,13489280.5213471,1.4406904283993989,0.5267603664678916,0.24352214123022953,0.8724505635080375,Upregulated
Feature1164,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,21546671.662306234,12625637.07462568,0.5859669313434139,-0.7711088454839085,0.09399641615514315,0.8724505635080375,Downregulated
Feature1163,arg-val,C11 H23 N5 O3,273.18012,NA,NA,arg-val,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,3560134.063150273,5266526.681448974,1.4793057194000039,0.5649202365367286,0.44402193060660516,0.8724505635080375,Upregulated
Feature1162,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature1162,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,1000269.534595209,126931.32629930467,0.1268971231345874,-2.978268732457837,0.4212127662649842,0.8724505635080375,Downregulated
Feature1161,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,7978898.895016683,7880084.795362573,0.9876155719035585,-0.017978511007992554,0.9839537757216921,0.9951332564369114,Downregulated
Feature1160,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature1160,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,24791140.944018234,29623006.9170378,1.194902928587699,0.2568934214416361,0.5286477836503362,0.8826174436414305,Upregulated
Feature1159,NA,C12 H22 N4 O6,318.1539,NA,NA,Feature1159,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,14335719.745530497,28851229.732255865,2.012541417130516,1.009018473500031,0.22412365396297362,0.8724505635080375,Upregulated
Feature1158,AC-LYS-OH,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,14273487.134619953,12520115.527243879,0.8771588476705654,-0.1890899660202548,0.7551260094515357,0.9412681824951447,Downregulated
Feature1157,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak2,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,2126899.1433389005,795675.3335336547,0.37410111148221553,-1.418499842638029,0.25754307639366625,0.8724505635080375,Downregulated
Feature1156,Trachelogenin,C21 H24 O7,388.1523,NA,NA,Trachelogenin,21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,6556311.994648849,518313.833462414,0.07905569989430841,-3.6609867055237837,0.41822933843062843,0.8724505635080375,Downregulated
Feature1155,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,291207.7905384716,103224.56469720697,0.3544704779578001,-1.496262617147355,0.4459694033724133,0.8724505635080375,Downregulated
Feature1154,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,7904591.095936293,8291631.723709793,1.0489640290150462,0.06896520598821118,0.9127428465849163,0.9838470257338569,Upregulated
Feature1153,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13724,NA,NA,L-gamma-Glutamyl-L-leucine-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,6328474.512111897,7820910.509861713,1.235828712732189,0.3054787979216744,0.5228294489076794,0.8826174436414305,Upregulated
Feature1152,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak1,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,22035397.5694582,12464163.3168213,0.5656427698902536,-0.8220368842596691,0.24927618459973602,0.8724505635080375,Downregulated
Feature1151,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak1,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,18000335.236422498,26379102.7577666,1.4654784153347442,0.5513717190893105,0.26385608947517775,0.8724505635080375,Upregulated
Feature1150,NA,C11 H14 N O P S,239.05347,NA,NA,Feature1150,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,10564132.758125348,3728023.73592026,0.3528944420972815,-1.5026913862824254,0.29976685648029017,0.8724505635080375,Downregulated
Feature1149,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,184044989.6796383,20761262.616800234,0.11280536706236205,-3.1480923848629643,0.419774930950652,0.8724505635080375,Downregulated
Feature1148,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature1148,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,20471670.263776235,26367404.20836003,1.2879947688008657,0.36512673394913314,0.09200083930017809,0.8724505635080375,Upregulated
Feature1147,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak5",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,8103882.67591775,8824065.081790846,1.0888688095168575,0.12283014389798817,0.9007519099271153,0.983565624317811,Upregulated
Feature1146,NA,C4 H11 O6 P,186.02935,NA,NA,Feature1146,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,17502915.368925992,5994927.90908034,0.3425102494481294,-1.5457809342397697,0.24547697751512332,0.8724505635080375,Downregulated
Feature1145,NA,C13 H19 N O6,285.1213,NA,NA,Feature1145,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,1157085.2143671545,357152.57862966834,0.3086657526991269,-1.6958826739752402,0.4006785776813742,0.8724505635080375,Downregulated
Feature1144,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,14714674.343331613,7733007.638542307,0.5255303283043261,-0.9281540705063943,0.39358025538386754,0.8724505635080375,Downregulated
Feature1143,asn-leu,C10 H19 N3 O4,245.13755,NA,NA,asn-leu-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,19321661.175049357,19303113.172039,0.9990400409756532,-0.0013855932867270916,0.9977887644488318,0.9990955178723921,Downregulated
Feature1142,NA,C15 H29 N O12,415.16907,NA,NA,Feature1142,15,29,12,1,0,0,1.9333333333333331,0.8,-0.13333333333333375,64.10000000000001,2,-10,-5.5,-0.625,-11,Carbohydrate,384305.7918572393,119257.62604523344,0.31031961675335584,-1.6881731956415909,0.3993051188440405,0.8724505635080375,Downregulated
Feature1141,mebutamate,C10 H20 N2 O4,232.14229,Other,NA,mebutamate-peak3,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,13375816.998676954,10959006.327091798,0.819314911991977,-0.2875100219632933,0.8190329216840149,0.9668583758416175,Downregulated
Feature1140,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak4",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,7100840.00110974,8103299.163042467,1.1411747288737755,0.19051970414218708,0.8331747254819847,0.9709621554641522,Upregulated
Feature1139,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,11992181.856138274,6697825.997078674,0.5585160463231592,-0.8403293645488871,0.594461470872774,0.9015409731649661,Downregulated
Feature1138,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,6196666.510851972,425473.12102368596,0.0686616135108404,-3.864352429526794,0.42071140326720974,0.8724505635080375,Downregulated
Feature1137,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06316,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of chorismate metabolism;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,Adenosine 5'-monophosphate,10,14,7,5,0,1,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,1044465.8613028583,1007480.5203996943,0.9645892295062389,-0.05201339366655816,0.9460233045089409,0.9882637829765163,Downregulated
Feature1136,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,20647629.3207921,25662468.50529383,1.2428772381850057,0.31368380515299793,0.4947351857454797,0.8724505635080375,Upregulated
Feature1135,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak2,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,16630087.222377399,14521891.883639466,0.8732300492145856,-0.19556631830699314,0.5579502886927042,0.8929340317679025,Downregulated
Feature1134,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12902471.45804988,10269387.24724963,0.7959240429741494,-0.3292973375521452,0.8317157215573601,0.9709621554641522,Downregulated
Feature1133,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,8479182.788698534,7675043.154377227,0.9051630735696483,-0.14375036430883628,0.9084100520514485,0.983565624317811,Downregulated
Feature1132,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,9476939.613158733,15300730.139076266,1.6145222786722413,0.6911073487302779,0.24624221377696554,0.8724505635080375,Upregulated
Feature1131,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,14611053.958453758,14449033.876556419,0.9889111297269835,-0.016087218456083498,0.9916295128300201,0.9956526818674369,Downregulated
Feature1130,Lys-phe,C15 H23 N3 O3,293.17394,NA,NA,Lys-phe-peak2,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,5604555.176341034,6091137.57449796,1.0868190931924404,0.12011181610138699,0.8757782641933314,0.9807974651872519,Upregulated
Feature1129,2805789,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,2805789,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,23961381.546701934,26630635.310281567,1.1113981578389844,0.15237575411188672,0.4180423358094539,0.8724505635080375,Upregulated
Feature1128,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,1127320.980287106,1153255.7201674846,1.0230056393288924,0.03281409797610826,0.8984965468103929,0.983565624317811,Upregulated
Feature1127,val-arg,C11 H23 N5 O3,273.18012,NA,NA,val-arg,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,7267065.233653877,11062874.2224597,1.5223303860308532,0.6062814958730692,0.39718863691383466,0.8724505635080375,Upregulated
Feature1126,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,9417451.714781687,7683580.049797737,0.8158873846666551,-0.29355806131204687,0.2477805825247192,0.8724505635080375,Downregulated
Feature1125,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,5467367.782159046,11230074.92524406,2.054018564818286,1.038449221213186,0.04317074129017043,0.8724505635080375,Upregulated
Feature1124,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak2",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,10405775.399130084,16425418.939337326,1.578490627494274,0.658545694475621,0.5453519049669561,0.8890580920144323,Upregulated
Feature1123,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,10229973.500573354,17909196.907470055,1.750659169006284,0.807898236800229,0.4797242719258944,0.8724505635080375,Upregulated
Feature1122,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak1,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,15741120.581278674,8454103.50482918,0.5370712625684264,-0.8968145665780448,0.32882886496449076,0.8724505635080375,Downregulated
Feature1121,L-Theanine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,L-Theanine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,6243090.581313871,5325809.7299968535,0.853072634559793,-0.2292595103684732,0.8229027048662501,0.9680535986412692,Downregulated
Feature1120,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,15796801.683678333,16127827.587334868,1.0209552484284563,0.029919629893176918,0.910131358523397,0.983565624317811,Upregulated
Feature1119,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak3,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,7552278.538840828,10764178.502870366,1.4252888644812245,0.5112543411165631,0.4604703796376332,0.8724505635080375,Upregulated
Feature1118,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,3863079.9092107182,408167.826509658,0.10565865477865626,-3.2425171478242163,0.4210958902627984,0.8724505635080375,Downregulated
Feature1117,NA,C5 H13 N O5,167.07939,NA,NA,Feature1117,5,13,5,1,0,0,2.6,1,0,60.3,0,-5,6,-2.3333333333333335,-6,Other,5494455.765602021,8251183.555901463,1.5017289988132958,0.5866244883892598,0.297740458501906,0.8724505635080375,Upregulated
Feature1116,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak3,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,13618910.416547317,23365185.243899267,1.7156427738528908,0.7787491903424467,0.07270494809614154,0.8724505635080375,Upregulated
Feature1115,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,5323134.36478102,5594803.71141845,1.051035598205984,0.071811533701138075,0.8754756787291866,0.9807974651872519,Upregulated
Feature1114,NA,C42 H55 N10 O17 P3,1064.29584,NA,NA,Feature1114,42,55,17,10,0,3,1.3095238095238095,0.4047619047619048,-0.14285714285714324,64.37142857142858,22,5,-0.6666666666666666,0.02439024390243902,-8,Lignin,2686427.225735172,2723152.674452095,1.0136707402177523,0.019589113293205517,0.990450549917202,0.9956526818674369,Upregulated
Feature1113,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature1113,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,8053039.324730317,1986352.8143968284,0.24665877494188793,-2.0194114824385583,0.31452467439116566,0.8724505635080375,Downregulated
Feature1112,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,8688675.133483153,16848282.495251067,1.9391083492491974,0.9553934174505374,0.43663638473581295,0.8724505635080375,Upregulated
Feature1111,Pro-tyr,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,Pro-tyr,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,14193752.880053667,8419065.189068453,0.5931528652228177,-0.7535241360211004,0.5626307003490583,0.8929340317679025,Downregulated
Feature1110,NA,C18 H28 O,260.21405,NA,NA,Feature1110,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,11929345.922660254,18489062.11880546,1.5498806253647799,0.6321571007727612,0.492129099107917,0.8724505635080375,Upregulated
Feature1109,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,662576.1447600207,343042.7658349561,0.517740894458558,-0.9496978189862372,0.6103092693542148,0.904145091526307,Downregulated
Feature1108,NA,C13 H18 O9,318.09513,NA,NA,Feature1108,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,541606.1911753984,132139.050869987,0.24397625622265817,-2.035187343396821,0.4244097299470416,0.8724505635080375,Downregulated
Feature1107,D-lysopine,C9 H18 N2 O4,218.12664,Lysine degradation,NA,D-lysopine-peak5,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,7523292.816173958,7047183.9734051665,0.9367153646146501,-0.09431736551148436,0.8641860559023353,0.9789760557739694,Downregulated
Feature1106,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,7727264.14075705,18571587.3105987,2.403384557885609,1.2650675079626885,0.11371147146244426,0.8724505635080375,Upregulated
Feature1105,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak2,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4736351.415948103,5177044.289864137,1.0930448007789595,0.1283525341635561,0.8788964298431218,0.9807974651872519,Upregulated
Feature1104,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,20884109.167065334,25630893.2253041,1.2272916704402477,0.2954781516026303,0.1957059410370883,0.8724505635080375,Upregulated
Feature1103,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature1103,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,11444068.632525435,5854279.86401031,0.511555815680075,-0.9670364343661026,0.6231400381433571,0.9043347628664763,Downregulated
Feature1102,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature1102,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,6867943.164839163,18498058.5787623,2.6933913305317074,1.4294238583584917,0.21571199963896048,0.8724505635080375,Upregulated
Feature1101,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,6459247.146450384,2460248.3644030197,0.3808877890289467,-1.3925620579437599,0.39992928638571823,0.8724505635080375,Downregulated
Feature1100,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,18680116.4895702,15281438.252161767,0.8180590447973898,-0.28972311900374415,0.6297787082518397,0.9043347628664763,Downregulated
Feature1099,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,1439669.1709284533,357171.592465602,0.24809282554495446,-2.0110480795295484,0.3612002494309347,0.8724505635080375,Downregulated
Feature1098,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,622329.7013395353,154037.5424445531,0.24751758129652912,-2.014397090711402,0.26357733400743416,0.8724505635080375,Downregulated
Feature1097,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,9299904.38413541,8288995.41878392,0.8912989936675062,-0.166018617885191,0.8756209304762217,0.9807974651872519,Downregulated
Feature1096,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,2830220.2986364635,3772848.184735707,1.3330581321013706,0.41473969495479324,0.19079628669665885,0.8724505635080375,Upregulated
Feature1095,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,5175588.5646755695,8776692.279683013,1.6957863187939046,0.7619543914588414,0.2973728049726049,0.8724505635080375,Upregulated
Feature1094,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak3,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,14685269.125281706,4123572.14115053,0.28079649790357025,-1.8324031524381186,0.09624090563259301,0.8724505635080375,Downregulated
Feature1093,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,13473183.920799194,10686077.187509766,0.7931367411242091,-0.3343584789769047,0.5046764274351835,0.8751236754042836,Downregulated
Feature1092,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,8124782.80522229,9743148.70792428,1.1991888203659757,0.2620588387004889,0.66729349691348006,0.914956445548846,Upregulated
Feature1091,Hydrocotarnine,C12 H15 N O3,221.10517,NA,NA,Hydrocotarnine,12,15,3,1,0,0,1.25,0.25,-0.5,74.55,6,3,0.25,0.3684210526315789,2,Lignin,20803628.914174967,22470179.6636678,1.0801086558680777,0.1111764507193973,0.4847994651510487,0.8724505635080375,Upregulated
Feature1090,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,6962523.441063643,4400128.488663821,0.6319732387129495,-0.6620646269811098,0.4364090710731774,0.8724505635080375,Downregulated
Feature1089,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine-peak1,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,11149548.891850308,15008024.926858487,1.3460656635021806,0.4287487889217198,0.5704325670853446,0.8929340317679025,Upregulated
Feature1088,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature1088,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,19367253.79885863,17658519.218970265,0.9117719735779439,-0.133255031156871,0.7790180083415212,0.9502143902366301,Downregulated
Feature1087,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,2615037.683406111,1369287.0654168667,0.5236203952645752,-0.9334068028486501,0.5659577560313943,0.8929340317679025,Downregulated
Feature1086,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak4,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,22480386.019559998,24756693.123803433,1.1012574740604026,0.1391518105221135,0.3572975214037496,0.8724505635080375,Upregulated
Feature1085,NP-016455,C11 H18 N2 O4,242.12664,NA,NA,NP-016455-peak2,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,18435260.62236883,9853729.933018303,0.5345045093130966,-0.9037259756858429,0.656349737294056,0.9089232543643583,Downregulated
Feature1084,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,20694905.14571613,20079983.49658397,0.9702863267648534,-0.043517552486092556,0.9463345070456863,0.9882637829765163,Downregulated
Feature1083,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,8888842.831651542,9318734.987816129,1.0483631181590722,0.06813850507336347,0.8731166618546865,0.9807974651872519,Upregulated
Feature1082,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak1,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,8799511.2881714,11322224.19025902,1.2866878420258108,0.36366208977808834,0.6941117686875496,0.9233562380758966,Upregulated
Feature1081,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,6834608.844138049,848033.80617051,0.12407934755444815,-3.0106650894938616,0.4363254085752434,0.8724505635080375,Downregulated
Feature1080,NA,C23 H26 N4 O5,438.1904,NA,NA,Feature1080,23,26,5,4,0,0,1.1304347826086956,0.21739130434782608,-0.17391304347826075,65.25652173913043,13,8,0.2857142857142857,0.3939393939393939,4,Lignin,21130789.4261747,21771329.548120834,1.0303131184087566,0.043082847822241824,0.653549989524334,0.9089232543643583,Upregulated
Feature1079,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,9056473.039242523,16548824.587948557,1.8272924256761978,0.8697075301415342,0.348823039464431,0.8724505635080375,Upregulated
Feature1078,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",C11 H11 N O5,237.06372,NA,NA,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",11,11,5,1,0,0,1,0.4545454545454546,0.18181818181818168,55.11818181818182,7,2,0.2,0.4666666666666667,1,Lignin,19678265.720798,24074886.547789264,1.223425218938093,0.29092592032671244,0.2555982788566144,0.8724505635080375,Upregulated
Feature1077,NA,C29 H30 O10,538.18408,NA,NA,Feature1077,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,2337928.2400532695,305116.0595907257,0.13050702513596982,-2.9378006263601293,0.4201055960214827,0.8724505635080375,Downregulated
Feature1076,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,11380553.905663477,5223029.11643769,0.45894331328095334,-1.123612125777484,0.4366916985341088,0.8724505635080375,Downregulated
Feature1075,Kanosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,14873232.632247698,7894563.70748908,0.5307900375586356,-0.9137868019856473,0.39645929422750964,0.8724505635080375,Downregulated
Feature1074,NA,C4 H N4 O7 P3,309.90566,NA,NA,Feature1074,4,1,7,4,0,3,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,22145557.91922657,19847170.16763513,0.8962145022503137,-0.15808402298818564,0.31640341150857104,0.8724505635080375,Downregulated
Feature1073,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak1,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,20663465.468397602,18279832.565570235,0.8846450559576824,-0.17682937271481303,0.6613020091191466,0.9105381213973839,Downregulated
Feature1072,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,15133491.889691344,15002663.48354603,0.9913550417115278,-0.012526261306619137,0.9867477868278056,0.995563282243182,Downregulated
Feature1071,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,3470402.133973301,2690659.1426438834,0.7753162425483293,-0.36714320579635,0.7183337706606652,0.930298368021698,Downregulated
Feature1070,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,4932462.345877867,6039483.248812013,1.2244357534445853,0.2921170771942238,0.5814726133641405,0.8964335502669541,Upregulated
Feature1069,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,15481168.514091337,17747413.227981634,1.146387187235092,0.19709439030961512,0.7851440724942349,0.952064465859151,Upregulated
Feature1068,Dicyclomine,C19 H35 N O2,309.26682,NA,NA,Dicyclomine,19,35,2,1,0,0,1.8421052631578947,0.10526315789473684,-1.473684210526316,102.3,3,1,0,0.0588235294117647,0,Lipid,8919753.026396146,498133.0733146293,0.05584606119031643,-4.162400658423082,0.21118482602042346,0.8724505635080375,Downregulated
Feature1067,Maltol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Maltol,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,5516328.178671765,736709.6108764086,0.13355072196843,-2.904540319757033,0.4303407255504219,0.8724505635080375,Downregulated
Feature1066,Proacaciberin,C16 H25 N O10,391.14794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,Proacaciberin,16,25,10,1,0,0,1.5625,0.625,-0.125,63.8625,5,-5,-1.2,-0.1,-6,Amino Sugar,340211.073369525,128837.09955300967,0.37869754878046386,-1.4008820118580956,0.33644660244043983,0.8724505635080375,Downregulated
Feature1065,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,2738287.24248285,6915718.776091633,2.5255636694348538,1.3366054125551265,0.17153948778278968,0.8724505635080375,Upregulated
Feature1064,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak2,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,20394216.757547498,23461883.385253735,1.1504184575546865,0.20215872797694373,0.3540264176938941,0.8724505635080375,Upregulated
Feature1063,N6-Me-Adenosine,C11 H15 N5 O4,281.11242,NA,NA,N6-Me-Adenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,923978.1269217203,1201302.8576461594,1.3001420949740015,0.37866930672412746,0.4246421820380788,0.8724505635080375,Upregulated
Feature1062,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,5766733.705550954,6300051.328758453,1.0924817497111299,0.12760917920306444,0.8278743997743387,0.9705323413271486,Upregulated
Feature1061,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature1061,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,21995837.273243,15071825.7341021,0.6852126403224639,-0.5453763293931662,0.18472535779889962,0.8724505635080375,Downregulated
Feature1060,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,12212051.599974453,15216579.695049632,1.246029757611036,0.31733852313336464,0.7028155802018161,0.9272348854064458,Upregulated
Feature1059,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,674181.2756682826,115807.45827036502,0.17177495497122908,-2.5414083900335207,0.419592079513977,0.8724505635080375,Downregulated
Feature1058,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature1058,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,13137864.56044941,10426445.686781196,0.7936179916307903,-0.33348336233004505,0.7526489222838372,0.9391931746219596,Downregulated
Feature1057,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,6813288.4238351565,6208748.847873313,0.9112705145657768,-0.13404870706186342,0.843696040483142,0.9755775375962064,Downregulated
Feature1056,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,950960.5477961653,1055567.8079617203,1.1100016824125674,0.15056186324783913,0.5606885539525931,0.8929340317679025,Upregulated
Feature1055,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,10355490.802652624,11873263.450158613,1.1465669446702809,0.19732059209641298,0.7845978636200891,0.952064465859151,Upregulated
Feature1054,NA,C23 H32 N2 O12,528.19573,NA,NA,Feature1054,23,32,12,2,0,0,1.391304347826087,0.5217391304347826,-0.08695652173913082,62.77826086956522,9,-3,-0.5555555555555556,0.06666666666666667,-5,Lignin,1456939.1799944667,1631022.8351247467,1.1194858766382692,0.16283632735758638,0.009775480636373369,0.8724505635080375,Upregulated
Feature1053,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,20924711.056489166,20164516.7412743,0.9636700209067349,-0.05338887031806788,0.8549250649230616,0.9789760557739694,Downregulated
Feature1052,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak3,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,10251934.457771244,7553813.7547603,0.7368183815332827,-0.4406190418509995,0.1744412114996795,0.8724505635080375,Downregulated
Feature1051,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature1051,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,26100639.431675803,15100128.19586188,0.5785347993251202,-0.7895243536983875,0.22420438267057188,0.8724505635080375,Downregulated
Feature1050,ascopyrone M,C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,ascopyrone M,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,4245530.201956393,7002397.497831724,1.64935759839959,0.7219042244313915,0.26145733795621623,0.8724505635080375,Upregulated
Feature1049,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,8323575.783468366,13227911.418626923,1.5892101859514711,0.6683099454393415,0.6065758402834227,0.9031677924568101,Upregulated
Feature1048,Xanthine,C5 H4 N4 O2,152.03344,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Other,Other,Xanthine,5,4,2,4,0,0,0.8,0.4,2.4,-8.099999999999994,6,4,-0,Inf,0,Condensed HC,2027661.2031340834,3368598.2312674588,1.6613220325272964,0.7323317540338494,0.723736917318766,0.930298368021698,Upregulated
Feature1047,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,4322831.126945537,5116966.943065857,1.1837073419709196,0.24331243529372873,0.6287836617317909,0.9043347628664763,Upregulated
Feature1046,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,13917149.24351146,7815439.257669257,0.5615689765857055,-0.8324648575394438,0.5159185372505699,0.8801268903348092,Downregulated
Feature1045,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak2,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,6189766.2158422,10860049.98655813,1.7545169894725134,0.8110739178221944,0.10255087158203802,0.8724505635080375,Upregulated
Feature1044,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak3",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,12268884.93414522,9217708.17853626,0.7513077372567651,-0.4125241351157565,0.7117695054676276,0.9283104618560314,Downregulated
Feature1043,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak4,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,15674638.254733266,22611849.866300233,1.4425755477624589,0.5286468748695317,0.1626695870282148,0.8724505635080375,Upregulated
Feature1042,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,3472991.261570203,607445.7242793743,0.17490562991072342,-2.5153513670139636,0.419932705605565,0.8724505635080375,Downregulated
Feature1041,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature1041,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,21438620.65584011,1988721.8047828623,0.09276351481321225,-3.430298704983528,0.23548727221600232,0.8724505635080375,Downregulated
Feature1040,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak2,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,4152863.8066245364,7292447.028990024,1.7560043787993502,0.8122964424041546,0.2299756615245036,0.8724505635080375,Upregulated
Feature1039,4-Oxo-4-(3-pyridyl)butyric acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Oxo-4-(3-pyridyl)butyric acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,18883760.350219235,21714493.927509934,1.1499030661685894,0.20151225086353775,0.03425836002124478,0.8724505635080375,Upregulated
Feature1038,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,1228571.220222222,154198.30936436166,0.12551027309305726,-2.9941226404018315,0.42098462849518603,0.8724505635080375,Downregulated
Feature1037,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak4,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,12085653.13007698,9971483.200708933,0.8250677967824003,-0.27741542272519637,0.719949245340755,0.930298368021698,Downregulated
Feature1036,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,549119.5409567037,507106.53196664335,0.9234902314405654,-0.1148313942392481,0.6392426691380304,0.9050396416750427,Downregulated
Feature1035,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak2,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,14222697.946615761,15768106.821723154,1.1086579269916308,0.14881429502170687,0.8320721588859716,0.9709621554641522,Upregulated
Feature1034,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,1284757.912888583,1094922.9849370867,0.8522407014994122,-0.2306671411778968,0.479396736227028,0.8724505635080375,Downregulated
Feature1033,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,187122335.3580391,3091502.215211913,0.016521289183873456,-5.9195299227138785,0.423618688832334,0.8724505635080375,Downregulated
Feature1032,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature1032,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,6928124.763284616,1929128.7452866985,0.2784489037365575,-1.8445154821840066,0.3107888724288136,0.8724505635080375,Downregulated
Feature1031,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak5,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,14253362.509850742,16294450.638948336,1.143200464289529,0.19307840747014687,0.8071531117699099,0.9626572180425523,Upregulated
Feature1030,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,827949.097655552,695317.8460849416,0.839807480983827,-0.25186945516621,0.7741648612746703,0.9502143902366301,Downregulated
Feature1029,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature1029,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,3808453.4389671027,467545.369604391,0.12276515312504248,-3.026026984896437,0.41922367370228364,0.8724505635080375,Downregulated
Feature1028,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,14117731.204314223,18459307.2041775,1.3075264670385947,0.38684014989773463,0.2672957755754935,0.8724505635080375,Upregulated
Feature1027,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak1,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,6189408.845207175,612438.6395068266,0.09894945621197314,-3.3371644109753618,0.41572908307802187,0.8724505635080375,Downregulated
Feature1026,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,4210462.453743063,3149302.8407777133,0.7479707693339034,-0.41894620413411343,0.6018633653817714,0.9026012960519595,Downregulated
Feature1025,(DL)-3-O-Methyldopa,C10 H13 N O4,211.08446,NA,NA,(DL)-3-O-Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,11017585.086361546,13431625.4818586,1.2191079421283841,0.2858258705675688,0.30818856241636655,0.8724505635080375,Upregulated
Feature1024,NA,C18 H29 N3 O12,479.17524,NA,NA,Feature1024,18,29,12,3,0,0,1.6111111111111112,0.6666666666666666,0.22222222222222232,53.96666666666666,6,-6,-3,-0.3333333333333333,-9,Amino Sugar,575280.5977313557,795411.4054204461,1.382649455860646,0.4674354353062845,0.4643366548983173,0.8724505635080375,Upregulated
Feature1023,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,8554829.41430282,8171382.138025923,0.9551776829546347,-0.06615896543162854,0.8389539125534311,0.9729838623914456,Downregulated
Feature1022,NA,C12 H23 N5 O2,269.18519,NA,NA,Feature1022,12,23,2,5,0,0,1.9166666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,2,-0.6,-0.3333333333333333,-3,Lipid,315443.08480123954,111904.6131116164,0.35475373689718837,-1.4951102134918894,0.4721022644750505,0.8724505635080375,Downregulated
Feature1021,NA,C10 H23 N O7,269.14745,NA,NA,Feature1021,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,464805.56118036096,716616.8121218791,1.5417561061490968,0.6245745601434488,0.43097803932682444,0.8724505635080375,Upregulated
Feature1020,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,16482469.098703211,15209495.9023384,0.9227680519986557,-0.1159600388735969,0.9122200952869848,0.9838470257338569,Downregulated
Feature1019,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature1019,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,13170980.672065834,17530835.333259568,1.3310197448273913,0.41253197286759247,0.06330480846840565,0.8724505635080375,Upregulated
Feature1018,MFCD03548046,C12 H16 N2 O4,252.111,NA,NA,MFCD03548046,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,8036860.169748397,8563851.882813243,1.0655718404867238,0.09162786240267597,0.8533628182298826,0.9789760557739694,Upregulated
Feature1017,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,1505220.0160424137,294016.164028945,0.1953310219737739,-2.35600700232637,0.41861719316298107,0.8724505635080375,Downregulated
Feature1016,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak3",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,17468367.493573867,20727800.863387167,1.186590611344326,0.24682227292607645,0.1516405348952912,0.8724505635080375,Upregulated
Feature1015,Guanine,C5 H5 N5 O,151.04939,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,16619420.704009132,15023508.816398934,0.9039730736688545,-0.14564829466167872,0.7524965033256044,0.9391931746219596,Downregulated
Feature1014,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,3655847.6400195677,6185346.7988272905,1.6919049719463102,0.7586485398811289,0.5335838290844019,0.8827060610048603,Upregulated
Feature1013,3-Hydroxy-2-methylpyridine,C6 H7 N O,109.05272,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,3-Hydroxy-2-methylpyridine,6,7,1,1,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,3,0.5,0.5555555555555556,2,Lignin,14880950.332462067,19495922.150069002,1.3101261488347018,0.38970573201926345,0.03480517985361833,0.8724505635080375,Upregulated
Feature1012,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,13469332.962362034,6908908.86220652,0.5129362293969861,-0.9631486204225057,0.40296079100428867,0.8724505635080375,Downregulated
Feature1011,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,C15 H13 N O3,255.08951,NA,NA,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,15,13,3,1,0,0,0.8666666666666667,0.2,-0.2666666666666666,67.89999999999999,10,7,0.5454545454545454,0.6,6,Lignin,18106200.6171966,20100227.008636333,1.11012947628261,0.15072795035674527,0.2819730692515715,0.8724505635080375,Upregulated
Feature1010,NA,C10 H15 N O5,229.09503,NA,NA,Feature1010,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,9706003.024194624,17459498.422466133,1.7988350486749278,0.8470628990022119,0.1331920635521078,0.8724505635080375,Upregulated
Feature1009,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,9456757.624132106,13881569.74574082,1.4678994955223674,0.553753192789294,0.5701213890502786,0.8929340317679025,Upregulated
Feature1008,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak3,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,6471070.16476168,6438620.422967346,0.9949854133909659,-0.007252719163508159,0.9951420730821419,0.9974974389355906,Downregulated
Feature1007,NA,C17 H29 N O12,439.16903,NA,NA,Feature1007,17,29,12,1,0,0,1.7058823529411764,0.7058823529411765,-0.117647058823529,63.65294117647058,4,-8,-2.25,-0.3,-9,Carbohydrate,442188.2049029167,163280.81527313867,0.36925637876068473,-1.4373052516849194,0.37354122356796576,0.8724505635080375,Downregulated
Feature1006,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature1006,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,831918.8802363169,2309520.8410124183,2.776137068023231,1.4730788007964133,0.3256671684557997,0.8724505635080375,Upregulated
Feature1005,Pyridoxine,C8 H11 N O3,169.07393,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak1,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,15354056.089692667,19269077.7465952,1.2549828940335008,0.32766769974479,0.029598668619520856,0.8724505635080375,Upregulated
Feature1004,Perillartine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Perillartine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,8321253.353281723,7352737.035053857,0.8836093221646827,-0.17851945554024362,0.45482026016228205,0.8724505635080375,Downregulated
Feature1003,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature1003,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,15257845.000604535,19107435.6639415,1.2523023836711173,0.3245829606330704,0.2791983229079992,0.8724505635080375,Upregulated
Feature1002,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,5152711.757403406,7338045.264116533,1.424113284344548,0.5100639133418963,0.002861773232290406,0.8724505635080375,Upregulated
Feature1001,2-Mercaptoethanol,C2 H6 O S,78.01397,Metabolic pathways;Other,Other,2-Mercaptoethanol,2,6,1,0,1,0,3,0.5,-1,88.8,0,-1,-Inf,-3,-2,Other,9076552.33273129,15492329.054834733,1.7068517303610176,0.7713377407538131,0.12926127279631705,0.8724505635080375,Upregulated
Feature1000,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,37955159.970708184,10926670.58805505,0.2878836657910989,-1.7964421606254735,0.525393044908954,0.8826174436414305,Downregulated
Feature0999,metharbital,C9 H14 N2 O3,198.10045,NA,NA,metharbital-peak2,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,16042094.2793368,18554794.9840011,1.1566317128494135,0.20992956398949092,0.47671184520606164,0.8724505635080375,Upregulated
Feature0998,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak1,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,18793795.7434273,19528287.323750533,1.0390815985419075,0.055308952788146064,0.8510935902069998,0.9789760557739694,Upregulated
Feature0997,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,1610910.64993066,195285.037869044,0.12122648632154108,-3.0442231525940677,0.41966027580936427,0.8724505635080375,Downregulated
Feature0996,Benserazide,C10 H15 N3 O5,257.1012,NA,NA,Benserazide,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,2544936.1806126046,2127633.5454375767,0.8360262868852857,-0.25837978970701664,0.784671749649285,0.952064465859151,Downregulated
Feature0995,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,5336868.03118693,9642254.03580212,1.806725214012396,0.8533771024798117,0.47889484332442706,0.8724505635080375,Upregulated
Feature0994,NA,C11 H18 N2 O4,242.12664,NA,NA,Feature0994,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,4436702.391339623,4381084.278322264,0.9874640874885082,-0.018199814299486982,0.9605960230745783,0.9882637829765163,Downregulated
Feature0993,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,5362230.75739786,5532145.47586056,1.0316873193545955,0.04500578939582326,0.9412131522174794,0.9882637829765163,Upregulated
Feature0992,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak1,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,3138731.859927976,592137.6911215864,0.18865507394288025,-2.40617719243989,0.17739256236810744,0.8724505635080375,Downregulated
Feature0991,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,6759988.453039144,2945055.5524565666,0.43565984955677456,-1.198725934387157,0.5601674095400667,0.8929340317679025,Downregulated
Feature0990,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3454601.1264959234,4138056.22756678,1.1978390778110177,0.2604341040882613,0.5447679203031652,0.8890580920144323,Upregulated
Feature0989,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,15300260.07088977,4461476.80862665,0.2915948348561109,-1.7779629300698092,0.3421086031165154,0.8724505635080375,Downregulated
Feature0988,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0988,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,677822.0126751554,119447.71008843403,0.17622282524731026,-2.5045272935666634,0.4191044141945468,0.8724505635080375,Downregulated
Feature0987,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,14925039.261787299,14661714.291410081,0.9823568323165882,-0.025680929100993156,0.9675937608993344,0.9897969993740776,Downregulated
Feature0986,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,10920555.35808571,7205624.512444656,0.6598221680282519,-0.5998508459824347,0.6090824089027648,0.904145091526307,Downregulated
Feature0985,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak1,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,9601427.41261471,1062902.7483307198,0.11070257604970682,-3.1752393008537525,0.4386777957656821,0.8724505635080375,Downregulated
Feature0984,Valylglutamine,C10 H19 N3 O4,245.13752,NA,NA,Valylglutamine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2799747.77914386,3486464.0022058166,1.2452778883074778,0.3164677208859186,0.6388640212014439,0.9050396416750427,Upregulated
Feature0983,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,15996470.71984554,4126714.90413167,0.2579765859860566,-1.9546879626290063,0.187841773228692,0.8724505635080375,Downregulated
Feature0982,NA,C16 H25 N O9,375.15303,NA,NA,Feature0982,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,14509250.223364346,15166124.990804,1.045272826460866,0.06387954901449494,0.913434811911848,0.9838470257338569,Upregulated
Feature0981,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak2,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,2548162.9227137337,356011.2753814513,0.1397129171796863,-2.8394626833771177,0.4337725024529788,0.8724505635080375,Downregulated
Feature0980,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0980,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,8738978.786624134,13449633.5925273,1.5390395057501784,0.6220302648164552,0.060889112752607055,0.8724505635080375,Upregulated
Feature0979,D-lysopine,C9 H18 N2 O4,218.12662,Lysine degradation,NA,D-lysopine-peak4,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6854359.019512027,6386828.615266607,0.931790791390629,-0.10192202209362097,0.909888862422161,0.983565624317811,Downregulated
Feature0978,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12236,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,3001564.598607213,2436880.87900349,0.8118702093349089,-0.3006789873235006,0.7098238425033294,0.9283104618560314,Downregulated
Feature0977,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,3861207.5475301566,3318341.33610887,0.8594050683008392,-0.2185898095244924,0.8068561112544888,0.9626572180425523,Downregulated
Feature0976,gamma-Glu-gln,C10 H17 N3 O6,275.11175,NA,NA,gamma-Glu-gln,10,17,6,3,0,0,1.7,0.6,0.3999999999999999,48.9,4,-2,-5,-0.5,-5,Amino Sugar,12208002.092966637,10429611.099638874,0.8543257955081494,-0.2271417511174012,0.7688707522160518,0.9502143902366301,Downregulated
Feature0975,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,3963146.2349495133,742264.2872410853,0.18729167263507274,-2.416641339007206,0.2750543170694115,0.8724505635080375,Downregulated
Feature0974,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,11395860.847666001,12345147.680102691,1.0833010200042161,0.11543418451998805,0.8639472615866575,0.9789760557739694,Upregulated
Feature0973,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",C11 H12 O6,240.06344000000001,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",11,12,6,0,0,0,1.0909090909090908,0.5454545454545454,0,60.3,6,0,0,0.375,0,Lignin,9165044.435058704,15190528.5472525,1.6574418874768067,0.7289582880640983,0.23166109625220935,0.8724505635080375,Upregulated
Feature0972,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,3743597.61404711,3613885.6984521803,0.9653509995015993,-0.05087449637309819,0.9565417048906459,0.9882637829765163,Downregulated
Feature0971,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,11802512.719532046,11733955.483024307,0.9941913016205198,-0.008404613980445267,0.9821172422357614,0.9951332564369114,Downregulated
Feature0970,Nojirimycin,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,10914015.70628777,1893296.6274003533,0.1734738778421942,-2.5272096605843077,0.44070617287192493,0.8724505635080375,Downregulated
Feature0969,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,4663312.058938763,3999206.25167152,0.8575892415361166,-0.22164128759896293,0.4666185707963781,0.8724505635080375,Downregulated
Feature0968,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0968,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,4510289.842622837,2528715.9080585665,0.560654857291402,-0.834815183070838,0.3187053283640426,0.8724505635080375,Downregulated
Feature0967,Methoxyphenamine,C11 H17 N O,179.13104,NA,NA,Methoxyphenamine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,1562794.9578294477,1470020.8203438183,0.9406357583758251,-0.0882919174321751,0.9580408437775834,0.9882637829765163,Downregulated
Feature0966,Vorinostat,C14 H20 N2 O3,264.14742,Metabolic pathways;Other,NA,Vorinostat,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,7989227.416242537,9297774.961350564,1.1637889969745607,0.21882951132794676,0.6790052776916615,0.9231420067493376,Upregulated
Feature0965,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0965,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,2894227.4332598667,3167791.71209713,1.0945206571168247,0.13029918306045002,0.7850333372798023,0.952064465859151,Upregulated
Feature0964,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0964,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,3001402.36788364,3048063.298703517,1.0155463763603207,0.02225612384610515,0.951045145296647,0.9882637829765163,Upregulated
Feature0963,pyroglutamylglycine,C7 H10 N2 O4,186.06407,NA,NA,pyroglutamylglycine,7,10,4,2,0,0,1.4285714285714286,0.5714285714285714,0.5714285714285716,44.014285714285705,4,0,-2,0,-2,Lignin,14057590.718088567,17145132.63625147,1.219635212041706,0.2864497080550972,0.028720536412968723,0.8724505635080375,Upregulated
Feature0962,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0962,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,6074050.662654564,12272358.897301417,2.020457118139674,1.0146817323163522,0.14186491753313057,0.8724505635080375,Upregulated
Feature0961,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak3,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,5462471.563343423,3398417.293898993,0.6221391277722128,-0.6846908513447436,0.382077834645259,0.8724505635080375,Downregulated
Feature0960,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak2",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,17002174.37496327,15606740.5585049,0.9179261554620196,-0.12354999727643855,0.7318573875019522,0.930298368021698,Downregulated
Feature0959,NA,C9 H19 N O9,285.106,NA,NA,Feature0959,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,7186428.707818263,6008187.8554530395,0.8360464007548852,-0.2583450804744094,0.6067325547909386,0.9031677924568101,Downregulated
Feature0958,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0958,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,15109483.342685653,8345178.151712327,0.5523139317501643,-0.8564395760002489,0.23059537242258896,0.8724505635080375,Downregulated
Feature0957,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak1,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,15246233.014131574,1520204.0111655067,0.09971013887538288,-3.3261159794187347,0.41540691714801664,0.8724505635080375,Downregulated
Feature0956,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0956,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,6968194.804663117,4660537.019749846,0.6688298978999574,-0.5802887549627151,0.6370436852068453,0.9050396416750427,Downregulated
Feature0955,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,6520895.098344861,13631356.50304152,2.0904118679200105,1.063787220423433,0.20125116150100364,0.8724505635080375,Upregulated
Feature0954,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,7627665.93684384,11029794.457711147,1.4460248454817664,0.5320923407713217,0.6769632884816974,0.9231420067493376,Upregulated
Feature0953,NA,C7 H9 O5 P S,235.99087,NA,NA,Feature0953,7,9,5,0,1,1,1.2857142857142858,0.7142857142857143,-0.2857142857142856,68.44285714285714,4,-1,-Inf,-0.2,-3,Tannin,8653448.015996132,5185283.54804895,0.5992158892575322,-0.7388522150007183,0.500492317869368,0.8747804400244787,Downregulated
Feature0952,NA,C19 H41 N O2,315.3138,NA,NA,Feature0952,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,2226621.94396425,234141.24921277267,0.10515536768487538,-3.2494056001700065,0.03167028842633404,0.8724505635080375,Downregulated
Feature0951,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,13516794.17590443,4812174.039996809,0.3560144496818025,-1.4899922973439437,0.12545382221929774,0.8724505635080375,Downregulated
Feature0950,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0950,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,5394340.906765087,10326918.686513936,1.9143986012383578,0.9368912478795521,0.5275968243778995,0.8826174436414305,Upregulated
Feature0949,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,2181028.8240540028,1659747.6119447467,0.7609929743430346,-0.3940449603796338,0.6805676690159628,0.9233562380758966,Downregulated
Feature0948,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak3,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,6987106.5857028235,7255220.156332414,1.0383726178126738,0.05432424466431973,0.9431394057550886,0.9882637829765163,Upregulated
Feature0947,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak2,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,13987217.626443934,9080154.009875737,0.6491751435045232,-0.6233203338019773,0.30596966236058154,0.8724505635080375,Downregulated
Feature0946,NA,C5 H11 N3,113.09524,NA,NA,Feature0946,5,11,0,3,0,0,2.2,0,-0.4000000000000003,71.7,2,2,-0.5,-0.5,-1,Lipid,12682582.61452236,9396323.036108954,0.7408840392925624,-0.43268034051978527,0.5103001865724445,0.8776127066535239,Downregulated
Feature0945,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10593,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak2,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,4304482.021804817,4677255.575341533,1.0866012569336778,0.11982262097051716,0.8867847080974987,0.9824808996188115,Upregulated
Feature0944,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak3,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,11008501.825987156,17178604.579194266,1.560485236841374,0.6419947085314026,0.13252523229489385,0.8724505635080375,Upregulated
Feature0943,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,12041514.308796033,15417111.672329534,1.2803299715441694,0.3565156750382753,0.08064246824264945,0.8724505635080375,Upregulated
Feature0942,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak1,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,974073.1963626437,524252.7497023887,0.5382067299049377,-0.8937676638871525,0.5990163143007923,0.9015641283557303,Downregulated
Feature0941,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,5369764.011017053,8889964.518409153,1.6555596298402993,0.7273189745679539,0.2259889736023618,0.8724505635080375,Upregulated
Feature0940,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,2868346.2536521745,498235.2177224107,0.17370121096364274,-2.525320283008589,0.4356359899979215,0.8724505635080375,Downregulated
Feature0939,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,12703187.92058168,11346701.164615227,0.8932168236471826,-0.16291767045807315,0.8887697153302485,0.983078949019388,Downregulated
Feature0938,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2003174.1217535797,224674.583527676,0.11215928814565343,-3.1563789969168687,0.4130327564078749,0.8724505635080375,Downregulated
Feature0937,NA,C19 H41 N O2,315.31381,NA,NA,Feature0937,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,1181199.692447687,261933.43367956966,0.22175203342356964,-2.1729807610638434,0.40682511642008307,0.8724505635080375,Downregulated
Feature0936,NA,C12 H21 N O8,307.12685,NA,NA,Feature0936,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1726643.0084246963,2230752.19629558,1.2919591284424266,0.3695604306153467,0.4776169127752385,0.8724505635080375,Upregulated
Feature0935,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,13789490.92267477,13696107.5635578,0.9932279328047263,-0.009803259518209968,0.9857341229640717,0.9951332564369114,Downregulated
Feature0934,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0934,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,5265379.857547477,1140717.5349593353,0.21664487004184763,-2.2065960196106515,0.2702951553691665,0.8724505635080375,Downregulated
Feature0933,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,3129316.7066099434,2979770.9407031676,0.9522113675516142,-0.07064624291765559,0.9261105141757998,0.9874405343841273,Downregulated
Feature0932,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,3423955.97157233,4481258.8368978035,1.3087956954189293,0.38823990842899225,0.2955188152760672,0.8724505635080375,Upregulated
Feature0931,NA,C9 H19 N O9,285.10601,NA,NA,Feature0931,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,3674555.2330109132,4809290.002886773,1.3088087395399044,0.38825428698702985,0.5658620256619715,0.8929340317679025,Upregulated
Feature0930,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak2,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,13514270.025298886,9450014.08215209,0.6992618960892111,-0.5160952023418863,0.4801908573398541,0.8724505635080375,Downregulated
Feature0929,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0929,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,9133654.74457597,13124974.971160434,1.4369904860871507,0.5230505101457547,0.19303786088660058,0.8724505635080375,Upregulated
Feature0928,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak1,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,8338605.133495933,13455897.500450367,1.6136868558985267,0.6903606435018695,0.26807668765180365,0.8724505635080375,Upregulated
Feature0927,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak3,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,6093849.737055164,1857080.2036166599,0.30474663533697316,-1.714317802538873,0.16162978331412456,0.8724505635080375,Downregulated
Feature0926,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0926,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,362415.33419110335,59471.81822839344,0.16409851520530216,-2.607365909756872,0.41772313364757624,0.8724505635080375,Downregulated
Feature0925,NA,C4 H5 N O,83.03712,NA,NA,Feature0925,4,5,1,1,0,0,1.25,0.25,0,60.3,3,2,0.5,0.6,1,Lignin,4442481.568499563,949481.466200053,0.2137277221210257,-2.2261540461661293,0.49226925197028865,0.8724505635080375,Downregulated
Feature0924,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197-peak2,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,4859699.830773033,6248119.615937944,1.2857007291629479,0.36255486755054406,0.2282488467330843,0.8724505635080375,Upregulated
Feature0923,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak2,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,12483852.223176781,14611494.973848833,1.1704315873526598,0.22704061025385516,0.4597747015859695,0.8724505635080375,Upregulated
Feature0922,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,10309358.6216898,10895943.287256537,1.056898269532755,0.07983651853349166,0.8770682533771323,0.9807974651872519,Upregulated
Feature0921,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,2234131.720833026,259310.03300091365,0.11606747739306367,-3.1069643154207607,0.42158132346159927,0.8724505635080375,Downregulated
Feature0920,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0920,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,13759027.49436154,11073545.4143381,0.8048203565895953,-0.31326129871578656,0.5694919676177617,0.8929340317679025,Downregulated
Feature0919,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0919,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,2960005.98553292,2852632.696763289,0.9637253136330063,-0.05330609483285083,0.9642366188315002,0.988553862051552,Downregulated
Feature0918,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,7322165.2615144765,10347679.836837754,1.4131994385903135,0.498965081214164,0.5876210998806332,0.9001845658902912,Upregulated
Feature0917,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0917,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,12586237.215771066,7217095.091857763,0.573411653390296,-0.8023568702573891,0.31215628295215186,0.8724505635080375,Downregulated
Feature0916,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,1406919.6738499787,2497990.730010818,1.7755034466005921,0.8282281609157733,0.6177517319422674,0.9043347628664763,Upregulated
Feature0915,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,3053468.0348518435,4246861.097873931,1.39083201441799,0.47594818077071255,0.629389652097216,0.9043347628664763,Upregulated
Feature0914,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,30059427.156462267,8833034.53111252,0.29385239063724367,-1.7668364594619606,0.3132793484160416,0.8724505635080375,Downregulated
Feature0913,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,2522420.75624599,2677100.5240489966,1.0613219532942673,0.08586236592615987,0.7405108389934884,0.9351636436381646,Upregulated
Feature0912,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0912,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,1178838.6048013268,168523.63312780732,0.14295734160844614,-2.806343383067193,0.42966739654730013,0.8724505635080375,Downregulated
Feature0911,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak2,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,8723485.017760932,8203917.792790836,0.9404404061092255,-0.08859156903861606,0.9545952870977553,0.9882637829765163,Downregulated
Feature0910,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak2,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,6406027.305394907,5220783.897480046,0.81497996317988,-0.29516350471710545,0.8022487799926394,0.9611099245456373,Downregulated
Feature0909,Methylone,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak2,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,8012504.630337487,6019575.69922981,0.7512726640354236,-0.4125914858711146,0.6261612704921908,0.9043347628664763,Downregulated
Feature0908,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,3087777.812505815,11304131.617691133,3.6609277947099197,1.8722093193291003,0.08908240970844471,0.8724505635080375,Upregulated
Feature0907,NA,C12 H18 N4 O4,282.13282,NA,NA,Feature0907,12,18,4,4,0,0,1.5,0.3333333333333333,0.16666666666666652,55.55,6,2,-0.5,0,-2,Protein,8777317.14958532,11374731.381847033,1.2959234795776324,0.3739805338914582,0.4894312654089006,0.8724505635080375,Upregulated
Feature0906,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,8726917.377572257,7133904.048052956,0.8174597901415607,-0.29078032695563494,0.7944439587415905,0.9578562748101455,Downregulated
Feature0905,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07429,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak1",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,13230426.316785367,15178831.119770534,1.1472669705671719,0.19820114749720485,0.41090768968711006,0.8724505635080375,Upregulated
Feature0904,NA,C15 H27 N O13,429.14831,NA,NA,Feature0904,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,1955171.6924556338,872017.397494147,0.4460055354007917,-1.1648664792581174,0.20241160886665266,0.8724505635080375,Downregulated
Feature0903,NA,C6 H2 O4,137.99529,NA,NA,Feature0903,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,2251164.737803256,863736.8274290201,0.38368441586015445,-1.3820079268136505,0.3087430227168847,0.8724505635080375,Downregulated
Feature0902,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0902,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,837298.4350900376,318206.99399830267,0.3800401155223523,-1.3957763831454715,0.29965613682840647,0.8724505635080375,Downregulated
Feature0901,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak1,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,2185166.741352289,257710.963159098,0.11793652094467343,-3.0839175536096204,0.4218584453870362,0.8724505635080375,Downregulated
Feature0900,Methyldopa,C10 H13 N O4,211.08447,NA,NA,Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,12230248.894009631,13834624.693294233,1.1311809606810557,0.17782974293835913,0.678706443581319,0.9231420067493376,Upregulated
Feature0899,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,1148472.2960613063,460784.526535085,0.4012151865703237,-1.317551879827014,0.3340991127663957,0.8724505635080375,Downregulated
Feature0898,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,6536684.2394563565,4534272.88625408,0.6936655833678738,-0.5276877887055972,0.7314239305221244,0.930298368021698,Downregulated
Feature0897,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0897,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,11724972.33820655,8474689.54766736,0.7227897263392306,-0.4683520948619124,0.529083851724092,0.8826174436414305,Downregulated
Feature0896,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0896,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,752910.5184542934,99704.9364737374,0.1324260108338361,-2.916741573834494,0.41681578111174394,0.8724505635080375,Downregulated
Feature0895,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2109563.908472153,2070022.9463436867,0.9812563336101519,-0.02729803395653267,0.974491527413711,0.9914646531164122,Downregulated
Feature0894,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak3,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,6276822.754265446,6645321.99170487,1.0587079246724003,0.08230463489615895,0.8227841780018108,0.9680535986412692,Upregulated
Feature0893,NA,C10 H17 N3 O3,227.12699,NA,NA,Feature0893,10,17,3,3,0,0,1.7,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,2688669.3313466557,5965960.597654123,2.2189268602494874,1.1498621145406147,0.3632043751974504,0.8724505635080375,Upregulated
Feature0892,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0892,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,5325542.251172837,3489678.97540332,0.6552720475806558,-0.6098341039450276,0.3840062983809546,0.8724505635080375,Downregulated
Feature0891,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,11151635.873236267,15414280.442255666,1.382243880402307,0.46701218447127074,0.3372526910085164,0.8724505635080375,Upregulated
Feature0890,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0890,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,10686104.9986427,9249988.891040111,0.8656090214549644,-0.20821255974699213,0.7615354944205929,0.9464718470641851,Downregulated
Feature0889,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,12631095.177474633,15723003.856874434,1.2447854786902155,0.31589713546902876,0.20882647241061075,0.8724505635080375,Upregulated
Feature0888,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,6495645.0472315755,10893617.92316011,1.6770648402044286,0.7459384687668997,0.295985770906586,0.8724505635080375,Upregulated
Feature0887,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,11381257.51447157,7620167.841320777,0.669536545643707,-0.5787652898531164,0.14361761451044294,0.8724505635080375,Downregulated
Feature0886,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1876741.7972480666,2222199.073835593,1.1840728847698083,0.24375788777400814,0.7059240107336352,0.9283104618560314,Upregulated
Feature0885,NA,C13 H27 N O11,373.15852,NA,NA,Feature0885,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,250966.2030655975,85001.54880331452,0.3386971941440929,-1.56193205966784,0.4270727579200784,0.8724505635080375,Downregulated
Feature0884,leu-phe,C15 H22 N2 O3,278.16308,NA,NA,leu-phe-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,10387552.517846683,5621256.21844225,0.5411530973041496,-0.8858912910847403,0.37665274059767867,0.8724505635080375,Downregulated
Feature0883,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",C12 H12 N2 O2,216.0899,NA,NA,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",12,12,2,2,0,0,1,0.16666666666666666,-0.16666666666666696,65.05000000000001,8,6,0.5,0.5555555555555556,4,Lignin,12791844.623680666,14247615.513884533,1.113804610127057,0.15549616919097972,0.47954800959858895,0.8724505635080375,Upregulated
Feature0882,NA,C11 H17 N5 O,235.1433,NA,NA,Feature0882,11,17,1,5,0,0,1.5454545454545454,0.09090909090909093,0,60.3,6,5,0,0.09090909090909093,0,Lipid,616959.7037794108,357275.24544664,0.5790900819908021,-0.7881403067200579,0.6782978334296339,0.9231420067493376,Downregulated
Feature0881,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,5646323.646643124,10169818.96178856,1.8011399271869164,0.8489102658732328,0.4658300633063607,0.8724505635080375,Upregulated
Feature0880,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,8280911.15966652,10460610.97235014,1.2632198040355982,0.3371056942335113,0.28016091228972095,0.8724505635080375,Upregulated
Feature0879,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,460280.79841671325,90839.99665266706,0.19735778021838196,-2.3411147007577973,0.41907145753368386,0.8724505635080375,Downregulated
Feature0878,NA,C12 H21 N O8,307.12682,NA,NA,Feature0878,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,15943905.18550801,13984637.225023694,0.8771149265071417,-0.18916220656287402,0.7747970479921407,0.9502143902366301,Downregulated
Feature0877,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak3,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,937039.9616866753,162972.32791272533,0.17392249485216676,-2.523483554348364,0.41793314384568664,0.8724505635080375,Downregulated
Feature0876,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak2,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,11341058.309402026,10026798.567331953,0.8841148941999074,-0.17769422920554073,0.7452582824090594,0.9351636436381646,Downregulated
Feature0875,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,6883447.585956886,5423244.65690405,0.7878675023208084,-0.34397506649657816,0.6405335190068415,0.9050396416750427,Downregulated
Feature0874,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak1,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,1974280.75933755,1457495.8369743268,0.7382414228984203,-0.43783540507746854,0.2940053286202242,0.8724505635080375,Downregulated
Feature0873,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,592802.6610144731,284383.68674701964,0.4797274125935081,-1.0597132144833294,0.46721839166899426,0.8724505635080375,Downregulated
Feature0872,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,9214357.11029584,12168898.59361811,1.3206454284283118,0.40124317868782466,0.17526804981770114,0.8724505635080375,Upregulated
Feature0871,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak6,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,13662516.748650834,13937338.147006266,1.0201149907744904,0.028731786774754176,0.8943651237292022,0.983565624317811,Upregulated
Feature0870,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,8802816.497812606,12357691.143103207,1.4038337782201802,0.48937212258396995,0.42991572708893927,0.8724505635080375,Upregulated
Feature0869,NA,C12 H21 N O8,307.12679,NA,NA,Feature0869,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,945745.4421130037,740019.1115618446,0.7824717715884296,-0.353889388495745,0.7455105884575668,0.9351636436381646,Downregulated
Feature0868,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0868,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,8690902.843295716,12558973.5994251,1.4450712228492197,0.5311406002132546,0.04029915607562846,0.8724505635080375,Upregulated
Feature0867,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,719484.9897313567,2086463.3078687643,2.899940009377838,1.5360230557339025,0.5332914307960906,0.8827060610048603,Upregulated
Feature0866,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0866,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,6587780.02132427,6948741.079647036,1.0547925184439,0.07695924343478984,0.8883736666911145,0.983078949019388,Upregulated
Feature0865,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak2",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,10064334.710919866,4949359.117765663,0.4917721101222496,-1.0239381772149958,0.3917260852858058,0.8724505635080375,Downregulated
Feature0864,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1861917.99378591,911546.8821046897,0.4895741300889445,-1.0304007692474415,0.021792323287931615,0.8724505635080375,Downregulated
Feature0863,Pro-Hyp,C10 H16 N2 O4,228.111,NA,NA,Pro-Hyp-peak2,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,10239222.785185404,7586919.01851637,0.7409662996583575,-0.4325201669600178,0.5454996281780262,0.8890580920144323,Downregulated
Feature0862,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,15663893.1300445,12478464.556709733,0.796638770011468,-0.3280024018508355,0.34047701098832106,0.8724505635080375,Downregulated
Feature0861,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1967748.4770032535,2597902.3674133033,1.320241076425444,0.40080139019536404,0.5673819736286725,0.8929340317679025,Upregulated
Feature0860,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,807529.9113763312,112610.64957689917,0.13945074726082748,-2.8421724296742275,0.41680187251976664,0.8724505635080375,Downregulated
Feature0859,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,4318281.7489712695,5407368.175946583,1.2522036518888011,0.32446921376979504,0.6272550097353162,0.9043347628664763,Upregulated
Feature0858,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,12237494.639646158,13549342.3355349,1.1071990415128528,0.14691459916634622,0.5121053026120113,0.8780428973934686,Upregulated
Feature0857,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,14498091.522119367,3892564.7221344467,0.26848807763391896,-1.8970700689497118,0.009898097419826625,0.8724505635080375,Downregulated
Feature0856,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0856,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,8775742.4976799,12112704.777210234,1.380248426889525,0.4649279568480376,0.03830427346482699,0.8724505635080375,Upregulated
Feature0855,NA,C11 H24 N4 O5,292.17471,NA,NA,Feature0855,11,24,5,4,0,0,2.1818181818181817,0.4545454545454546,-0.18181818181818168,65.48181818181817,2,-3,-3.5,-1,-7,Protein,8326115.637649421,6931124.58284672,0.8324559595960012,-0.2645541452897706,0.37389303233832044,0.8724505635080375,Downregulated
Feature0854,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,2566286.83429384,3090394.9041799037,1.204228172347025,0.2681087740954554,0.6303356259482867,0.9043347628664763,Upregulated
Feature0853,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10734,NA,NA,N(6)-OH-Me-Adenosine-peak2,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,10920035.454737261,12270822.483112535,1.1236980442027122,0.16825441219896745,0.5725881595132633,0.8929340317679025,Upregulated
Feature0852,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,6246111.409283316,4780767.3529555,0.7653989882169023,-0.38571610098236764,0.6603093775973927,0.9101416482099132,Downregulated
Feature0851,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0851,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,6820960.7150630085,9604668.430371284,1.4081107972313782,0.4937608569349554,0.6462792188390449,0.905539285949828,Upregulated
Feature0850,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak1,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,9119335.635104926,10956846.66070349,1.2014961505008168,0.2648320261937233,0.7860635990503129,0.9524976658020243,Upregulated
Feature0849,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,12772961.120946554,6173498.520776735,0.48332555484356166,-1.0489328185752642,0.6587739725973607,0.9098405617363219,Downregulated
Feature0848,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,2989998.91591254,3965530.7099403865,1.3262649323503573,0.4073689944625916,0.29289159255857483,0.8724505635080375,Upregulated
Feature0847,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,2481318.711986919,327643.3212987023,0.13204402953796351,-2.9209090243607956,0.42003982743283463,0.8724505635080375,Downregulated
Feature0846,Leucylasparagine,C10 H19 N3 O4,245.13754,NA,NA,Leucylasparagine-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,6091329.423916557,7917710.764195753,1.2998329614399484,0.3783262377261752,0.5666618251469907,0.8929340317679025,Upregulated
Feature0845,NA,C17 H29 N O14,471.15895,NA,NA,Feature0845,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,751900.8531075796,235523.77658397733,0.3132378100258377,-1.6746697282211995,0.11192071893277904,0.8724505635080375,Downregulated
Feature0844,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,2949855.768366827,3964606.5988263004,1.3440001512417283,0.4265333004646488,0.6290356491376518,0.9043347628664763,Upregulated
Feature0843,NA,C13 H19 N O6,285.1213,NA,NA,Feature0843,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,1659754.3029091926,348261.04043141933,0.20982686402499007,-2.2527286976464804,0.3868751787643737,0.8724505635080375,Downregulated
Feature0842,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,4644700.92111744,551167.4622904686,0.11866586711418799,-3.0750230750428176,0.41909796203673616,0.8724505635080375,Downregulated
Feature0841,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,3277780.0076065836,3934271.2970141782,1.2002853418728858,0.2633774161415503,0.8657729027013437,0.9790516002510522,Upregulated
Feature0840,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,11642378.81294182,13999160.741019232,1.2024313042844461,0.2659544742039408,0.39292643664248883,0.8724505635080375,Upregulated
Feature0839,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,9697199.667200157,6297777.566034983,0.6494429095171267,-0.6227253864222185,0.5653958287121832,0.8929340317679025,Downregulated
Feature0838,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,4276016.17129396,6784028.471007523,1.586530125061388,0.66587491543396,0.05818125396087541,0.8724505635080375,Upregulated
Feature0837,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12237,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,6701292.986334686,6763349.378703521,1.009260361022176,0.013298397537853113,0.9853022204335504,0.9951332564369114,Upregulated
Feature0836,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak1,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,2645051.9497991162,245651.0122084369,0.09287190454882875,-3.428613968823102,0.4167643903292417,0.8724505635080375,Downregulated
Feature0835,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak3,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,3144724.8951433543,806375.1670047026,0.256421529352234,-1.9634106980409192,0.2460901125224746,0.8724505635080375,Downregulated
Feature0834,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,4035276.320388627,3598717.7009659032,0.891814442243529,-0.1651845317186036,0.748620920911106,0.9373691092667948,Downregulated
Feature0833,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0833,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,9888163.711343989,8019154.947451663,0.8109852528282734,-0.3022524145569684,0.6509544454658812,0.9089232543643583,Downregulated
Feature0832,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,2297768.1302997214,279911.9255834093,0.12181904774999971,-3.0371883627437333,0.4226180262214636,0.8724505635080375,Downregulated
Feature0831,NA,C6 H11 N O7,209.05351,NA,NA,Feature0831,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,3640899.6704465733,1908404.1006021167,0.5241572889505197,-0.9319282946924675,0.1029581664574642,0.8724505635080375,Downregulated
Feature0830,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0830,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,6187901.241587563,2076517.359118684,0.33557700390608275,-1.57528423932228,0.2656584895069855,0.8724505635080375,Downregulated
Feature0829,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0829,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,6361886.573516097,11668972.67847274,1.8342000511372707,0.8751509982808368,0.10433417739949784,0.8724505635080375,Upregulated
Feature0828,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0828,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,9570214.892950527,12113391.003534934,1.2657386630322924,0.33997956237504934,0.2301260854630617,0.8724505635080375,Upregulated
Feature0827,N-glycoloyl-beta-D-glucosamine,C8 H15 N O7,237.08484,NA,NA,N-glycoloyl-beta-D-glucosamine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1112786.9787506626,479440.7342277063,0.4308468227818224,-1.2147530499160795,0.30740455430909597,0.8724505635080375,Downregulated
Feature0826,Pro-Hyp,C10 H16 N2 O4,228.11102,NA,NA,Pro-Hyp-peak1,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,3013018.1454873346,4482858.555258573,1.4878299229537173,0.573209618290666,0.5843052416583092,0.8990127878012496,Upregulated
Feature0825,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak3,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6223642.787648973,6709318.9907851005,1.0780372877601472,0.10840707970108254,0.9368881256654937,0.9882637829765163,Upregulated
Feature0824,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,5179125.898280416,13993707.894913234,2.70194395149951,1.433997748041695,0.03641325424699989,0.8724505635080375,Upregulated
Feature0823,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,2089017.8614504912,308985.39650435135,0.1479094086298573,-2.7572142686038084,0.4252056440050209,0.8724505635080375,Downregulated
Feature0822,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,4143326.920119457,5382551.255425763,1.2990892003449677,0.37750049504837896,0.6128090708123748,0.9043347628664763,Upregulated
Feature0821,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak3,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,7619366.457503486,6422649.522524543,0.8429374749654642,-0.24650247190819322,0.8144830500696347,0.9660274597293932,Downregulated
Feature0820,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,8803491.31583534,9786147.301640423,1.1116211683014356,0.1526652127643966,0.7771917184739429,0.9502143902366301,Upregulated
Feature0819,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,11190415.139348513,5212073.93150485,0.4657623391627175,-1.102334104758442,0.620650192343083,0.9043347628664763,Downregulated
Feature0818,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1432726.9080225602,1384543.7662746266,0.9663696260060923,-0.04935298490466406,0.902345799271067,0.983565624317811,Downregulated
Feature0817,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,4621122.301074957,4819339.037468157,1.0428936356752756,0.06059202544275977,0.8164852277509946,0.9660274597293932,Upregulated
Feature0816,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,454024.089805507,56100.5690579848,0.12356297896443542,-3.0166815366352444,0.38507828328804417,0.8724505635080375,Downregulated
Feature0815,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0815,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,11614227.289862746,13242846.842908366,1.140226251165855,0.18932012180096786,0.5635196213578942,0.8929340317679025,Upregulated
Feature0814,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0814,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,266587.0982886318,57688.909241324,0.21639797879064895,-2.2082410707795903,0.42857509732411814,0.8724505635080375,Downregulated
Feature0813,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,493610.1229669895,73904.8536904999,0.14972313218836142,-2.7396309602294124,0.3511725683846485,0.8724505635080375,Downregulated
Feature0812,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,4090292.1339998203,3463124.0358067835,0.846669118574731,-0.24012982575070338,0.8017820477356032,0.9611099245456373,Downregulated
Feature0811,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,4555828.270907873,5786854.863623196,1.2702091737250683,0.3450660946721868,0.4272072200246972,0.8724505635080375,Upregulated
Feature0810,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak1",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,9191619.35830624,3717670.2699595504,0.4044630358414465,-1.305920235112217,0.24551794961015408,0.8724505635080375,Downregulated
Feature0809,MFCD02728197,C14 H20 N2 O4,280.14233,NA,NA,MFCD02728197-peak1,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,6044189.307145554,8062740.27263176,1.3339655432532262,0.41572140174010663,0.4876951302251882,0.8724505635080375,Upregulated
Feature0808,NA,C11 H23 N O11,345.1272,NA,NA,Feature0808,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,8723587.518431846,6508415.049207821,0.7460709295867504,-0.4226152996633977,0.5992973576807883,0.9015641283557303,Downregulated
Feature0807,NA,C11 H19 N3 O5,273.13241,Biosynthesis of secondary metabolites;Other,NA,Feature0807,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,5933051.047557843,6439801.345610984,1.0854114171597644,0.1182419892058308,0.5682483982321733,0.8929340317679025,Upregulated
Feature0806,NA,C10 H15 N O5,229.09493,NA,NA,Feature0806,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,6091534.588470524,2780714.5115902233,0.4564883398763416,-1.131350085099375,0.5464030090101355,0.8890580920144323,Downregulated
Feature0805,Methohexital,C14 H18 N2 O3,262.13173,NA,NA,Methohexital,14,18,3,2,0,0,1.2857142857142858,0.21428571428571427,-0.4285714285714288,72.51428571428572,7,4,0.2222222222222222,0.3333333333333333,2,Lignin,11537993.967532156,6689889.851955974,0.579813949528946,-0.7863380518051578,0.652610655224723,0.9089232543643583,Downregulated
Feature0804,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0804,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,3485113.6319308234,6741259.582160263,1.9343012292042452,0.9518124835627415,0.10626957046198306,0.8724505635080375,Upregulated
Feature0803,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,5235224.127041194,9087878.01043959,1.7359100183502194,0.7956921669964546,0.053707394127307385,0.8724505635080375,Upregulated
Feature0802,2-Aminooctanedioic acid,C8 H15 N O4,189.10014,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2488034.2127506803,5433236.6917789765,2.183746776444922,1.1268055734979099,0.28709252012075676,0.8724505635080375,Upregulated
Feature0801,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,5571613.379963142,762710.9584829643,0.1368922978801537,-2.8688868179241185,0.42107796063757524,0.8724505635080375,Downregulated
Feature0800,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,1339617.8841802047,292428.92282532,0.21829278802460553,-2.1956636276507795,0.4217520130593138,0.8724505635080375,Downregulated
Feature0799,NA,C12 H23 N3 O2,241.17901,NA,NA,Feature0799,12,23,2,3,0,0,1.9166666666666667,0.16666666666666666,-0.833333333333333,84.04999999999998,3,1,-0.2857142857142857,-0.125,-2,Lipid,616422.2802616253,507428.4960034537,0.8231832499436719,-0.2807144681815419,0.6320734115902644,0.9043347628664763,Downregulated
Feature0798,b-Ala-Lys,C9 H19 N3 O3,217.14263,Metabolic pathways;Other,Other,b-Ala-Lys,9,19,3,3,0,0,2.111111111111111,0.3333333333333333,-0.44444444444444464,72.96666666666667,2,-1,-1.3333333333333333,-0.5555555555555556,-4,Protein,5599923.495400943,5593982.513821304,0.9989390959386287,-0.0015313734920864453,0.9979159481936761,0.9990955178723921,Downregulated
Feature0797,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,1061588.9612609276,1524545.8988337244,1.4360981080878128,0.5221543112897544,0.7126374225565553,0.9283104618560314,Upregulated
Feature0796,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8597062.452527234,9765253.238284957,1.1358825520005749,0.1838136707528099,0.7701205084946237,0.9502143902366301,Upregulated
Feature0795,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,10721055.76160248,10088824.268295087,0.9410289893676579,-0.08768892754167522,0.654073094806208,0.9089232543643583,Downregulated
Feature0794,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,9240955.79669046,7884128.867471663,0.8531724467608937,-0.22909072035197575,0.6925729478210984,0.9233562380758966,Downregulated
Feature0793,Aspartame,C14 H18 N2 O5,294.1216,Other,NA,Aspartame-peak2,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,5513583.967038297,6948342.60299235,1.2602225058204302,0.33367847952148255,0.5197896793764966,0.8823277748748858,Upregulated
Feature0792,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate-peak1,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,3511880.597893272,3089391.37227633,0.8796971554584209,-0.1849211478594558,0.8066927902409363,0.9626572180425523,Downregulated
Feature0791,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,6192589.16324534,7532533.95488255,1.2163787644092616,0.2825925350715543,0.28335540032979667,0.8724505635080375,Upregulated
Feature0790,delta-guanidinovaleric acid,C6 H13 N3 O2,159.1008,NA,NA,delta-guanidinovaleric acid-peak2,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,252975.87050178388,248839.27444800298,0.9836482584462468,-0.02378557862640809,0.9832655747059065,0.9951332564369114,Downregulated
Feature0789,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,4200383.465163087,1671891.8205645732,0.3980331401718008,-1.3290395405730075,0.1420832770689021,0.8724505635080375,Downregulated
Feature0788,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,6088075.39044546,6254792.247827266,1.0273841644016843,0.03897574197132067,0.9548510835902917,0.9882637829765163,Upregulated
Feature0787,Fluoranthene,C16 H10,202.0783,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,6485413.206790507,5844741.808666087,0.9012134805144552,-0.15005920105892048,0.8624129495002603,0.9789760557739694,Downregulated
Feature0786,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0786,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,13083003.631779,11952031.973066777,0.91355412789422,-0.13043788411767487,0.6854100865713415,0.9233562380758966,Downregulated
Feature0785,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0785,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,9195230.372936023,5678690.590385923,0.6175691483597627,-0.6953274125859777,0.4244640520523657,0.8724505635080375,Downregulated
Feature0784,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,8184584.761663043,8395671.75606979,1.0257908007007868,0.036736538386471125,0.633955919124415,0.9043690984397965,Upregulated
Feature0783,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0783,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,2155375.9248135523,335752.99562426633,0.1557746803046945,-2.682467338813722,0.43408040187595365,0.8724505635080375,Downregulated
Feature0782,NA,C13 H24 N2 O8,336.15338,NA,NA,Feature0782,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4220451.351675127,6081095.86257364,1.440863868780293,0.5269340377243749,0.15686895400674997,0.8724505635080375,Upregulated
Feature0781,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,363416.5766145833,132963.36012028667,0.36587037762259045,-1.4505954810332244,0.3609316725558874,0.8724505635080375,Downregulated
Feature0780,NA,C11 H19 N O5,245.12631,NA,NA,Feature0780,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,1361135.2623306143,338072.56772861036,0.24837543856570363,-2.0094055799901436,0.399683956862955,0.8724505635080375,Downregulated
Feature0779,7-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,7-Methylguanine-peak2,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,4132482.6207118304,7760060.358386747,1.8778204461147998,0.9090591216264574,0.36490240590463907,0.8724505635080375,Upregulated
Feature0778,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak5,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,7637586.950911227,5741635.85082155,0.7517604562441709,-0.41165506548788294,0.6444215576028867,0.9054136314946792,Downregulated
Feature0777,Alanyltyrosine,C12 H16 N2 O4,252.11102,NA,NA,Alanyltyrosine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,5052216.01536865,5921792.43457681,1.1721178224689803,0.2291175982141208,0.6875487805606242,0.9233562380758966,Upregulated
Feature0776,asn-leu,C10 H19 N3 O4,245.13754,NA,NA,asn-leu-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,6604630.419590597,7184842.4747671895,1.0878492842620795,0.12147869270098563,0.9151702953566623,0.9838470257338569,Upregulated
Feature0775,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,13927251.226415692,7611055.667636156,0.5464865639244257,-0.8717420690686642,0.6937136689185747,0.9233562380758966,Downregulated
Feature0774,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0774,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,8808962.304165417,7425839.959914743,0.8429869153150253,-0.24641785678836542,0.7325962355023289,0.930298368021698,Downregulated
Feature0773,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak2,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,5238618.940760738,4139835.438781277,0.7902532109312194,-0.3396131028339749,0.8118123732209991,0.9650597615693841,Downregulated
Feature0772,Betaine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak1,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,7389998.11237507,7796376.43667195,1.0549903150335547,0.0772297548403313,0.9172418574914952,0.9838470257338569,Upregulated
Feature0771,"3-(2,6-Dioxocyclohexyl)propanenitrile",C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,"3-(2,6-Dioxocyclohexyl)propanenitrile",9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,6848853.55533066,9392243.200982623,1.37135991083827,0.455607253420992,0.15419918913951852,0.8724505635080375,Upregulated
Feature0770,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0770,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,2177604.7928045746,284178.03056559135,0.1305002778762227,-2.937875216136481,0.4274029496651468,0.8724505635080375,Downregulated
Feature0769,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0769,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,7118379.892958794,10923342.0228673,1.5345264213381218,0.617793486211908,0.006972594298332736,0.8724505635080375,Upregulated
Feature0768,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,4912557.831163797,5229155.354746937,1.0644465743639169,0.09010354130313844,0.9087762025960799,0.983565624317811,Upregulated
Feature0767,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,4612983.669898754,7114217.437248982,1.542216046345797,0.6250048840328963,0.6775690512894046,0.9231420067493376,Upregulated
Feature0766,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak1,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,5199685.45941974,6865744.747049234,1.320415398322078,0.4009918680849061,0.5709529525324996,0.8929340317679025,Upregulated
Feature0765,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0765,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,5138752.597679865,8744610.819958128,1.7016991290661279,0.7669759821621407,0.29415565386603276,0.8724505635080375,Upregulated
Feature0764,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,6438000.231267336,1303708.623248944,0.20250210879416292,-2.3039911630331122,0.4572977142264659,0.8724505635080375,Downregulated
Feature0763,Prolylleucine,C11 H20 N2 O3,228.14738,NA,NA,Prolylleucine-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,3914792.711986297,5423041.59212785,1.3852691549985783,0.4701663162422971,0.5006449174738695,0.8747804400244787,Upregulated
Feature0762,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak2,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,4655682.842194237,6010847.2627804,1.2910774781100576,0.3685755799876204,0.5630981650604383,0.8929340317679025,Upregulated
Feature0761,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak1,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,5806470.206768423,6011365.13838295,1.0352873474448705,0.050031248109026843,0.8983509745848626,0.983565624317811,Upregulated
Feature0760,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0760,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,2105878.3723491533,7061577.085352166,3.3532692001935622,1.7455683072278896,0.2660942938705079,0.8724505635080375,Upregulated
Feature0759,MFCD15144952,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,MFCD15144952,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,6369025.101085877,7478641.00764694,1.1742206835347344,0.23170357464996388,0.39907710396991253,0.8724505635080375,Upregulated
Feature0758,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,6192767.933948077,6212524.630630334,1.003190285328464,0.004595282582424859,0.992126167055628,0.9956526818674369,Upregulated
Feature0757,NA,C6 H14 O4,150.08923,NA,NA,Feature0757,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,12028834.514124516,5204737.31732088,0.43268841309682704,-1.208599607341257,0.5170132054809033,0.880583845645293,Downregulated
Feature0756,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0756,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,8429778.266827516,10816408.57049112,1.2831189893873443,0.3596549642227179,0.2837548287274631,0.8724505635080375,Upregulated
Feature0755,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,327246.1042780258,164146.97810187566,0.5016010151259666,-0.9953878270589817,0.5788036446715584,0.89624622858649,Downregulated
Feature0754,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0754,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,3341670.7803449025,4712885.857058008,1.4103381711862049,0.4960411338275449,0.7307371406108965,0.930298368021698,Upregulated
Feature0753,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak1,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,4652526.463720923,8601741.855785903,1.8488324403654308,0.8866144792538208,0.04086096411775371,0.8724505635080375,Upregulated
Feature0752,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak5,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,4110773.5992849767,3404492.1942114467,0.8281877150333992,-0.2719702923146142,0.13357896029640803,0.8724505635080375,Downregulated
Feature0751,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,313843.4175772127,109215.22044095071,0.34799270694941775,-1.5228710237506025,0.27826175278291143,0.8724505635080375,Downregulated
Feature0750,NA,C12 H19 N O9,321.10608,NA,NA,Feature0750,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,858943.4016766327,785883.573202288,0.9149422088443383,-0.12824747460189867,0.8078138261334309,0.9626572180425523,Downregulated
Feature0749,NA,C6 H15 N O4,165.10013,NA,NA,Feature0749,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,2411954.65381562,3292056.6232252335,1.3648915903196297,0.4487863662957576,0.18315032408085627,0.8724505635080375,Upregulated
Feature0748,NA,C18 H29 N O12,451.16875,NA,NA,Feature0748,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,533234.494299554,150818.89040813368,0.28283783592478634,-1.82195296890603,0.25446753500544783,0.8724505635080375,Downregulated
Feature0747,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1247699.386448931,2606266.05690064,2.088857368374859,1.0627139854813994,0.16497612278825874,0.8724505635080375,Upregulated
Feature0746,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0746,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,7075608.865537496,7587554.481716603,1.0723535777496962,0.10078067143057999,0.797967561627678,0.9586929428349551,Upregulated
Feature0745,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0745,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,7116977.097707204,6412271.774195064,0.900982493854144,-0.15042902023053858,0.849004127815773,0.9789760557739694,Downregulated
Feature0744,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,6197734.206360173,5037545.5842449665,0.8128043921398549,-0.29901989688497643,0.7952187701606852,0.9581085324695595,Downregulated
Feature0743,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0743,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,4816112.987296063,5223164.447375277,1.0845186691327495,0.1170548880801837,0.4724164276448258,0.8724505635080375,Upregulated
Feature0742,Gly-Phe,C11 H14 N2 O3,222.1005,NA,NA,Gly-Phe-peak1,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,4493784.30858682,4667919.49225451,1.038750231811293,0.05484879895274651,0.8849884271179402,0.9814814661453127,Upregulated
Feature0741,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0741,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,7943692.27458092,8832642.468197668,1.1119064237245577,0.15303537825103905,0.7489016386051979,0.9373691092667948,Upregulated
Feature0740,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0740,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,393977.89252287184,65441.12574209863,0.16610354789970744,-2.5898452059179085,0.4029491398327092,0.8724505635080375,Downregulated
Feature0739,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,904447.315418739,345337.5876460487,0.3818216735887652,-1.3890290971964299,0.47173185621272473,0.8724505635080375,Downregulated
Feature0738,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,5356178.938989707,3359345.4637051066,0.6271906711799947,-0.673023993888403,0.16549545209904823,0.8724505635080375,Downregulated
Feature0737,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak1,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,5149852.201454062,907721.9219858766,0.1762617423718648,-2.5042087233483534,0.21170978682260644,0.8724505635080375,Downregulated
Feature0736,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15866,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak2",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,334129.721708483,59192.55872520897,0.17715442500159412,-2.496920593031895,0.41430081724735224,0.8724505635080375,Downregulated
Feature0735,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,8901039.827999143,10132878.055534976,1.1383926205633816,0.18699821498202235,0.39993232522991595,0.8724505635080375,Upregulated
Feature0734,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,7049467.408268883,9999373.518825317,1.4184580110401324,0.5043234448239297,0.35351671686715447,0.8724505635080375,Upregulated
Feature0733,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,5092414.48111073,493441.510784887,0.09689735833860487,-3.3673988550295606,0.25008881567642355,0.8724505635080375,Downregulated
Feature0732,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,3387015.3000882817,375186.5133914533,0.11077201611155231,-3.1743346297114003,0.41879820237609966,0.8724505635080375,Downregulated
Feature0731,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0731,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,4762586.738625743,8708478.058995623,1.8285185209054013,0.8706752396861461,0.17190897448487935,0.8724505635080375,Upregulated
Feature0730,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0730,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4698559.150365637,3797588.2567009265,0.8082452801313361,-0.3071349173439163,0.5867757078047634,0.9001845658902912,Downregulated
Feature0729,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak3,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,10420216.232757036,9709837.66876186,0.9318268884131189,-0.10186613402611887,0.731817839776181,0.930298368021698,Downregulated
Feature0728,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0728,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,5475173.76832984,10301549.11097505,1.8815017653982986,0.9118846430758318,0.1088121171376652,0.8724505635080375,Upregulated
Feature0727,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,6635000.89766093,6575523.047609383,0.9910357434808315,-0.012991003154104062,0.9760735860949974,0.9918828163436866,Downregulated
Feature0726,NA,C16 H23 N5 O10,445.14456,NA,NA,Feature0726,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,337704.69023866864,152524.90428522634,0.4516517202572201,-1.146717391136641,0.2674231943450668,0.8724505635080375,Downregulated
Feature0725,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,9161803.31975866,8925090.62721193,0.974163089483025,-0.03776477361477257,0.9485486681517459,0.9882637829765163,Downregulated
Feature0724,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,5534661.409976941,9185742.968307596,1.659675685263982,0.7309013542391055,0.43753715613380617,0.8724505635080375,Upregulated
Feature0723,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine-peak1,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,2535015.8131600134,2576028.95431655,1.0161786529865515,0.02315406266105752,0.9534819279628377,0.9882637829765163,Upregulated
Feature0722,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak1,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,6891784.905390463,10360661.742333464,1.5033350408585435,0.5881665714092256,0.04200162604267634,0.8724505635080375,Upregulated
Feature0721,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0721,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,2627207.3339763633,2885717.1830623164,1.0983972013714998,0.13539985473038768,0.5890709468739755,0.9006192996430636,Upregulated
Feature0720,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,2953517.0752057997,6799633.14750443,2.302215621025531,1.2030229598022169,0.3735679582763544,0.8724505635080375,Upregulated
Feature0719,N2-Dimethylguanosine,C12 H17 N5 O5,311.12308,NA,NA,N2-Dimethylguanosine,12,17,5,5,0,0,1.4166666666666667,0.4166666666666667,0.6666666666666665,41.3,7,2,-1.5,-0.1111111111111111,-3,Lignin,3426028.5981367566,2105869.4202867,0.6146677880715812,-0.7021212128869315,0.5226904066441289,0.8826174436414305,Downregulated
Feature0718,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,12867880.439969921,5756831.356144336,0.44737992266874005,-1.1604275817093368,0.6063654777664066,0.9031677924568101,Downregulated
Feature0717,NA,C33 H47 N O8,585.33043,NA,NA,Feature0717,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,968157.501924425,136563.27768158034,0.14105481536850245,-2.825672176998787,0.4286081463988417,0.8724505635080375,Downregulated
Feature0716,perlolyrine,C16 H12 N2 O2,264.0899,Other,NA,perlolyrine,16,12,2,2,0,0,0.75,0.125,-0.125,63.8625,12,10,0.6666666666666666,0.6923076923076923,8,Condensed HC,7594094.977243,7354590.11269918,0.9684616975081907,-0.04623310326865352,0.9073955409045735,0.983565624317811,Downregulated
Feature0715,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",C16 H13 N S,251.07697,NA,NA,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",16,13,0,1,1,0,0.8125,0,-0.5,74.55,11,11,0.6428571428571429,0.6428571428571429,9,Unsaturated HC,7859576.81534068,8935111.19188681,1.1368438023847358,0.18503404754150576,0.6876409967373919,0.9233562380758966,Upregulated
Feature0714,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,4488211.044865509,3163242.2429448063,0.7047891044614625,-0.5047364734963983,0.7458123273643213,0.9351636436381646,Downregulated
Feature0713,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak1,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,4377014.22466246,10739175.55817141,2.4535391038167296,1.2948642648575,0.057003952164166254,0.8724505635080375,Upregulated
Feature0712,threonylphenylalanine,C13 H18 N2 O4,266.12668,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,5034777.386539619,5972025.963783033,1.1861549191328955,0.24629244704144138,0.6307647191503744,0.9043347628664763,Upregulated
Feature0711,NA,C29 H28 O9,520.17351,NA,NA,Feature0711,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,2911797.56831786,472492.87699470803,0.1622684496119235,-2.6235455756742847,0.4126625720538259,0.8724505635080375,Downregulated
Feature0710,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,7736309.896218737,7426035.624286951,0.959893763810646,-0.0590533504125348,0.8339728076743456,0.9709621554641522,Downregulated
Feature0709,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak4,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,4875030.765161767,6792635.65988833,1.3933523678312483,0.4785601502846494,0.42896966687107474,0.8724505635080375,Upregulated
Feature0708,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,5929340.64386566,6095687.91748848,1.0280549362254838,0.03991735996216418,0.9101111817497086,0.983565624317811,Upregulated
Feature0707,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak2,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,3533896.2875286704,4382987.95086645,1.2402706797973313,0.31065501237457777,0.638092048551791,0.9050396416750427,Upregulated
Feature0706,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0706,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,6067928.047874777,6620314.676852724,1.0910338132917403,0.12569581432180676,0.293298135298876,0.8724505635080375,Upregulated
Feature0705,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,1231008.1720304277,162908.08619752267,0.13233712813524356,-2.9177102179878815,0.4223982944728054,0.8724505635080375,Downregulated
Feature0704,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12667,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak1,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,1794123.1284706367,2983830.4907690934,1.6631135530327834,0.733886675422816,0.07057217873197129,0.8724505635080375,Upregulated
Feature0703,NA,C12 H17 N3 O5,283.11687,NA,NA,Feature0703,12,17,5,3,0,0,1.4166666666666667,0.4166666666666667,0.16666666666666652,55.55,6,1,-0.5,0.07692307692307693,-2,Lignin,1572832.5698141993,2144449.2451088433,1.363431357072018,0.44724206856660603,0.36311488597499547,0.8724505635080375,Upregulated
Feature0702,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,8932675.888403304,7345646.785787653,0.8223344132886334,-0.2822028904193997,0.529623681789095,0.8826174436414305,Downregulated
Feature0701,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0701,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,151268.04370906946,41229.09946307567,0.27255657210964335,-1.8753723867179117,0.4465248527172844,0.8724505635080375,Downregulated
Feature0700,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0700,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,1134565.0308696884,150145.07790338332,0.13233712816645798,-2.9177102176475924,0.4223982944708545,0.8724505635080375,Downregulated
Feature0699,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12154,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak2",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2237176.3401403166,2182380.795317083,0.9755068280313581,-0.035776123916203426,0.9500332948800227,0.9882637829765163,Downregulated
Feature0698,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak1",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,1956643.0410732073,2085418.7096203316,1.0658145946112336,0.09195649372671262,0.9465075832723873,0.9882637829765163,Upregulated
Feature0697,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,5978207.315760137,8770875.715936396,1.4671414443614303,0.5530079652457321,0.28382260765914635,0.8724505635080375,Upregulated
Feature0696,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak3",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,3856252.464612053,233318.07695670432,0.06050383866144941,-4.046829512806444,0.3712869006774605,0.8724505635080375,Downregulated
Feature0695,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak1,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,3070707.83051809,1993794.3563763334,0.6492947119752321,-0.6230546351575335,0.11934087810416279,0.8724505635080375,Downregulated
Feature0694,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,4188317.25144599,205616.37663864932,0.049092837121557965,-4.348343645948586,0.35708392235698494,0.8724505635080375,Downregulated
Feature0693,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,518609.707110913,92157.5597227517,0.17770118541773136,-2.492474789488255,0.4028578554885607,0.8724505635080375,Downregulated
Feature0692,NA,C10 H23 N O6,253.1525,NA,NA,Feature0692,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,3298710.769582308,10327427.692084186,3.1307466502714556,1.646506765843067,0.026312079544135888,0.8724505635080375,Upregulated
Feature0691,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,5004382.211224677,825414.864025659,0.1649384138114548,-2.600000656322695,0.3482649852322959,0.8724505635080375,Downregulated
Feature0690,1581740,C12 H13 N O4,235.08444,NA,NA,1581740-peak2,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,7428097.996329224,8852904.65772694,1.1918131212191625,0.2531580359453006,0.29817245193248565,0.8724505635080375,Upregulated
Feature0689,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak2,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,5495058.427088153,1790808.5886848166,0.3258943671748676,-1.617523678432591,0.36551994412602584,0.8724505635080375,Downregulated
Feature0688,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0688,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,8444504.170474146,7640835.89270875,0.9048294297046607,-0.1442822409370784,0.690376636369896,0.9233562380758966,Downregulated
Feature0687,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0687,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7378070.161087057,6054023.274473687,0.8205429254933664,-0.2853492867101869,0.7077975074509893,0.9283104618560314,Downregulated
Feature0686,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,373770.8486340263,266641.5706654703,0.7133824685363559,-0.48725233305858384,0.6917324339751743,0.9233562380758966,Downregulated
Feature0685,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,3605705.872619123,3780776.46825688,1.0485537650109515,0.06840083809260018,0.9169839342572195,0.9838470257338569,Upregulated
Feature0684,dihydroxyphenylalanine,C9 H11 N O4,197.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,dihydroxyphenylalanine,9,11,4,1,0,0,1.2222222222222223,0.4444444444444444,0,60.3,5,1,0,0.3333333333333333,0,Lignin,4588889.489085786,3471440.38617583,0.756488120804021,-0.4026106670278855,0.6736068624683459,0.9217205371739724,Downregulated
Feature0683,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,314254.8941578597,132072.80042789635,0.42027285138016723,-1.2506018300325583,0.41623644937687204,0.8724505635080375,Downregulated
Feature0682,NA,C18 H29 N O12,451.16881,NA,NA,Feature0682,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,392866.97688156704,96096.8908739026,0.24460414473286662,-2.031479244845075,0.18919969978960374,0.8724505635080375,Downregulated
Feature0681,leu-lys,C12 H25 N3 O3,259.18959,NA,NA,leu-lys,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,2460339.7890942665,2429235.6920480533,0.9873578043227664,-0.018355103439160306,0.9308987800539854,0.9874405343841273,Downregulated
Feature0680,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,2311486.39661959,2894870.2867634534,1.252384738667304,0.32467783327690203,0.565559663966263,0.8929340317679025,Upregulated
Feature0679,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0679,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,7763539.31211466,5533968.557705663,0.7128151652520327,-0.48840006414262005,0.4549188768108796,0.8724505635080375,Downregulated
Feature0678,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine-peak1,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,3983958.1486638696,7599089.929443983,1.9074221279138055,0.9316241590436339,0.12802376207756655,0.8724505635080375,Upregulated
Feature0677,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,835862.5459999517,331691.512619634,0.396825428064644,-1.3334236201520546,0.26919081764223346,0.8724505635080375,Downregulated
Feature0676,2'-O-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,2'-O-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,4790491.094618133,4303549.01848126,0.8983523679474267,-0.1546466590764804,0.7814641010555954,0.9510058816007031,Downregulated
Feature0675,NA,C16 H23 N5 O10,445.14457,NA,NA,Feature0675,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,9321987.839060016,9368634.869630404,1.0050039789126233,0.007201213191414252,0.9682875210460149,0.9898726803046187,Upregulated
Feature0674,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,10332627.448774487,9695394.15032909,0.9383280485428732,-0.09183570384633645,0.6953118171280586,0.9233562380758966,Downregulated
Feature0673,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0673,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,343676.30538357934,160311.243685397,0.4664599833452952,-1.1001747743796166,0.4049071751013765,0.8724505635080375,Downregulated
Feature0672,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,6117791.153788963,7287847.4886297705,1.1912547037693744,0.25248191074915394,0.3928835356519246,0.8724505635080375,Upregulated
Feature0671,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak5,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,6180396.49516031,10072657.64252212,1.629775314643604,0.7046730842154417,0.04372770237512943,0.8724505635080375,Upregulated
Feature0670,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,4174409.0938671934,2160162.231162973,0.5174773680750556,-0.9504323273089632,0.08731459339609395,0.8724505635080375,Downregulated
Feature0669,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0669,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,6697647.386084383,9301550.592875693,1.388778784055041,0.4738168134563962,0.13918912643617998,0.8724505635080375,Upregulated
Feature0668,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine-peak1,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,5692267.15430222,5827401.35140941,1.023739960448809,0.03384930380109606,0.9651307862964034,0.988553862051552,Upregulated
Feature0667,2762577,C15 H23 N3 O4,309.16893,NA,NA,2762577-peak1,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,6299688.926577358,4375276.114738017,0.6945225654364365,-0.5259065259299807,0.6215685043740801,0.9043347628664763,Downregulated
Feature0666,NA,C19 H35 P S,326.21985,NA,NA,Feature0666,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,7710101.681892638,1023031.6885715154,0.1326871850437628,-2.913899053241614,0.4057044052014011,0.8724505635080375,Downregulated
Feature0665,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,1582502.36704073,117571.78858673747,0.07429485796384369,-3.750593826208359,0.1562058657778749,0.8724505635080375,Downregulated
Feature0664,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,5892988.679243857,6296733.796575677,1.0685127936447394,0.09560418194935918,0.8895881695968969,0.983078949019388,Upregulated
Feature0663,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,1835387.2137824812,3962061.0019990318,2.15870578821009,1.1101666306629574,0.38803870599235923,0.8724505635080375,Upregulated
Feature0662,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,4417565.60190883,8582597.920482367,1.9428342879104787,0.95816285295353,0.15244688144420404,0.8724505635080375,Upregulated
Feature0661,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,4887208.463291027,9074978.606599588,1.8568838785502786,0.8928835982147574,0.13268790455845075,0.8724505635080375,Upregulated
Feature0660,Prolylleucine,C11 H20 N2 O3,228.14739,NA,NA,Prolylleucine-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,1384039.4328221488,2788563.078896853,2.0148003104295857,1.0106368583914396,0.32774931952890496,0.8724505635080375,Upregulated
Feature0659,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,12501456.938396674,7723591.99995866,0.6178153504841989,-0.6947523777057195,0.4474443646278366,0.8724505635080375,Downregulated
Feature0658,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1565996.6269412034,5423504.750169498,3.463292740778763,1.7921443389703016,0.2670130008048155,0.8724505635080375,Upregulated
Feature0657,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak3,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1840155.7936830532,2320753.40289148,1.2611722392518274,0.3347653190805174,0.6268094034408619,0.9043347628664763,Upregulated
Feature0656,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0656,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,964876.1436087687,2056891.2956578368,2.131767179945793,1.092049883369646,0.15869691519835397,0.8724505635080375,Upregulated
Feature0655,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,24653628.819452513,2621395.317830243,0.10632898454940139,-3.2333931756683234,0.4223189578034464,0.8724505635080375,Downregulated
Feature0654,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0654,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,6528387.205645727,2442036.2887791833,0.37406425382785485,-1.4186419886332153,0.21070377017185377,0.8724505635080375,Downregulated
Feature0653,NA,C18 H31 N O14,485.17464,NA,NA,Feature0653,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,6999406.62075685,8373073.502893287,1.1962547622341022,0.2585246680240259,0.35522484632914675,0.8724505635080375,Upregulated
Feature0652,NA,C29 H28 O9,520.17353,NA,NA,Feature0652,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,982882.8154510786,126049.679964572,0.12824487109048038,-2.963026965743459,0.41971647063507384,0.8724505635080375,Downregulated
Feature0651,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11098,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak1,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,3606239.442541133,2398237.79771324,0.6650245597733588,-0.5885204736585663,0.4844951492189857,0.8724505635080375,Downregulated
Feature0650,1-(5-Amino-5-carboxypentyl)-5-oxoproline,C11 H18 N2 O5,258.12159,NA,NA,1-(5-Amino-5-carboxypentyl)-5-oxoproline,11,18,5,2,0,0,1.6363636363636365,0.4545454545454546,-0.18181818181818168,65.48181818181817,4,-1,-0.75,-0.07692307692307693,-3,Protein,6892943.444641744,8846224.593630712,1.2833740280441963,0.35994169245785246,0.07576247799168911,0.8724505635080375,Upregulated
Feature0649,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,975199.4534427144,1203840.3065094787,1.2344554770407234,0.3038748039080881,0.7244115883105527,0.930298368021698,Upregulated
Feature0648,NA,C14 H29 N O2,243.2198,NA,NA,Feature0648,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,1126457.903920178,159243.63079420233,0.14136669487605324,-2.82248582478779,0.11780746795972517,0.8724505635080375,Downregulated
Feature0647,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak1,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,4249571.164508087,4620408.386404984,1.0872646221327191,0.12070311108895294,0.8657481880713082,0.9790516002510522,Upregulated
Feature0646,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak2",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,3486554.2527348315,373473.23213248065,0.1071181473340134,-3.2227251810836104,0.42610564682458274,0.8724505635080375,Downregulated
Feature0645,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0645,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,1906905.9452299436,219040.646658719,0.11486704271211765,-3.121963171021694,0.4146970514072361,0.8724505635080375,Downregulated
Feature0644,N-Acetylserotonin,C12 H14 N2 O2,218.10552,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-Acetylserotonin,12,14,2,2,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,7,5,0.375,0.4444444444444444,3,Lignin,4973031.383891187,7742656.724885213,1.556928989019754,0.638703145107185,0.18134842104994991,0.8724505635080375,Upregulated
Feature0643,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,5996719.42749657,3868924.6514606467,0.6451735316680963,-0.6322408419400788,0.49263409226060595,0.8724505635080375,Downregulated
Feature0642,NA,C9 H19 N O3,189.13649,NA,NA,Feature0642,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1483667.9336573128,5893659.0603073435,3.9723572415420416,1.989995372973383,0.01594467684636198,0.8724505635080375,Upregulated
Feature0641,N-Aceyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Aceyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,3148116.214230121,5456267.059061383,1.7331847643990885,0.7934254597339074,0.3746034271496298,0.8724505635080375,Upregulated
Feature0640,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0640,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,6053511.392771397,5432294.708327639,0.8973791169889325,-0.15621048360216283,0.856893644913487,0.9789760557739694,Downregulated
Feature0639,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak4,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,7983539.278027473,6942419.317330293,0.8695916780214785,-0.20158996102466106,0.6123272262786582,0.9043347628664763,Downregulated
Feature0638,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak2,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,2028536.7006347997,6063945.96496219,2.9893203130436685,1.5798174936304,0.09528301047081437,0.8724505635080375,Upregulated
Feature0637,Leucylasparagine,C10 H19 N3 O4,245.13752,NA,NA,Leucylasparagine-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2584311.0306044132,2281084.53628018,0.8826664086739918,-0.18005980025820867,0.701827458157551,0.9272348854064458,Downregulated
Feature0636,Acetophenone,C8 H8 O,120.05748,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak2,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,538352.2103304777,376183.48424045736,0.698768347230394,-0.5171138362720678,0.6878784846942183,0.9233562380758966,Downregulated
Feature0635,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0635,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,8208494.888774107,8937645.501096433,1.088828783132887,0.1227771100278489,0.45908731407333303,0.8724505635080375,Upregulated
Feature0634,NA,C9 H12 N2 O4,212.0797,NA,NA,Feature0634,9,12,4,2,0,0,1.3333333333333333,0.4444444444444444,0.22222222222222232,53.96666666666666,5,1,-0.3333333333333333,0.2,-1,Lignin,7839440.667001253,9157798.90589526,1.168169936465417,0.22425016177151,0.2268193834163834,0.8724505635080375,Upregulated
Feature0633,HC Blue 1,C11 H17 N3 O4,255.12193,NA,NA,HC Blue 1,11,17,4,3,0,0,1.5454545454545454,0.3636363636363637,0,60.3,5,1,-0.5,0,-2,Protein,6383020.431201827,8702546.856099956,1.3633900987626006,0.4471984110266017,0.4753179599542619,0.8724505635080375,Upregulated
Feature0632,beta-Pyracin,C8 H7 N O3,165.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,beta-Pyracin,8,7,3,1,0,0,0.875,0.375,0.25,53.175,6,3,0.5,0.6363636363636364,2,Lignin,7998764.404646279,8601070.478609502,1.0752998892695675,0.10473906765280966,0.5172260486523416,0.880583845645293,Upregulated
Feature0631,ET8750000,C4 H7 N,69.05786,NA,Superpathway of linamarin and lotaustralin biosynthesis;Other,ET8750000,4,7,0,1,0,0,1.75,0,-1,88.8,2,2,0.3333333333333333,0.3333333333333333,1,Lipid,1027163.6762671907,955276.394006713,0.9300138002136885,-0.10467597076117163,0.9282563834135433,0.9874405343841273,Downregulated
Feature0630,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1698988.6074457667,1938407.8091623366,1.140918662236652,0.1901959434490406,0.47087505531514257,0.8724505635080375,Upregulated
Feature0629,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NA,NP-021733-peak1,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,990746.8347215541,172852.09295404868,0.1744664599434508,-2.5189783806536084,0.40612154980917003,0.8724505635080375,Downregulated
Feature0628,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,3352393.1724062334,5065191.279522707,1.5109180275197511,0.5954253914764505,0.03267601529509234,0.8724505635080375,Upregulated
Feature0627,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,2775969.357946642,7684938.825875063,2.768380279081877,1.469042132664935,0.04536018703009497,0.8724505635080375,Upregulated
Feature0626,4-[(Z)-2-Aminovinyl]phenol,C8 H9 N O,135.06839,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,4-[(Z)-2-Aminovinyl]phenol,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,5179779.2880454995,5475876.0828265995,1.0571639790646035,0.08019917372606013,0.9291248135063814,0.9874405343841273,Upregulated
Feature0625,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,3608551.51472455,4480243.777384147,1.2415629260390746,0.3121573833704934,0.4813952486207515,0.8724505635080375,Upregulated
Feature0624,NA,C13 H15 N O4,249.1001,NA,NA,Feature0624,13,15,4,1,0,0,1.1538461538461535,0.3076923076923077,-0.3076923076923075,69.06923076923076,7,3,0.25,0.4,2,Lignin,7941009.512624877,8871337.374591826,1.1171548605360417,0.15982918675373348,0.326808943674757,0.8724505635080375,Upregulated
Feature0623,NA,C10 H20 N2 O4 S,264.11437,NA,NA,Feature0623,10,20,4,2,1,0,2,0.4,-0.4000000000000003,71.7,2,-2,-1.6666666666666667,-0.6,-5,Protein,340114.905967302,240803.27786028798,0.7080056581919946,-0.49816720489983474,0.6595538428643467,0.9098405617363219,Downregulated
Feature0622,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,883544.418509403,982320.1797950236,1.1117949015537463,0.15289067133281695,0.8109243351394373,0.9646810559875049,Upregulated
Feature0621,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,6289268.700121317,8685998.860767277,1.3810824874758059,0.4657994895585595,0.12129352193739629,0.8724505635080375,Upregulated
Feature0620,Pyridostigmine,C9 H12 N2 O2,180.08989,Metabolic pathways;Other,NA,Pyridostigmine,9,12,2,2,0,0,1.3333333333333333,0.2222222222222222,-0.22222222222222232,66.63333333333333,5,3,0.2,0.3333333333333333,1,Lignin,6057218.755088616,7972427.633064187,1.316186183034354,0.3963635820378082,0.3637708004039579,0.8724505635080375,Upregulated
Feature0619,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,4109139.295076413,1511505.3179485067,0.3678398831014559,-1.4428501822032356,0.32253354892370895,0.8724505635080375,Downregulated
Feature0618,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak6,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5944838.1071368735,6458653.917717463,1.086430580836801,0.11959599423197725,0.8370359079393495,0.9725232016798752,Upregulated
Feature0617,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0617,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,3867247.4558634902,1247297.5104969507,0.3225284972663976,-1.632501458231852,0.14331981713345024,0.8724505635080375,Downregulated
Feature0616,5-Hydroxyindole-3-acetic acid,C10 H9 N O3,191.05831,Metabolic pathways;Other,NA,5-Hydroxyindole-3-acetic acid,10,9,3,1,0,0,0.9,0.3,0,60.3,7,4,0.5,0.6,3,Lignin,7685365.663340894,8395290.37736101,1.092373576628429,0.1274663223573811,0.6561656755919917,0.9089232543643583,Upregulated
Feature0615,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0615,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,6483562.607355607,3587161.485347986,0.5532701236320828,-0.8539440739650591,0.3147512665722413,0.8724505635080375,Downregulated
Feature0614,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0614,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,6229508.062585203,3480284.9660109365,0.5586773355208794,-0.839912800807823,0.35240250810647544,0.8724505635080375,Downregulated
Feature0613,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0613,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4262144.85427665,4393961.054568777,1.0309271985816866,0.043942456902368955,0.816167100570653,0.9660274597293932,Upregulated
Feature0612,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,6197454.58191367,3148890.71284715,0.508094197581812,-0.9768321061852021,0.2214463153040626,0.8724505635080375,Downregulated
Feature0611,NP-015145,C14 H13 N O2,227.09462,Other,NA,NP-015145,14,13,2,1,0,0,0.9285714285714286,0.14285714285714285,-0.4285714285714288,72.51428571428572,9,7,0.5454545454545454,0.5833333333333334,6,Lignin,8433533.70034479,8965212.833094673,1.0630434586071729,0.0882005773351103,0.5962302284125609,0.9015409731649661,Upregulated
Feature0610,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0610,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2739536.557105353,2593626.928354856,0.9467393021742817,-0.07896088063909834,0.9179058166440094,0.9838470257338569,Downregulated
Feature0609,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,1422111.0739526832,279871.4250721543,0.19679997589377204,-2.3451980509273724,0.4335784785373557,0.8724505635080375,Downregulated
Feature0608,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak3,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,4143679.560230384,2849555.6829392132,0.6876872696161817,-0.5401754560437825,0.646088432999375,0.905539285949828,Downregulated
Feature0607,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,1577113.0870924927,5987136.585376403,3.7962633335406952,1.9245800705509193,0.18817775356435135,0.8724505635080375,Upregulated
Feature0606,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,5121303.266148264,2074204.6784480768,0.4050150070507517,-1.303952729614588,0.30284597639005506,0.8724505635080375,Downregulated
Feature0605,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3748640.070936577,4752731.061107746,1.2678547342957636,0.34238945674172505,0.798928362374185,0.9591670062805593,Upregulated
Feature0604,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,6808669.6472523,5620446.815800663,0.8254838473575885,-0.27668810938553,0.602089412360516,0.9026012960519595,Downregulated
Feature0603,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam-peak2,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,5597036.490013557,3953556.28996972,0.7063660022627696,-0.5015121878398928,0.5935875634991248,0.9015409731649661,Downregulated
Feature0602,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,2393433.353531103,355052.2432757417,0.1483443199919992,-2.7529784068710317,0.42156691665311474,0.8724505635080375,Downregulated
Feature0601,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0601,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,427866.02576194267,189380.61042474033,0.4426166113270897,-1.1758704986298056,0.22014356321611636,0.8724505635080375,Downregulated
Feature0600,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0600,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,297475.04606912367,243245.75903805168,0.8177013912673844,-0.2903539998722887,0.6616720350886538,0.9105381213973839,Downregulated
Feature0599,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0599,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,4300025.738098213,5399377.409579347,1.2556616491247672,0.32844776766055606,0.5569031645348868,0.8929340317679025,Upregulated
Feature0598,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0598,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,359262.4802180807,152025.83750983066,0.42316090847434845,-1.2407217371780919,0.4179871620288139,0.8724505635080375,Downregulated
Feature0597,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,323923.6771887457,135312.753792345,0.41773035848040274,-1.259356099967982,0.3854689848765161,0.8724505635080375,Downregulated
Feature0596,NA,C7 H15 N O6,209.08992,NA,NA,Feature0596,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,3040920.5771748335,4886233.733799167,1.6068271465145338,0.6842147402893112,0.17657222030376118,0.8724505635080375,Upregulated
Feature0595,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0595,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,195186.103607834,47847.86092451257,0.24513968996813432,-2.0283240085426884,0.39955161190875216,0.8724505635080375,Downregulated
Feature0594,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,5111655.546245677,3299651.3933927733,0.6455152080457075,-0.6314770097132747,0.41337921515982834,0.8724505635080375,Downregulated
Feature0593,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak1,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,2709033.59161366,3066824.0306439865,1.1320730906172356,0.17896710663880447,0.6898239704425051,0.9233562380758966,Upregulated
Feature0592,7098783,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,7098783,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,5905284.150572694,6259946.00354656,1.0600583890513502,0.08414373202888772,0.8794891814112964,0.9808128198227362,Upregulated
Feature0591,NA,C18 H27 N O12,449.1534,NA,NA,Feature0591,18,27,12,1,0,0,1.5,0.6666666666666666,0,60.3,6,-6,-1.4,-0.09090909090909093,-7,Amino Sugar,5945483.08565831,7482183.49968418,1.2584651897728374,0.3316653108678515,0.15805977354207298,0.8724505635080375,Upregulated
Feature0590,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,12242284.06235634,6147644.475851763,0.5021648284371284,-0.9937671089228515,0.5871482227431949,0.9001845658902912,Downregulated
Feature0589,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0589,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,3846572.9157024366,5653930.520974557,1.4698617821318674,0.5556804981853362,0.5937949528445136,0.9015409731649661,Upregulated
Feature0588,NA,C16 H25 N O9,375.15307,NA,NA,Feature0588,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,644831.9143230097,296496.83735923335,0.4598048433606404,-1.1209064321031796,0.41863202977640357,0.8724505635080375,Downregulated
Feature0587,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,2026825.4462088167,2540382.3949536765,1.253379959140275,0.3258238305189415,0.4539693932077925,0.8724505635080375,Upregulated
Feature0586,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,5160770.9588590795,317124.213082728,0.06144899969612998,-4.02446666404544,0.4162799965381061,0.8724505635080375,Downregulated
Feature0585,N6-Dimethyladenosine,C12 H17 N5 O4,295.1281,NA,NA,N6-Dimethyladenosine,12,17,4,5,0,0,1.4166666666666667,0.3333333333333333,0.5,46.05,7,3,-0.6666666666666666,0,-2,Lignin,2692856.3576062154,1378569.7539663434,0.5119358669364034,-0.9659650078028941,0.5500238233802759,0.8906171704145945,Downregulated
Feature0584,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0584,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,2905799.28541073,5122319.5982478075,1.7627919533071863,0.81786221621045,0.48055619028927893,0.8724505635080375,Upregulated
Feature0583,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0583,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,5717807.115338617,5449967.777906798,0.9531569827332383,-0.06921425267291377,0.9241047985237457,0.9874405343841273,Downregulated
Feature0582,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,7056032.846519177,4022645.4028291632,0.5701001526393944,-0.8107127071471933,0.14745426562561992,0.8724505635080375,Downregulated
Feature0581,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0581,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,1155396.3798532793,140062.43285831134,0.12122457305612944,-3.0442459222080953,0.4161542641970351,0.8724505635080375,Downregulated
Feature0580,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0580,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5198077.32918502,3508919.7335884534,0.6750418493944566,-0.5669511496982674,0.5633267965800784,0.8929340317679025,Downregulated
Feature0579,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,1637681.3646634868,3318523.2681386834,2.026354661989195,1.018886703414985,0.40259362154093503,0.8724505635080375,Upregulated
Feature0578,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,5034456.447976227,1885608.8686788434,0.3745407052705419,-1.4168055748663901,0.26814482778935644,0.8724505635080375,Downregulated
Feature0577,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0577,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,5333873.596026117,4971507.45981713,0.9320632314048538,-0.10150026389211596,0.6824462069631908,0.9233562380758966,Downregulated
Feature0576,NA,C15 H21 N5 O2,303.16956,NA,NA,Feature0576,15,21,2,5,0,0,1.4,0.13333333333333333,-0.13333333333333375,64.10000000000001,8,6,0.125,0.2222222222222222,1,Lignin,1084772.278530713,156059.232276673,0.1438635881145948,-2.7972266028353783,0.44463176715301767,0.8724505635080375,Downregulated
Feature0575,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,3922540.57376743,3366785.34153848,0.8583175312587853,-0.2204166289508643,0.8054965035172269,0.9626572180425523,Downregulated
Feature0574,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0574,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,233803.3152051628,99666.45340429923,0.4262833198786842,-1.2301154899704683,0.45343017951107745,0.8724505635080375,Downregulated
Feature0573,NA,C19 H23 N3 O5,373.16384,NA,NA,Feature0573,19,23,5,3,0,0,1.2105263157894737,0.2631578947368421,-0.21052631578947345,66.29999999999998,10,5,0.18181818181818185,0.3333333333333333,2,Lignin,672885.3018844227,168818.110656656,0.2508869047724464,-1.9948909247098034,0.3991625837074211,0.8724505635080375,Downregulated
Feature0572,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06369,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak1,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,2854430.9725636323,2046524.7053582633,0.7169641602929465,-0.4800270918039049,0.6278916380999564,0.9043347628664763,Downregulated
Feature0571,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0571,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,364196.899020014,316600.975641131,0.8693126616208025,-0.2020529371319257,0.8080865195138781,0.9626572180425523,Downregulated
Feature0570,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,3751933.383632627,644942.771377861,0.17189611473150054,-2.5403911581047938,0.41452663666726236,0.8724505635080375,Downregulated
Feature0569,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0569,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,1057693.7779293398,2971050.391784769,2.808989193073662,1.4900510740445794,0.2949529058857946,0.8724505635080375,Upregulated
Feature0568,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,1318661.8129908147,1399935.2273731946,1.0616332509076352,0.08628546249021019,0.9621475254993865,0.988553862051552,Upregulated
Feature0567,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak3,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,5290197.734269164,8134292.779302074,1.5376160188889083,0.6206952713044299,0.1655491105204186,0.8724505635080375,Upregulated
Feature0566,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0566,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,1297953.5734625917,164978.84858537,0.1271068950064606,-2.9758858023743806,0.41079415061253377,0.8724505635080375,Downregulated
Feature0565,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0565,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,6996726.673600214,2775700.6103291432,0.3967141693275389,-1.333828168154086,0.0133593090289961,0.8724505635080375,Downregulated
Feature0564,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,2111926.1511333557,425394.13156653603,0.20142471901219186,-2.311687351920122,0.34692265616161144,0.8724505635080375,Downregulated
Feature0563,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0563,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2993665.841344767,5022381.245343584,1.6776692895983039,0.7464583526794291,0.40399303906612616,0.8724505635080375,Upregulated
Feature0562,1774244,C7 H15 N3 O2,173.11643,NA,NA,1774244,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,3249040.086382902,4438913.276986011,1.3662229947823676,0.4501929793895094,0.7165201728747963,0.9301035807278966,Upregulated
Feature0561,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1802580.1036848428,517678.33049661433,0.28718742065241587,-1.7999355370907197,0.4060982743613839,0.8724505635080375,Downregulated
Feature0560,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,1658897.8030459103,4740205.920723147,2.857443003432539,1.5147247217169841,0.3142448947010378,0.8724505635080375,Upregulated
Feature0559,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,5227386.847224817,4939838.0779623035,0.9449918711458727,-0.08162617561500383,0.9502417905335281,0.9882637829765163,Downregulated
Feature0558,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0558,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,1513497.3562268433,2136767.631780933,1.4118079711139409,0.49754387192234545,0.4773507969423608,0.8724505635080375,Upregulated
Feature0557,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0557,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5357119.613031797,4612699.073490657,0.8610408963558974,-0.21584633279526144,0.5968050062343859,0.9015409731649661,Downregulated
Feature0556,NA,C12 H23 N3 O5,289.16381,NA,NA,Feature0556,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,6931493.164025503,5403050.3920452,0.7794929987216994,-0.35939202995640684,0.5398748707704416,0.8890580920144323,Downregulated
Feature0555,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0555,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,2459808.028387998,4762108.082268343,1.9359673711566532,0.9530546375984719,0.3789429374645984,0.8724505635080375,Upregulated
Feature0554,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak1",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3429648.6654902566,5314899.06134364,1.5496919888101406,0.6319814991294895,0.021522781085169324,0.8724505635080375,Upregulated
Feature0553,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,5855243.4167027,7111062.259733059,1.214477649118396,0.2803359392922085,0.5749095966996789,0.893483354870877,Upregulated
Feature0552,4-Acetamidobenzoic acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Acetamidobenzoic acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,2671767.048765033,2731959.23604258,1.022528980326099,0.032141732340871046,0.9499652655723668,0.9882637829765163,Upregulated
Feature0551,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,4566264.537195743,1500851.7062858134,0.3286826012948264,-1.6052330050344492,0.4733963110380224,0.8724505635080375,Downregulated
Feature0550,NA,C32 H66 N3 O18 P3 S,905.32735,NA,NA,Feature0550,32,66,18,3,1,3,2.0625,0.5625,-1.0625,90.58125,3,-15,-3.142857142857143,-0.8125,-22,Amino Sugar,366512.8954794218,68844.32485284503,0.18783602351233059,-2.4124543228502104,0.43160013862522956,0.8724505635080375,Downregulated
Feature0549,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1733299.266846891,2574118.9514764408,1.4850978135813304,0.5705579549462115,0.5428629596104545,0.8890580920144323,Upregulated
Feature0548,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,5073623.763677363,5304258.21079137,1.0454575384097544,0.06413446759971782,0.7260879968481033,0.930298368021698,Upregulated
Feature0547,4-Hydroxyprolylproline,C10 H16 N2 O4,228.111,NA,NA,4-Hydroxyprolylproline,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,7238152.93392927,6087556.251827206,0.8410372518231034,-0.24975839211178746,0.5826930939958284,0.8973473647535757,Downregulated
Feature0546,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0546,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4341013.9882085165,5050196.096552733,1.1633678468372979,0.21830733662128915,0.7317947005441088,0.930298368021698,Upregulated
Feature0545,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,5497667.123099977,6234636.292301964,1.1340512535044922,0.1814858444298782,0.6188798689274678,0.9043347628664763,Upregulated
Feature0544,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak1,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,3134116.191844473,1935689.93208745,0.6176190714066246,-0.6952107927364352,0.5815705264128587,0.8964335502669541,Downregulated
Feature0543,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0543,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,3593879.58333755,3787695.919585807,1.053929557669894,0.07577844363879668,0.907045538305838,0.983565624317811,Upregulated
Feature0542,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0542,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5878370.49118276,3577007.8825197835,0.6085033068067253,-0.7166629918486037,0.3180153499723461,0.8724505635080375,Downregulated
Feature0541,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0541,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,462962.56254643365,71933.13475071613,0.15537570544594836,-2.686167153385558,0.37691011663900276,0.8724505635080375,Downregulated
Feature0540,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0540,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,4081676.924300093,7533629.47351434,1.845719201503478,0.8841830852630449,0.0692321314440333,0.8724505635080375,Upregulated
Feature0539,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak4,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,4828901.315102413,4625756.663660732,0.9579314965898463,-0.062005604963242374,0.9323934748147835,0.987788959559877,Downregulated
Feature0538,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0538,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5960779.65570118,3884270.091819783,0.6516379259388791,-0.6178575223749714,0.1139627468204244,0.8724505635080375,Downregulated
Feature0537,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,723324.9783788166,395095.3182333043,0.546221034864341,-0.8724432218128401,0.5057532929284496,0.8751236754042836,Downregulated
Feature0536,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak2",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,2012850.5657870877,1829932.4960106001,0.9091248635713001,-0.1374496401996784,0.8977394107732455,0.983565624317811,Downregulated
Feature0535,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0535,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,5182589.87900383,1962125.4437595534,0.37859940484750504,-1.4012559517385808,0.24584501900920921,0.8724505635080375,Downregulated
Feature0534,NA,C10 H21 N O10,315.11663,NA,NA,Feature0534,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,1689807.9713957652,1911276.61509147,1.1310614267683765,0.17767728272087094,0.8336896057455659,0.9709621554641522,Upregulated
Feature0533,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0533,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,2957254.152435093,3078011.2249104134,1.040834188152508,0.05774025597312801,0.916332260007422,0.9838470257338569,Upregulated
Feature0532,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0532,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,780665.8975421654,330097.16706303833,0.42284051103335035,-1.2418144914233737,0.13887843338300687,0.8724505635080375,Downregulated
Feature0531,1-Aminocyclohexanecarboxylic acid,C7 H13 N O2,143.09463,ABC transporters,NA,1-Aminocyclohexanecarboxylic acid,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,1058235.8464338435,3086005.7772105136,2.9161795904098944,1.5440795695330036,0.46358939348065165,0.8724505635080375,Upregulated
Feature0530,ascopyrone P,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,3207410.5664739884,7966521.869428984,2.4837861272580524,1.3125409519689477,0.049674067022495674,0.8724505635080375,Upregulated
Feature0529,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,2141144.5512955235,3059094.11223468,1.428719098102807,0.5147222945930588,0.3002310731869798,0.8724505635080375,Upregulated
Feature0528,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,7054234.695986766,6109712.239524307,0.8661056093016285,-0.20738514299984298,0.5450282774178234,0.8890580920144323,Downregulated
Feature0527,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,339117.59791720036,258719.079783972,0.7629184724502012,-0.3903991999194718,0.7231784094781089,0.930298368021698,Downregulated
Feature0526,NA,C9 H16 N2 O3,200.11609,NA,NA,Feature0526,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,1751841.69758744,3732396.092285838,2.130555573272363,1.0912296831701063,0.42778799063405976,0.8724505635080375,Upregulated
Feature0525,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10586,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak1",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1581455.624098472,1203731.4404754613,0.7611541052008102,-0.3937395198693975,0.7650930386202299,0.9486064407934096,Downregulated
Feature0524,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak1",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,424381.06115386775,1334660.1468951432,3.1449569009189027,1.6530402462757507,0.5497683252183397,0.8906171704145945,Upregulated
Feature0523,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,14777776.07250912,5138242.8091439335,0.34770068134288024,-1.5240822007610468,0.42045661477160573,0.8724505635080375,Downregulated
Feature0522,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak2,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,4384182.169764673,7306008.599830333,1.6664473137580624,0.7367757060581107,0.05204030279422006,0.8724505635080375,Upregulated
Feature0521,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,4119298.86504499,2698347.24055761,0.6550501259947157,-0.6103227855548178,0.16804025922653634,0.8724505635080375,Downregulated
Feature0520,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,2309833.74098706,2335779.1001283065,1.0112325656521752,0.01611482981078369,0.9671165079914291,0.9897969993740776,Upregulated
Feature0519,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak2,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,5479506.781517323,5509152.553726686,1.005410299392157,0.007784373145203244,0.991043105674634,0.9956526818674369,Upregulated
Feature0518,NA,C13 H17 N O5,267.11069,NA,NA,Feature0518,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,4308282.31148257,7160267.573024967,1.6619773393078712,0.7329007114156981,0.007339034173566559,0.8724505635080375,Upregulated
Feature0517,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0517,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,1708652.4390509224,235005.663910575,0.13753859974068794,-2.862091531963058,0.42525321181537507,0.8724505635080375,Downregulated
Feature0516,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,4273056.458191114,3528512.907333687,0.8257585505498775,-0.2762080915063985,0.8001731437233497,0.9599810945236221,Downregulated
Feature0515,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,639165.761971131,168093.9920472734,0.262989668797162,-1.9269219686315877,0.42728509117289976,0.8724505635080375,Downregulated
Feature0514,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0514,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,3481578.497414967,4423639.438509766,1.2705844322609037,0.3454922478483929,0.8154306653033895,0.9660274597293932,Upregulated
Feature0513,NP-019722,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak1,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,2801487.3559655133,1604810.5896970101,0.5728423461486312,-0.8037899501893375,0.48618532144952487,0.8724505635080375,Downregulated
Feature0512,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,5596111.48557825,5558781.08381364,0.9933292247910331,-0.009656137200692421,0.9828000458743373,0.9951332564369114,Downregulated
Feature0511,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,3807259.74199693,6193683.56737605,1.6268087777293143,0.7020446802453536,0.22503784077167163,0.8724505635080375,Upregulated
Feature0510,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak1,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,2393289.5795312366,2845416.1992406934,1.1889142975326925,0.24964472266907486,0.6153944379540609,0.9043347628664763,Upregulated
Feature0509,NA,C14 H25 N3 O6,331.17445,NA,NA,Feature0509,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,6755041.890388443,4736144.065865373,0.7011272680047029,-0.5122517501465057,0.1855836195834971,0.8724505635080375,Downregulated
Feature0508,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,5981898.708900957,4849670.816734618,0.8107243289690604,-0.30271665743400333,0.8627493279122402,0.9789760557739694,Downregulated
Feature0507,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,4755414.00204431,5138034.3522120165,1.0804599452336268,0.11164558965791763,0.610591490381402,0.904145091526307,Upregulated
Feature0506,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1830549.4527407032,2048234.5827791467,1.1189179181761655,0.16210420665962255,0.7123962453617296,0.9283104618560314,Upregulated
Feature0505,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak3,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,4737632.193691414,4517860.671361034,0.9536115271626561,-0.06852641982566132,0.9234949883570822,0.9874405343841273,Downregulated
Feature0504,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0504,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,1154886.4589202637,2356261.0951321432,2.040253461223434,1.0287483897142689,0.23309495412124048,0.8724505635080375,Upregulated
Feature0503,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine-peak2,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,4667397.962408863,6038610.024661293,1.2937851182385018,0.37159802336242176,0.5070825859603727,0.8756349649509392,Upregulated
Feature0502,NA,C20 H31 N O14,509.17464,NA,NA,Feature0502,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,4802433.368344497,5191380.6366521865,1.080989623067226,0.11235267402417458,0.8171885181772258,0.9660274597293932,Upregulated
Feature0501,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0501,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,4466040.7932632165,5218555.10891595,1.1684969641987735,0.22465398594695654,0.7766687002278794,0.9502143902366301,Upregulated
Feature0500,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0500,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,5566207.835593387,4004252.509543553,0.719386093335963,-0.4751618243064282,0.484880289714844,0.8724505635080375,Downregulated
Feature0499,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0499,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,360160.1095179225,235986.5916413267,0.6552268988289592,-0.609933510175577,0.7045343407096456,0.9283104618560314,Downregulated
Feature0498,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0498,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,4079906.0759682134,4767527.986636523,1.1685386618869966,0.22470546744544206,0.7752872584428225,0.9502143902366301,Upregulated
Feature0497,NA,C14 H27 N3 O5,317.19512,NA,NA,Feature0497,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,6154262.121964376,3291514.1072036796,0.5348348903528767,-0.9028345110993715,0.26918628942707734,0.8724505635080375,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak1",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,2458976.0693037836,443755.51004637434,0.18046353341373347,-2.470220756269771,0.3815789099090105,0.8724505635080375,Downregulated
Feature0495,7-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,7-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,3753119.290869043,2178927.182386413,0.5805643289003686,-0.7844721624327634,0.5093618987871374,0.8772526573874708,Downregulated
Feature0494,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,3866196.2996655037,2271679.61450388,0.5875748250807704,-0.7671555106153345,0.495635984148195,0.8724505635080375,Downregulated
Feature0493,NA,C7 H10 N2 O2,154.07425,NA,NA,Feature0493,7,10,2,2,0,0,1.4285714285714286,0.2857142857142857,0,60.3,4,2,0,0.25,0,Lignin,6476591.677908333,6878584.972811856,1.062068648896722,0.0868770205883851,0.34007097446044443,0.8724505635080375,Upregulated
Feature0492,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,4154838.545485972,3411544.99087496,0.8211016995068162,-0.28436717338670997,0.765492918869298,0.9486064407934096,Downregulated
Feature0491,NA,C16 H33 N O2,271.25118,NA,NA,Feature0491,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,2396457.1173003074,210557.77588747334,0.08786210876357096,-3.508615064049524,0.1635173790835318,0.8724505635080375,Downregulated
Feature0490,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak2,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,4387490.741234046,3419962.4432641966,0.7794802644534543,-0.3594155988861389,0.6786489073606083,0.9231420067493376,Downregulated
Feature0489,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0489,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,1185329.055512314,156052.826864024,0.13165359115960928,-2.9251812200852516,0.4246216409865545,0.8724505635080375,Downregulated
Feature0488,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,3068523.90822484,3353497.45516992,1.092869912527401,0.12812168305830893,0.8332167201944514,0.9709621554641522,Upregulated
Feature0487,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,1868425.6775413733,1200452.9569392407,0.6424943584156338,-0.638244308474265,0.4399593664309129,0.8724505635080375,Downregulated
Feature0486,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,1309515.809823788,1054453.1023953054,0.8052236517382677,-0.31253854589640573,0.8416577611169249,0.9745510918195973,Downregulated
Feature0485,Υ-L-Glutamyl-L-glutamic acid,C10 H16 N2 O7,276.09576,Other,NA,Υ-L-Glutamyl-L-glutamic acid,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,3302315.7691487265,501746.30072204594,0.15193771153247,-2.7184480980664607,0.3890294119755782,0.8724505635080375,Downregulated
Feature0484,NA,C13 H17 N5 O7,355.11293,NA,NA,Feature0484,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,5916783.05688697,7215088.439706603,1.219427579199214,0.2862040802065741,0.37484080685070514,0.8724505635080375,Upregulated
Feature0483,NA,C25 H34 O2,366.25594,NA,NA,Feature0483,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,2396246.5578810717,308937.43394285266,0.12892556190713392,-2.9553897615172366,0.41940397256804074,0.8724505635080375,Downregulated
Feature0482,NA,C15 H29 N3 O4,315.21585,NA,NA,Feature0482,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,2241512.3581635365,800549.3406065623,0.35714696717641553,-1.4854102245956824,0.21500611764727373,0.8724505635080375,Downregulated
Feature0481,NA,C16 H29 N3 O4,327.2159,NA,NA,Feature0481,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,3092365.1552917366,4229463.22540937,1.3677114483623647,0.45176389109590326,0.3094636450353678,0.8724505635080375,Upregulated
Feature0480,Gly-Tyr,C11 H14 N2 O4,238.09535,Other,NA,Gly-Tyr-peak2,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,2927106.9685431276,2287921.654206083,0.7816324031864206,-0.35543781828301046,0.7418251679167627,0.9351636436381646,Downregulated
Feature0479,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak1,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,4989160.2131216265,3786043.55412278,0.7588538736770535,-0.39810599056110113,0.6376167447326792,0.9050396416750427,Downregulated
Feature0478,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,6267301.734981947,7200718.648812943,1.148934414410109,0.2002964457595921,0.54639065327196,0.8890580920144323,Upregulated
Feature0477,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital-peak1,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,5184236.18248634,3218874.2614921033,0.6208965309810294,-0.6875752236682281,0.6221775856805516,0.9043347628664763,Downregulated
Feature0476,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0476,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,3915154.7766064834,2949890.230076707,0.7534543072735344,-0.40840807167566784,0.15041334978788293,0.8724505635080375,Downregulated
Feature0475,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe-peak1,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,3224860.492463037,4574942.42881772,1.418648167730052,0.5045168377367524,0.42322816407779484,0.8724505635080375,Upregulated
Feature0474,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0474,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,424917.79411843396,84125.75571651506,0.19798124926975255,-2.3365642952214842,0.41769468039670027,0.8724505635080375,Downregulated
Feature0473,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0473,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,5026958.905995077,3202837.0712248003,0.6371321371664972,-0.6503354855684992,0.5242798560631884,0.8826174436414305,Downregulated
Feature0472,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0472,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,4506009.68253637,3773547.074829407,0.8374476178900108,-0.25592914177137926,0.74437669286377806,0.9351636436381646,Downregulated
Feature0471,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0471,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4746879.076888373,4323436.576403517,0.910795599882349,-0.13480077315728037,0.8525165646533032,0.9789760557739694,Downregulated
Feature0470,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0470,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,1125295.8090922118,822956.592251882,0.731324675345383,-0.4514160546202752,0.48221932220032615,0.8724505635080375,Downregulated
Feature0469,NA,C17 H25 N3 O4,335.18461,NA,NA,Feature0469,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,2800283.1546801636,1695605.4670974377,0.6055121476781881,-0.7237721915833102,0.2924311049467452,0.8724505635080375,Downregulated
Feature0468,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,541652.9853508737,418987.510978885,0.7735349426856236,-0.37046163126653336,0.41115062778580674,0.8724505635080375,Downregulated
Feature0467,NA,C6 H9 O P S,160.01125,NA,NA,Feature0467,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,5819958.071676825,6787774.092157173,1.1662926104554399,0.221929790847466,0.7738273902468386,0.9502143902366301,Upregulated
Feature0466,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,1030514.579560015,421656.34437537834,0.40917067331100476,-1.2892253490831445,0.5016614589632105,0.8747804400244787,Downregulated
Feature0465,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0465,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,1794356.5538892094,3735363.8289049137,2.081728863089465,1.0577821755781773,0.44378475537833306,0.8724505635080375,Upregulated
Feature0464,NA,C14 H25 N3 O6,331.17446,NA,NA,Feature0464,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5368277.49616064,3787979.7028396735,0.7056229312938487,-0.5030306486087821,0.4405490450023108,0.8724505635080375,Downregulated
Feature0463,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0463,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,255108.32491042453,115166.89384129124,0.4514431031669761,-1.1473839232417682,0.37942671622210716,0.8724505635080375,Downregulated
Feature0462,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,2261606.808344371,4511149.31222559,1.9946656048174953,0.9961469064938947,0.4457837662221123,0.8724505635080375,Upregulated
Feature0461,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3316626.2580350167,5941467.251992317,1.7914189871705428,0.8411028024378427,0.10926033502049845,0.8724505635080375,Upregulated
Feature0460,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,7682867.510837159,3877959.2970169457,0.5047541548187372,-0.9863472139235451,0.6319926128958142,0.9043347628664763,Downregulated
Feature0459,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0459,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1389227.8002073464,1098941.3584916987,0.7910447504201099,-0.33816878276454115,0.6263150395827854,0.9043347628664763,Downregulated
Feature0458,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,1272200.548899649,156181.895232849,0.12276515315760063,-3.0260269845138246,0.41922367371487884,0.8724505635080375,Downregulated
Feature0457,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,4855353.41530662,6404065.080820023,1.3189699148636742,0.3994116577115293,0.06281452558111113,0.8724505635080375,Upregulated
Feature0456,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,4172684.521426317,6712118.032237727,1.6085850722171,0.6857922369046784,0.11161024894920034,0.8724505635080375,Upregulated
Feature0455,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,3591686.4240689427,2686892.3259745697,0.7480865556550029,-0.41872289136554974,0.7093130672383083,0.9283104618560314,Downregulated
Feature0454,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,5276247.194384804,2957683.85997923,0.5605658247261267,-0.8350443027129035,0.17452410739694535,0.8724505635080375,Downregulated
Feature0453,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak1,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,4529212.548376904,6140225.049398993,1.3556937290565916,0.43903128947848424,0.6173013266534875,0.9043347628664763,Upregulated
Feature0452,NA,C28 H40,376.313,NA,NA,Feature0452,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,29470339.665401723,3426439.609191513,0.1162673945429331,-3.104481523668625,0.384251573271903,0.8724505635080375,Downregulated
Feature0451,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,2392928.2759602335,4502225.97576862,1.8814713424546619,0.9118613152291228,0.1917975250744002,0.8724505635080375,Upregulated
Feature0450,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3444701.00556562,4486584.1287573865,1.302459668200053,0.38123869888484924,0.07601315941363328,0.8724505635080375,Upregulated
Feature0449,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0449,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,3623918.26756662,3242867.4676533532,0.8948511606005027,-0.16028035409752908,0.7756668768117498,0.9502143902366301,Downregulated
Feature0448,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,2735129.65488286,1715797.9270271035,0.6273186808398623,-0.6727295697745922,0.19348525835626887,0.8724505635080375,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak5,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5735972.856306493,4112663.614616925,0.7169949575502612,-0.47996512204499775,0.49192930569586446,0.8724505635080375,Downregulated
Feature0446,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,5700453.256278563,6900313.546336207,1.2104850677858114,0.27558528275342875,0.3814989941434933,0.8724505635080375,Upregulated
Feature0445,NA,C15 H29 N3 O4,315.21587,NA,NA,Feature0445,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,2988030.2549586934,1134717.7824270516,0.3797544487857731,-1.396861229031424,0.08021044626503673,0.8724505635080375,Downregulated
Feature0444,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak2,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,2193532.664958817,2973524.357546305,1.3555869967416838,0.4389177031721793,0.8313697508391678,0.9709621554641522,Upregulated
Feature0443,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,812876.528904812,497298.26666375267,0.6117758958224102,-0.7089248295449204,0.4085020231683299,0.8724505635080375,Downregulated
Feature0442,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak4,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5415196.139699187,852586.6436276083,0.1574433541524443,-2.6670952337853735,0.11336719939409924,0.8724505635080375,Downregulated
Feature0441,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,2452964.507808567,1840314.9995429066,0.7502411851800538,-0.4145736316425805,0.683351260794474,0.9233562380758966,Downregulated
Feature0440,NA,C11 H21 N O12,359.10644,NA,NA,Feature0440,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1754674.4159947,1195476.1597344433,0.6813093921226091,-0.5536179998558611,0.5280131222804803,0.8826174436414305,Downregulated
Feature0439,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak1,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,9207592.114818782,5122190.303043404,0.556300739560314,-0.8460630713391798,0.4953088915030462,0.8724505635080375,Downregulated
Feature0438,NA,C17 H33 N O15,491.18523,NA,NA,Feature0438,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,3619540.7466822998,4538104.472120263,1.2537790813047003,0.3262831644207008,0.6376230037189554,0.9050396416750427,Upregulated
Feature0437,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak1,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,2917508.3530717967,4456786.051597673,1.52760009989524,0.6112669194160619,0.4944882220900315,0.8724505635080375,Upregulated
Feature0436,NA,C8 H19 N O4,193.13145,NA,NA,Feature0436,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,4604594.041551847,5033210.655183543,1.0930845607156376,0.12840501181148334,0.8588772379764567,0.9789760557739694,Upregulated
Feature0435,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0435,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,1089312.616062668,533461.8936648517,0.48972341437947847,-1.0299609198706698,0.03843724851450184,0.8724505635080375,Downregulated
Feature0434,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak3,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5789559.670264893,4967819.8042849135,0.8580652220927223,-0.22084078281113945,0.5956134428507682,0.9015409731649661,Downregulated
Feature0433,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,3287601.895918565,6664095.971598,2.027038608254615,1.0193735675453244,0.1715286599346153,0.8724505635080375,Upregulated
Feature0432,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0432,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,439894.7456169677,155868.0771698982,0.354330390901323,-1.4968328842369791,0.15113290866348103,0.8724505635080375,Downregulated
Feature0431,Fenspiride,C15 H20 N2 O2,260.15248,NA,NA,Fenspiride,15,20,2,2,0,0,1.3333333333333333,0.13333333333333333,-0.666666666666667,79.30000000000001,7,5,0.2727272727272727,0.3333333333333333,3,Lignin,1375080.6237972127,1758251.0787757,1.278653082842795,0.3546248931859054,0.773357235566315,0.9502143902366301,Upregulated
Feature0430,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0430,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,4325247.550701327,5585120.910506424,1.2912835265581069,0.3688058073448931,0.42103682505665724,0.8724505635080375,Upregulated
Feature0429,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,3666374.037966699,2703729.7425496834,0.73743969233677,-0.4394030239990412,0.7317890192662861,0.930298368021698,Downregulated
Feature0428,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,2367288.584631207,3269597.9701125463,1.3811573254478848,0.4658776640680353,0.6780316224029846,0.9231420067493376,Upregulated
Feature0427,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,5198787.45577258,6246738.0973832635,1.2015759733449134,0.2649278701929337,0.3255935826257557,0.8724505635080375,Upregulated
Feature0426,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,2444381.6594868912,221332.33023999,0.09054736987613082,-3.4651834538645634,0.40871360721214783,0.8724505635080375,Downregulated
Feature0425,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,3895108.20533376,5734799.022556793,1.4723080130877637,0.5580795208983687,0.3088651589396742,0.8724505635080375,Upregulated
Feature0424,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0424,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,3550003.7339168666,3746029.596100779,1.055218494648632,0.07754175581281958,0.9154883651138132,0.9838470257338569,Upregulated
Feature0423,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,4463439.00341451,4303993.4081469,0.9642774113983333,-0.05247984213148948,0.8929035106821924,0.983565624317811,Downregulated
Feature0422,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0422,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,3293369.2499093935,1585864.4257614403,0.48153252958351705,-1.0542948333012523,0.4347551808065958,0.8724505635080375,Downregulated
Feature0421,1-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,1-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1625934.3993954093,1686726.8072132317,1.0373892131444096,0.05295727363413988,0.9702615574962244,0.9898726803046187,Upregulated
Feature0420,NA,C10 H23 N O7,269.14745,NA,NA,Feature0420,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,1019060.584509609,1756026.4382340824,1.7231815899141218,0.7850747416466386,0.38964103651132836,0.8724505635080375,Upregulated
Feature0419,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,1340322.5541040767,3976348.25586346,2.9667099488013946,1.568863883380002,0.22620229101293124,0.8724505635080375,Upregulated
Feature0418,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,981076.6777543089,373994.886152296,0.3812086197058244,-1.3913473537448282,0.23390539398999727,0.8724505635080375,Downregulated
Feature0417,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0417,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,3424243.6859246036,5555230.783594547,1.6223234363925068,0.6980614727995106,0.03721013622265378,0.8724505635080375,Upregulated
Feature0416,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0416,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,3095861.3388139945,6395028.603233497,2.0656702298183007,1.0466099561490052,0.12364267234028747,0.8724505635080375,Upregulated
Feature0415,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,6372496.228690476,4395073.21892079,0.6896941263194691,-0.5359714145619865,0.024500719127927208,0.8724505635080375,Downregulated
Feature0414,Levetiracetam,C8 H14 N2 O2,170.10556,NA,NA,Levetiracetam-peak1,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,1817905.2987577673,5112474.58445871,2.8122887303052733,1.4917447197290128,0.018500529473581225,0.8724505635080375,Upregulated
Feature0413,NP-003800,C10 H15 N O3,197.10521,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,3859570.233565113,4638151.110990336,1.2017273505361352,0.2651096126481603,0.35428802729508047,0.8724505635080375,Upregulated
Feature0412,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,2811205.9488062705,4303728.795798454,1.530919069670423,0.6143980183888313,0.4984427114561918,0.8747804400244787,Upregulated
Feature0411,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,1219471.2640317737,149708.57650723367,0.12276515316340654,-3.0260269844455956,0.4192236737127165,0.8724505635080375,Downregulated
Feature0410,NA,C7 H16 O6,196.09463,NA,NA,Feature0410,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,2734631.528067714,993411.6430933668,0.3632707488731799,-1.4608828925101864,0.3793846323963644,0.8724505635080375,Downregulated
Feature0409,NA,C20 H29 N3 O4,375.21585,NA,NA,Feature0409,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,1748256.9602758568,2638231.3996400335,1.5090638616555245,0.5936538601682593,0.5469798658715479,0.8890580920144323,Upregulated
Feature0408,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,466312.4767523683,70195.91501889064,0.15053407000338023,-2.731838049349534,0.3990784055790941,0.8724505635080375,Downregulated
Feature0407,NA,C11 H21 N3 O2,227.16337,NA,NA,Feature0407,11,21,2,3,0,0,1.9090909090909092,0.18181818181818185,-0.7272727272727275,81.02727272727273,3,1,-0.3333333333333333,-0.14285714285714285,-2,Lipid,225368.635602989,206437.89040110834,0.9160009770160334,-0.1265789577710005,0.8706088018858004,0.9807974651872519,Downregulated
Feature0406,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,1244820.3515380821,1325439.13123116,1.0647633850085005,0.09053286594273331,0.7352614722486834,0.9316757611309602,Upregulated
Feature0405,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0405,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,656692.3516361676,202302.4777033607,0.30806278952285393,-1.6987036631199235,0.3169350543579042,0.8724505635080375,Downregulated
Feature0404,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,565262.8995835833,194198.87166018033,0.34355495788462737,-1.541387191985085,0.3194122671525026,0.8724505635080375,Downregulated
Feature0403,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0403,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,5504209.27306716,3169016.97772845,0.5757442750650632,-0.7964999342905287,0.13255329374536373,0.8724505635080375,Downregulated
Feature0402,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0402,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6332836.974285929,5517807.989163237,0.8713011264253185,-0.1987566866022282,0.4561462933092822,0.8724505635080375,Downregulated
Feature0401,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0401,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,253422.00468002798,57655.63679675813,0.22750840784151502,-2.1360082320941944,0.33971457498544294,0.8724505635080375,Downregulated
Feature0400,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,1519365.8870673066,1699765.7377972333,1.118733645572454,0.16186659221021113,0.418310985525163,0.8724505635080375,Upregulated
Feature0399,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak1,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,1360256.4265745874,1327803.159808045,0.9761418022863039,-0.034837354276222914,0.9721619280683523,0.990823661930775,Downregulated
Feature0398,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0398,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,5703233.023410827,6156776.3239894565,1.0795238943800665,0.11039517659072487,0.6858796754410761,0.9233562380758966,Upregulated
Feature0397,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,3471828.4654068667,4089399.433122087,1.1778806107123863,0.23619331585591896,0.7144313493061336,0.9288084039760771,Upregulated
Feature0396,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,4742852.1682266835,5952866.74127823,1.2551238221502405,0.3278296978734313,0.44953938227265183,0.8724505635080375,Upregulated
Feature0395,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1256860.9216043497,983652.9286968281,0.7826267105522074,-0.35360374554360663,0.5734409775210181,0.8929340317679025,Downregulated
Feature0394,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,3413061.17249305,4431535.780304223,1.2984050259688826,0.37674048950741673,0.4713064624694942,0.8724505635080375,Upregulated
Feature0393,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,4034591.56678125,5458338.027382413,1.3528849047134184,0.4360391087437655,0.15386343326950314,0.8724505635080375,Upregulated
Feature0392,N-Acetyltyramine,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,8454052.768010149,3982868.5783578865,0.4711194367545146,-1.0858352410583534,0.5344973294730547,0.8833546108559558,Downregulated
Feature0391,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,1345244.75284449,861912.8552919783,0.6407108100362278,-0.6422547631114378,0.20761941862000555,0.8724505635080375,Downregulated
Feature0390,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,3791261.902977057,4695361.69657204,1.2384693584173245,0.3085581745945842,0.4041130145415703,0.8724505635080375,Upregulated
Feature0389,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3814476.59571496,3788174.0065559465,0.9931045351835267,-0.009982509607769752,0.991248664950239,0.9956526818674369,Downregulated
Feature0388,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0388,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4833153.953563636,3138825.096813313,0.6494361915574733,-0.622740310008361,0.42242181344180624,0.8724505635080375,Downregulated
Feature0387,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0387,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,1050461.720232675,171720.97435891134,0.16347190102355705,-2.612885420863106,0.41464026028429235,0.8724505635080375,Downregulated
Feature0386,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak1,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,2386522.0661691264,4294202.939379953,1.7993560588664737,0.8474806971693373,0.23316733293678515,0.8724505635080375,Upregulated
Feature0385,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,2233887.8492136733,2411159.7964242883,1.0793557954456015,0.11017050867544972,0.9300652303701019,0.9874405343841273,Upregulated
Feature0384,NA,C8 H19 N O7,241.11608,NA,NA,Feature0384,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,647716.97428089,902214.240149779,1.392914306671425,0.47810650478554917,0.4445957898950141,0.8724505635080375,Upregulated
Feature0383,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,2907681.0974912564,3658539.587287413,1.2582327513302598,0.33139882057205927,0.6441484868006424,0.9054136314946792,Upregulated
Feature0382,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0382,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,3456653.7760030166,3810813.2981243473,1.1024573315904524,0.14072282023261753,0.8591615693342681,0.9789760557739694,Upregulated
Feature0381,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak2,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,3395964.6433913056,729064.5776381083,0.21468556189384938,-2.219702925043976,0.21337071677415625,0.8724505635080375,Downregulated
Feature0380,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,422300.4425142345,1758279.3322882426,4.1635744490818904,2.0578226210933925,0.26278351742476075,0.8724505635080375,Upregulated
Feature0379,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",C7 H10 N4 O,166.08548,Metabolic pathways;ABC transporters;Other,NA,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",7,10,1,4,0,0,1.4285714285714286,0.14285714285714285,0.5714285714285716,44.014285714285705,5,4,0,0.2,0,Lignin,2196154.405873633,1924435.559193416,0.8762751626417966,-0.19054412752180067,0.8944126775371538,0.983565624317811,Downregulated
Feature0378,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,4580707.02831116,5776012.422145117,1.2609434278259546,0.33450355066551557,0.23713674768955018,0.8724505635080375,Upregulated
Feature0377,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,2594197.7810342065,2365872.1743031065,0.9119860450115429,-0.13291634609677025,0.5047837894485322,0.8751236754042836,Downregulated
Feature0376,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,6157888.407617367,5661115.282892633,0.9193273583668355,-0.12134942031873477,0.6312150994629676,0.9043347628664763,Downregulated
Feature0375,NA,C31 H37 N O11,599.23689,NA,NA,Feature0375,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,1209434.7926512172,148476.44752480666,0.12276515313349765,-3.026026984797075,0.4192236737077385,0.8724505635080375,Downregulated
Feature0374,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0374,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,733016.211790141,797191.4397893096,1.0875495343308201,0.12108111250706857,0.9349626282224279,0.9882637829765163,Upregulated
Feature0373,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0373,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,2563301.372165093,3736786.337544427,1.4578021835911354,0.5437949665001675,0.4176228406191842,0.8724505635080375,Upregulated
Feature0372,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,1324262.9244847335,2996515.5202881233,2.2627798942978474,1.1780962572302385,0.20828746683893623,0.8724505635080375,Upregulated
Feature0371,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0371,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,1085991.5774770142,1555922.2212064867,1.4327203391588172,0.5187570292207921,0.1755172788580942,0.8724505635080375,Upregulated
Feature0370,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,4994308.28195846,5097598.926433267,1.0206816717438,0.02953299138295115,0.9510012135522623,0.9882637829765163,Upregulated
Feature0369,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,4485047.387708364,314700.6929839477,0.0701666372235911,-3.8330709676952988,0.38194857409697264,0.8724505635080375,Downregulated
Feature0368,NA,C11 H21 N5 O2,255.16954,NA,NA,Feature0368,11,21,2,5,0,0,1.9090909090909092,0.18181818181818185,-0.18181818181818168,65.48181818181817,4,2,-0.75,-0.4,-3,Lipid,268487.9935527167,198059.49438618968,0.7376847350431013,-0.43892371270309866,0.6095093446060447,0.904145091526307,Downregulated
Feature0367,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,5820460.831659377,3747860.0919692335,0.6439112297746951,-0.6350662841736109,0.2774869802494179,0.8724505635080375,Downregulated
Feature0366,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak2,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,1177022.8371842909,2449609.6908919234,2.0811913019053674,1.0574095828653487,0.13464360509743947,0.8724505635080375,Upregulated
Feature0365,NA,C20 H36 N4 O6,428.2636,NA,NA,Feature0365,20,36,6,4,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,5,-1,-0.5,-0.15384615384615383,-5,Lipid,514819.00677656307,88930.1655513693,0.1727406416250788,-2.5333205414188638,0.3088256088497886,0.8724505635080375,Downregulated
Feature0364,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0364,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,4720726.67145466,5730735.210084926,1.2139519207366096,0.279711283958966,0.3096905874123234,0.8724505635080375,Upregulated
Feature0363,Acetylcarnitine,C9 H17 N O4,203.11573,NA,NA,Acetylcarnitine-peak1,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,3199296.4054030785,4390278.718646843,1.3722638237683742,0.4565578726567063,0.5971245406677048,0.9015409731649661,Upregulated
Feature0362,NA,C8 H12 N6,192.11229,NA,NA,Feature0362,8,12,0,6,0,0,1.5,0,0.75,38.925,6,6,0,0,0,Lipid,49943792.41243745,4435881.667487796,0.08881747767282354,-3.4930125889783654,0.4157730068066032,0.8724505635080375,Downregulated
Feature0361,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,4260936.50096034,2493697.02542102,0.5852462304610699,-0.7728843578399243,0.30683462514656895,0.8724505635080375,Downregulated
Feature0360,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,487815.6970230781,110482.98427100996,0.22648509456591578,-2.142511988118856,0.4366223035292388,0.8724505635080375,Downregulated
Feature0359,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,4487210.581031093,3569581.42594328,0.7955012053664404,-0.33006397831611967,0.5694949776349191,0.8929340317679025,Downregulated
Feature0358,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0358,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,1292016.9052756822,169820.45148136932,0.1314382581125238,-2.927542828697598,0.4214429937539208,0.8724505635080375,Downregulated
Feature0357,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,887248.6061430994,404424.83626549836,0.45581907197752297,-1.1334668050543273,0.31486180210303005,0.8724505635080375,Downregulated
Feature0356,MFCD00037215,C8 H14 N2 O5,218.09028,NA,NA,MFCD00037215,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,978629.426354706,487186.33215718064,0.4978251409952995,-1.0062890042362347,0.22739288909452113,0.8724505635080375,Downregulated
Feature0355,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak1,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,1371518.218439056,675288.539414088,0.49236570855226647,-1.0221978079316134,0.09228744662055917,0.8724505635080375,Downregulated
Feature0354,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0354,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,3890821.2794909365,1947125.966745743,0.5004408650197624,-0.9987284929252253,0.2621873779081359,0.8724505635080375,Downregulated
Feature0353,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1829841.7987306933,527445.2624749613,0.2882463734519751,-1.7946256380450556,0.04210476056245749,0.8724505635080375,Downregulated
Feature0352,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,4472654.12195905,5873035.19982034,1.3130984510932657,0.39297508803527426,0.21191150074727505,0.8724505635080375,Upregulated
Feature0351,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2093958.4422259766,1552623.2910324233,0.7414776051533819,-0.43152497526486155,0.3298592981541449,0.8724505635080375,Downregulated
Feature0350,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,4869690.2958133,3314599.12832036,0.6806591234703521,-0.5549956226428803,0.40908425601110315,0.8724505635080375,Downregulated
Feature0349,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0349,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,1335161.6120807682,3435422.4446796523,2.5730386595865014,1.3634731335484822,0.3350688839432771,0.8724505635080375,Upregulated
Feature0348,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,2375170.42270456,1636967.7279294706,0.6892001147713381,-0.5370051530748979,0.3295452253673507,0.8724505635080375,Downregulated
Feature0347,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,3072099.2556471783,411228.557309114,0.13385913770630542,-2.901212468993432,0.2483166212307483,0.8724505635080375,Downregulated
Feature0346,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak1,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,3443576.286653877,1531877.520856115,0.4448507578569257,-1.168606684679767,0.3889004157599518,0.8724505635080375,Downregulated
Feature0345,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,3068209.5894516627,2521582.4773958675,0.8218416649452275,-0.28306762214993875,0.8362790809380065,0.972310750246385,Downregulated
Feature0344,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,476319.1261046963,909098.4026021002,1.908591011317647,0.932507983224166,0.4056456452874637,0.8724505635080375,Upregulated
Feature0343,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,3057055.94418951,2183306.8410420897,0.7141860930585392,-0.48562805347363375,0.6886481247695286,0.9233562380758966,Downregulated
Feature0342,NA,C13 H21 N3 O5,299.1482,NA,NA,Feature0342,13,21,5,3,0,0,1.6153846153846154,0.38461538461538464,-0.1538461538461542,64.6846153846154,5,0,-0.6,-0.06666666666666667,-3,Protein,767396.314587925,425083.08690597833,0.55392901793415394,-0.8522269778825281,0.6186285619742541,0.9043347628664763,Downregulated
Feature0341,NA,C19 H41 N O2,315.3138,NA,NA,Feature0341,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,1031054.988410241,132187.48806932534,0.12820605065219853,-2.9634637436956814,0.24743708152934613,0.8724505635080375,Downregulated
Feature0340,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,4933617.631127994,5363713.07910515,1.087176485924553,0.1205861581210914,0.7268682340406417,0.930298368021698,Upregulated
Feature0339,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,330233.04968477925,543744.7286419267,1.646548487987356,0.7194449974169461,0.4733165298862217,0.8724505635080375,Upregulated
Feature0338,1581740,C12 H13 N O4,235.08445,NA,NA,1581740-peak1,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,2307762.2248187033,3665862.06393473,1.58849210049043,0.6676579156027941,0.26368531757117947,0.8724505635080375,Upregulated
Feature0337,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,2357700.70620418,2033055.4216491366,0.862304284975292,-0.21373104580320837,0.7302517597867355,0.930298368021698,Downregulated
Feature0336,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",C9 H15 N O3,185.10525,Other,NA,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,1408117.2244819996,964381.4797686407,0.6848730084410445,-0.5460915915981681,0.587723807482091,0.9001845658902912,Downregulated
Feature0335,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,2833069.069090863,3687254.8624724634,1.3015054601742237,0.38018136425816124,0.3497253490158354,0.8724505635080375,Upregulated
Feature0334,Alanyltryptophan,C14 H17 N3 O3,275.12704,NA,NA,Alanyltryptophan-peak2,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,3142456.91112652,4100226.6847810103,1.304783741111392,0.3838107098754096,0.599800928368895,0.9015641283557303,Upregulated
Feature0333,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak3,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,3450433.8242113497,3365713.0471591502,0.9754463405564476,-0.03586558273205025,0.9604592450334423,0.9882637829765163,Downregulated
Feature0332,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5092013.57217978,5440266.798771187,1.0683920460255818,0.09544114053702368,0.5915127275976062,0.9015409731649661,Upregulated
Feature0331,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr-peak2,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,2232340.357349863,2350079.82061811,1.0527426128728963,0.07415275210731054,0.9279786130477372,0.9874405343841273,Upregulated
Feature0330,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan-peak1,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,4380513.474890858,4233253.275898066,0.966382890992828,-0.04933318171681353,0.9445039372519841,0.9882637829765163,Downregulated
Feature0329,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0329,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2694133.5337160667,564704.723031709,0.209605320584389,-2.254252756431422,0.09834129523154932,0.8724505635080375,Downregulated
Feature0328,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,532795.0189297734,364650.9620875387,0.6844113573359112,-0.5470643943291101,0.35253479023541706,0.8724505635080375,Downregulated
Feature0327,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,4653176.725927633,4208654.405814987,0.9044690656953226,-0.144856933700471,0.685815131952858,0.9233562380758966,Downregulated
Feature0326,Brivaracetam,C11 H20 N2 O2,212.15246,NA,NA,Brivaracetam,11,20,2,2,0,0,1.818181818181818,0.18181818181818185,-0.9090909090909092,86.2090909090909,3,1,-0.14285714285714285,0,-1,Lipid,3323539.34287762,2204185.8202244933,0.6632043712520169,-0.5924745790627095,0.7338080831421231,0.9311392455750985,Downregulated
Feature0325,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3191504.8229091004,2253971.980044253,0.7062411323538991,-0.5017672470057972,0.6145703746247173,0.9043347628664763,Downregulated
Feature0324,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,326874.6485235338,64125.795087280334,0.1961785515546444,-2.3497607763538446,0.41317087603207925,0.8724505635080375,Downregulated
Feature0323,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine-peak1,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,3305378.1243759897,3048219.1945604635,0.9221998451798691,-0.11684867133905504,0.8912361716316778,0.983565624317811,Downregulated
Feature0322,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",C9 H14 N2 O4,214.09536,NA,NA,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",9,14,4,2,0,0,1.5555555555555556,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Protein,3662087.8567671934,3961527.1947428132,1.0817673823478278,0.11339030284950245,0.5883354336107707,0.9003073392381622,Upregulated
Feature0321,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0321,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,3958642.728816317,3700976.3878079867,0.9349104330298138,-0.09709993738786606,0.8614201106510878,0.9789760557739694,Downregulated
Feature0320,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,2166840.8212072,1425665.2921933136,0.6579464805352155,-0.6039578595692413,0.5289857340090993,0.8826174436414305,Downregulated
Feature0319,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,1253855.6103087943,1016417.5221734087,0.8106336278409997,-0.3028780703622752,0.6211870786742817,0.9043347628664763,Downregulated
Feature0318,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,4407074.079835194,5009944.293647253,1.136796024503088,0.18497341444376303,0.8852308405059977,0.9814814661453127,Upregulated
Feature0317,CMPF,C12 H16 O5,240.09978,NA,NA,CMPF,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,917785.2512688763,298539.9171878413,0.3252829752658342,-1.6202327786328024,0.4302896944882514,0.8724505635080375,Downregulated
Feature0316,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,1354481.0328119467,1215496.2555489112,0.8973889084482057,-0.15619474219209029,0.8146925831859837,0.9660274597293932,Downregulated
Feature0315,Aspartame,C14 H18 N2 O5,294.12149,Other,NA,Aspartame-peak1,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,2786513.397056579,739109.638460643,0.26524532027779646,-1.9146007969860517,0.3797122214453394,0.8724505635080375,Downregulated
Feature0314,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,2848080.742012935,2343806.367572504,0.8229423881838316,-0.2811366596120046,0.877875280779278,0.9807974651872519,Downregulated
Feature0313,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,2013041.700339512,406382.3541795673,0.2018747818840655,-2.3084673938421476,0.30220375909196723,0.8724505635080375,Downregulated
Feature0312,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1921960.5559970872,2744518.3258157535,1.427978486474159,0.5139742442893918,0.28826485742686214,0.8724505635080375,Upregulated
Feature0311,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0311,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2550484.2211108403,3404789.3338440377,1.3349580074489198,0.41679436109033413,0.5808126004091547,0.8964335502669541,Upregulated
Feature0310,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0310,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3501199.4290705933,3543209.132056129,1.0119986604124083,0.017207380330983426,0.9821199787932822,0.9951332564369114,Upregulated
Feature0309,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2443687.3168148133,1033208.6004989339,0.422807203437817,-1.2419281385180265,0.21795498457321957,0.8724505635080375,Downregulated
Feature0308,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,22684509.36851393,2624020.8577094465,0.11567456959644823,-3.1118563639739953,0.4189301743768296,0.8724505635080375,Downregulated
Feature0307,NA,C11 H14 N2 O5 S,286.06233,NA,NA,Feature0307,11,14,5,2,1,0,1.2727272727272727,0.4545454545454546,0.36363636363636376,49.93636363636363,6,1,-0.6666666666666666,0.09090909090909093,-2,Lignin,3346679.185785317,4466568.456432097,1.3346270163580054,0.41643661319796205,0.08030155726000127,0.8724505635080375,Upregulated
Feature0306,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,2035243.9432273116,1862160.5051320468,0.914956907907165,-0.12822429707822852,0.9064535259851607,0.983565624317811,Downregulated
Feature0305,tyr-thr,C13 H18 N2 O5,282.12161,NA,NA,tyr-thr-peak1,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,2721499.0529363267,3246327.922676993,1.1928455088655676,0.2544072047881748,0.5405916472520369,0.8890580920144323,Upregulated
Feature0304,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,2688763.714620673,3624616.14625778,1.34806049581383,0.43088524062381306,0.1619943660965007,0.8724505635080375,Upregulated
Feature0303,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,3408220.4359187423,3443716.436883113,1.010414819590389,0.014947704167607923,0.9918696714713866,0.9956526818674369,Upregulated
Feature0302,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,3479854.767024457,3050739.1902310466,0.8766857798607678,-0.1898682477323715,0.9159298736547692,0.9838470257338569,Downregulated
Feature0301,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0301,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,3850635.22449369,3195963.5788258263,0.8299834683110123,-0.268845493877491,0.7261875309039135,0.930298368021698,Downregulated
Feature0300,NA,C9 H15 N O5,217.09502,NA,NA,Feature0300,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,1142066.217665272,450673.9541254853,0.39461280541753424,-1.3414903217640084,0.48567001980896995,0.8724505635080375,Downregulated
Feature0299,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,2663658.36438584,3114528.7967555965,1.1692673649136358,0.22560485453300091,0.6445860918433195,0.9054136314946792,Upregulated
Feature0298,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,5346178.149007264,4312177.6658750335,0.8065907168985316,-0.3100912931127288,0.5425795607478442,0.8890580920144323,Downregulated
Feature0297,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak2,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,1186110.971008795,161548.79890250633,0.13620040860519825,-2.8761970634036857,0.42390191263297966,0.8724505635080375,Downregulated
Feature0296,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,2949560.2089299667,2200339.2138448334,0.7459889129176537,-0.42277390595856695,0.7871212161427867,0.9530974554295074,Downregulated
Feature0295,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,3522170.7961019934,4217368.134045953,1.1973775203386896,0.259878090335543,0.17964196271189703,0.8724505635080375,Upregulated
Feature0294,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0294,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,4394755.19891278,4748140.449085813,1.0804106791341774,0.11157980510185,0.6965244941638719,0.9233562380758966,Upregulated
Feature0293,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,292747.2176206196,173066.74023949093,0.5911815034354096,-0.7583269629531207,0.5054440953757251,0.8751236754042836,Downregulated
Feature0292,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,3556873.9958757367,3852587.02026087,1.0831384594247697,0.11521767688663072,0.8575620256500043,0.9789760557739694,Upregulated
Feature0291,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0291,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,261397.9468182561,288933.1459651083,1.1053382380466699,0.14448790779215892,0.8974165963027075,0.983565624317811,Upregulated
Feature0290,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2127415.0063205203,2472346.376020443,1.1621363808542935,0.21677938409244288,0.7230597826775719,0.930298368021698,Upregulated
Feature0289,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3649516.6545072235,4526912.66411279,1.2404143048701983,0.31082206879801305,0.23003289410758385,0.8724505635080375,Upregulated
Feature0288,NA,C24 H36 N4 O6,476.26356,NA,NA,Feature0288,24,36,6,4,0,0,1.5,0.25,-0.5,74.55,9,3,-0.07142857142857142,0.1176470588235294,-1,Lipid,689797.949309518,104439.34048098451,0.15140569870572596,-2.723508587451661,0.1518022361734266,0.8724505635080375,Downregulated
Feature0287,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,890581.1160324697,172441.96229337231,0.1936285860872501,-2.3686361362733828,0.39428866584479344,0.8724505635080375,Downregulated
Feature0286,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,404780.8159965707,349213.78941461234,0.8627231716869974,-0.21303038936876623,0.779422470820028,0.9502143902366301,Downregulated
Feature0285,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak1,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,3533675.718634824,1425175.4595763767,0.40331246358026573,-1.3100301047954397,0.49336639766876217,0.8724505635080375,Downregulated
Feature0284,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,1802873.2886249467,3477320.412469587,1.9287658397344956,0.947678004786974,0.4142860322354084,0.8724505635080375,Upregulated
Feature0283,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1137947.7016909088,2116539.820200152,1.8599622962066935,0.8952733763725804,0.34809370151424324,0.8724505635080375,Upregulated
Feature0282,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0282,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,3235867.1403196966,4632578.6143294405,1.431634369843674,0.5176630846645134,0.013865272953046345,0.8724505635080375,Upregulated
Feature0281,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0281,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,601205.8209776663,695285.7447883446,1.1564853840864147,0.20974703299589872,0.8047263427197506,0.9626572180425523,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,15082231.300927904,3687791.5992410667,0.24451233545358655,-2.032020845052167,0.41026578243512496,0.8724505635080375,Downregulated
Feature0279,Acetophenone,C8 H8 O,120.05746,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak1,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,243838.94342269172,80196.3658088038,0.3288907205843015,-1.6043197907452609,0.4662898701653298,0.8724505635080375,Downregulated
Feature0278,NA,C19 H41 N O,299.31886,NA,NA,Feature0278,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,3716960.7494442603,1750211.4740585533,0.47087165887351257,-1.0865942034945524,0.1798746577060032,0.8724505635080375,Downregulated
Feature0277,NA,C16 H35 N O,257.27187,NA,NA,Feature0277,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,43694178.56788685,4767379.225785637,0.10910788077589437,-3.19617278474111,0.41876976435421664,0.8724505635080375,Downregulated
Feature0276,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0276,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,1384316.2466498625,834971.3624952829,0.6031651831840948,-0.729374941309541,0.447287463241284,0.8724505635080375,Downregulated
Feature0275,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,2912145.6168172797,643219.595021714,0.22087480492294087,-2.1786992343009857,0.20212535709666163,0.8724505635080375,Downregulated
Feature0274,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,896510.8248820318,412075.92107754236,0.4596441109696202,-1.1214108381927297,0.5995320311547822,0.9015641283557303,Downregulated
Feature0273,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15865,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak1",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,309624.33717031014,78354.66763319283,0.253063658849574,-1.9824277504646888,0.4067221223319604,0.8724505635080375,Downregulated
Feature0272,N-benzoyl-4-methoxyanthranilic acid,C15 H13 N O4,271.08448,NA,NA,N-benzoyl-4-methoxyanthranilic acid,15,13,4,1,0,0,0.8666666666666667,0.26666666666666666,-0.13333333333333375,64.10000000000001,10,6,0.5,0.5833333333333334,5,Lignin,3760813.088276933,5161270.167543704,1.3723814628363806,0.4566815442298308,0.2512029621185571,0.8724505635080375,Upregulated
Feature0271,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,1866473.5235372747,3375966.500768447,1.8087406321041375,0.854985544717247,0.24898458893623843,0.8724505635080375,Upregulated
Feature0270,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0270,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,293425.0859180932,83413.93501730976,0.28427676780367017,-1.8146318936698995,0.37850497852738013,0.8724505635080375,Downregulated
Feature0269,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0269,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,1906906.10808663,784723.1879948507,0.41151642687968204,-1.2809780737062175,0.07339346690877412,0.8724505635080375,Downregulated
Feature0268,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,3203193.0465090135,3691828.281692987,1.1525462961767199,0.20482470286553908,0.8032585779718311,0.9616395979394218,Upregulated
Feature0267,Methylone,C11 H13 N O3,207.08954,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak1,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,4279104.869242483,4825058.461787607,1.1275859342614738,0.1732373866589783,0.4868783343868174,0.8724505635080375,Upregulated
Feature0266,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak1,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,2454897.879575647,980530.132445485,0.3994178904969274,-1.3240291402898976,0.40093883155103427,0.8724505635080375,Downregulated
Feature0265,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,3137939.169147317,3025703.692842421,0.9642327431301373,-0.05254667371012725,0.9528548431077717,0.9882637829765163,Downregulated
Feature0264,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,759508.8471456257,3099794.2724134894,4.081314238883573,2.029033794503332,0.20719111001143212,0.8724505635080375,Upregulated
Feature0263,asn-ile,C10 H19 N3 O4,245.13753,NA,NA,asn-ile,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1086770.740301846,761766.7481146484,0.7009452130658862,-0.5126264094632278,0.5308345512636463,0.8826174436414305,Downregulated
Feature0262,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0262,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1649258.5138887237,2891308.4924857034,1.7530959932220678,0.8099049950442787,0.49596805942044875,0.8724505635080375,Upregulated
Feature0261,beta-Aspartylleucine,C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,beta-Aspartylleucine,10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,1528899.303779407,1543130.2413888588,1.0093079626462471,0.013366440443503802,0.9888170235323152,0.9956526818674369,Upregulated
Feature0260,.alpha.-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,.alpha.-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,3578988.97938865,591143.9310808977,0.16517064860643263,-2.5979707572350645,0.16594728905595763,0.8724505635080375,Downregulated
Feature0259,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,808574.5911095273,110496.57072016974,0.13665600172835776,-2.871379272614256,0.4030044021585395,0.8724505635080375,Downregulated
Feature0258,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0258,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,351172.3505304598,109654.90085828667,0.3122537998582422,-1.6792089665984495,0.42656406065994373,0.8724505635080375,Downregulated
Feature0257,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak1,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,2897068.364500127,4139880.8558460665,1.428989700959432,0.5149955186532555,0.3999454400022881,0.8724505635080375,Upregulated
Feature0256,NA,C19 H41 N O2,315.31381,NA,NA,Feature0256,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,2980416.4029516736,2793063.606071665,0.9371387176991568,-0.09366547974116816,0.9288174981689383,0.9874405343841273,Downregulated
Feature0255,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,560297.859681672,100713.78339306594,0.17975043390364823,-2.4759328416643136,0.21749227302074967,0.8724505635080375,Downregulated
Feature0254,Desthiobiotin,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak1,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,2547359.758673114,4198835.249172267,1.648308698791483,0.7209864588495147,0.25719696801477326,0.8724505635080375,Upregulated
Feature0253,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2971385.0657060537,1596231.22381605,0.537201065670954,-0.89646592817733906,0.40216528876224455,0.8724505635080375,Downregulated
Feature0252,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1096020.8532118278,2573962.7082803114,2.3484614373325634,1.2317159041659203,0.334182131798067,0.8724505635080375,Upregulated
Feature0251,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0251,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,3882343.6777081965,3229471.3842921834,0.8318355231751628,-0.2656297989216757,0.6020237816191292,0.9026012960519595,Downregulated
Feature0250,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0250,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,3951340.3605210166,4494234.868178713,1.137395025010225,0.18573339903811398,0.6932509536836855,0.9233562380758966,Upregulated
Feature0249,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,2020185.0861761,775601.3407197597,0.38392588185464427,-1.3811002740494251,0.0674330629074823,0.8724505635080375,Downregulated
Feature0248,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,3184619.1219398957,3726961.7061376534,1.1703006116057584,0.2268791581571029,0.824990007079206,0.9691630180250866,Upregulated
Feature0247,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,1018765.561937981,339873.058028135,0.333612629564745,-1.5837541890018683,0.4648038905810512,0.8724505635080375,Downregulated
Feature0246,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0246,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,2560071.5807168153,2494479.9833081565,0.9743789986566339,-0.03744505653273589,0.9512137231739194,0.9882637829765163,Downregulated
Feature0245,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak1,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,2703029.6266890867,2948171.84112362,1.0906916491088576,0.12524329306524248,0.7933437516648888,0.9578562748101455,Upregulated
Feature0244,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,484177.1106277247,192094.3046579388,0.39674387830703706,-1.333720132202999,0.21969352295310618,0.8724505635080375,Downregulated
Feature0243,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,2370175.9967953134,636346.5084072823,0.2684806990146212,-1.8971097178005691,0.22987144628240555,0.8724505635080375,Downregulated
Feature0242,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,3071731.80264678,2097102.95992496,0.6827103063223086,-0.5506545636510072,0.4872877555551058,0.8724505635080375,Downregulated
Feature0241,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,2673413.7553439867,2577814.4264626103,0.964240728285968,-0.05253472628654227,0.9423834949131287,0.9882637829765163,Downregulated
Feature0240,ELK,C17 H32 N4 O6,388.23223,NA,NA,ELK,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,1604526.1394690473,1100823.7794410763,0.6860740703204431,-0.5435637530150986,0.39204533028258065,0.8724505635080375,Downregulated
Feature0239,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine-peak1,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1099882.6832393613,257547.72385147968,0.23415926787114533,-2.0944379547912964,0.29027370598524416,0.8724505635080375,Downregulated
Feature0238,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,2445425.8276880737,2616836.7247378933,1.0700944985159795,0.09773820458953614,0.8716410097228531,0.9807974651872519,Upregulated
Feature0237,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,3971838.8122506067,4678733.369248274,1.1779766476971183,0.2363109393504639,0.4314906688588695,0.8724505635080375,Upregulated
Feature0236,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,C11 H9 N3 O2,215.06947,NA,NA,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,11,9,2,3,0,0,0.8181818181818182,0.18181818181818185,0.36363636363636376,49.93636363636363,9,7,0.6666666666666666,0.7142857142857143,4,Lignin,1800936.4300094044,4326477.583088693,2.402348861956277,1.264445670139525,0.11639022618341936,0.8724505635080375,Upregulated
Feature0235,NA,C14 H21 N O10,363.11672,NA,NA,Feature0235,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,359942.1856804847,60288.75388554737,0.16749565981428138,-2.577804382275386,0.41770748462568835,0.8724505635080375,Downregulated
Feature0234,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0234,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,826108.4361306423,85310.63241667287,0.10326808041841821,-3.2755337006868506,0.055996804701721095,0.8724505635080375,Downregulated
Feature0233,Anhalamine,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,3183727.4035593634,3708696.6799047664,1.1648914023727328,0.22019546512757432,0.3844917944018127,0.8724505635080375,Upregulated
Feature0232,NA,C19 H37 N O2,311.28246,NA,NA,Feature0232,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,1527828.968578892,191062.81745894867,0.12505510851562493,-2.9993641019056803,0.14741899866930788,0.8724505635080375,Downregulated
Feature0231,NA,C13 H25 N O9,339.15309,NA,NA,Feature0231,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,490984.67551382806,81372.96946784756,0.16573423474508378,-2.5930564525242814,0.3923169483264723,0.8724505635080375,Downregulated
Feature0230,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0230,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,3065713.8670716635,2668397.1914026034,0.8703999483002722,-0.20024962399182952,0.7561883560067804,0.9418993199084456,Downregulated
Feature0229,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0229,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,2056205.57423855,2625577.7460415564,1.2769043032158178,0.35265040722599555,0.6862995477374499,0.9233562380758966,Upregulated
Feature0228,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0228,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,1577452.7290268568,1928441.4282791286,1.2225034657417593,0.28983855515817303,0.8549731421703537,0.9789760557739694,Upregulated
Feature0227,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0227,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3200070.5791213433,3092465.438699664,0.9663741352694712,-0.049346253032550254,0.9490364306829799,0.9882637829765163,Downregulated
Feature0226,NA,C16 H32 N2 O10,412.20583,NA,NA,Feature0226,16,32,10,2,0,0,2,0.625,-0.375,70.9875,2,-8,-2.5,-0.5555555555555556,-10,Amino Sugar,417747.0313263983,1548410.7528063632,3.7065751200911428,1.8900867503693048,0.004789544842495353,0.8724505635080375,Upregulated
Feature0225,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0225,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,1406298.31486961,1446322.9302777536,1.028460970894255,0.040487046010931116,0.9442922629959356,0.9882637829765163,Upregulated
Feature0224,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak1",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,3878790.5378456,3933077.9275162234,1.013995958054692,0.020051901546309082,0.9225627152282323,0.9872528361317912,Upregulated
Feature0223,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0223,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,3484582.3865018967,2239765.2115372135,0.642764315234248,-0.6376382586927215,0.37416961166158785,0.8724505635080375,Downregulated
Feature0222,NA,C9 H21 N O7,255.13179,NA,NA,Feature0222,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,359223.45662392967,150971.86640263733,0.42027285139313575,-1.2506018299880406,0.41623644940320276,0.8724505635080375,Downregulated
Feature0221,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0221,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,2727437.516918293,3116841.536837087,1.1427728472250311,0.19253866273871112,0.745294239747678,0.9351636436381646,Upregulated
Feature0220,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,592106.4905652336,1554619.9257542002,2.6255748763539764,1.3926333391451968,0.38686557725757176,0.8724505635080375,Upregulated
Feature0219,NA,C17 H31 N O9,393.19997,NA,NA,Feature0219,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,1372470.4046991367,248246.070798621,0.1808753543600379,-2.4669322516868597,0.4142717301705266,0.8724505635080375,Downregulated
Feature0218,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2691097.1303899665,3026798.777193066,1.1247452732241043,0.16959830396032582,0.8382232735743103,0.9729838623914456,Upregulated
Feature0217,NA,C10 H23 N O6,253.15257,NA,NA,Feature0217,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,490944.4532675948,612905.5173467566,1.2484213097172636,0.3201048884199312,0.7378397750718169,0.932761626098252,Upregulated
Feature0216,NP-008521,C14 H18 N2 O2,246.13679,NA,NA,NP-008521,14,18,2,2,0,0,1.2857142857142858,0.14285714285714285,-0.5714285714285712,76.58571428571427,7,5,0.3,0.3636363636363637,3,Lignin,1540128.381414691,2350700.1038890034,1.526301399452011,0.6100398799700333,0.5114201679404705,0.8780428973934686,Upregulated
Feature0215,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,2025702.07086612,1877607.0668719967,0.9268920113554492,-0.10952682912947402,0.8584816118864735,0.9789760557739694,Downregulated
Feature0214,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,2251967.2121996097,2833146.2024292066,1.258076133205301,0.3312192303843269,0.7504372544767111,0.9381850251539103,Upregulated
Feature0213,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0213,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3127134.58030095,4021090.8704865603,1.2858707443603459,0.3627456303467911,0.2940926263608037,0.8724505635080375,Upregulated
Feature0212,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1636443.4761100768,3336873.42633075,2.0391009375176807,1.0279331919567263,0.1448884532674691,0.8724505635080375,Upregulated
Feature0211,N-Acetyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Acetyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,1340812.6824786386,3220402.302362253,2.4018286405294047,1.2641332250330495,0.20901183680977684,0.8724505635080375,Upregulated
Feature0210,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0210,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,3958468.0760390433,4521570.050155033,1.1422524985169127,0.19188159824259005,0.41924081702573535,0.8724505635080375,Upregulated
Feature0209,NA,C20 H33 N O11,463.2054,NA,NA,Feature0209,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,470889.234865808,68902.58473046163,0.14632439994109697,-2.772757732527339,0.40722812730424046,0.8724505635080375,Downregulated
Feature0208,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,295781.61370385997,316806.148536352,1.0710812770584923,0.0990679605364945,0.8896458257654791,0.983078949019388,Upregulated
Feature0207,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0207,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,435811.911863548,236256.39310095168,0.5421063230940856,-0.8833522603612601,0.13449130026545422,0.8724505635080375,Downregulated
Feature0206,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,2589236.9231197434,3336962.77946325,1.2887823241152379,0.36600861246704824,0.04158234687191006,0.8724505635080375,Upregulated
Feature0205,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2803508.8326203134,2862427.5944753266,1.0210160785546534,0.030005585381647732,0.9690671013299812,0.9898726803046187,Upregulated
Feature0204,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,282158.4717189198,49668.49557022464,0.17603049544336674,-2.5061027125372686,0.41102337889853385,0.8724505635080375,Downregulated
Feature0203,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0203,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,1496683.3893795053,2734602.5133712715,1.8271082132507548,0.8695620822943273,0.44611499293547063,0.8724505635080375,Upregulated
Feature0202,NL8513000,C11 H13 N O2,191.09465,NA,Other,NL8513000-peak1,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,2151150.9728530166,2677720.64961269,1.2447850864048362,0.3158966808137727,0.28957502445792516,0.8724505635080375,Upregulated
Feature0201,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0201,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,3245774.872168613,2627449.2347140145,0.8094982980007254,-0.30490004767452356,0.6659129310674112,0.9141462765220378,Downregulated
Feature0200,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,3395933.664604653,3600091.050924537,1.060118190307363,0.08422511673651215,0.3766489755558286,0.8724505635080375,Upregulated
Feature0199,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,1278312.9796873769,2910801.153095117,2.2770645368921936,1.1871751811253404,0.1948042422324029,0.8724505635080375,Upregulated
Feature0198,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0198,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,2019098.944989608,2655798.530015603,1.3153384764060052,0.39543409639779076,0.656742658407305,0.9089232543643583,Upregulated
Feature0197,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0197,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1600649.9517671564,1049790.6636860296,0.6558527443973838,-0.6085561653725008,0.46342471058299817,0.8724505635080375,Downregulated
Feature0196,Crotetamide,C12 H22 N2 O2,226.16812,Microbial metabolism in diverse environments;Other,NA,Crotetamide,12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,1181114.1714051731,231984.89120629965,0.19641191073874503,-2.3480456752006904,0.4412334628467757,0.8724505635080375,Downregulated
Feature0195,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0195,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,3152651.19707234,1373587.3460014355,0.43569277415687335,-1.1986169081307008,0.23394088577382158,0.8724505635080375,Downregulated
Feature0194,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,1715582.4451721795,3191545.08114777,1.8603274299810522,0.895556567589389,0.31956763600373783,0.8724505635080375,Upregulated
Feature0193,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0193,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,857104.3078293283,429768.11761205364,0.501418688117983,-0.9959123277687575,0.09176459255504454,0.8724505635080375,Downregulated
Feature0192,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,2596080.5225356068,3170015.4902766235,1.2210774907630566,0.28815475805846497,0.531472874463857,0.8826174436414305,Upregulated
Feature0191,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,312048.1248323066,66421.56983817507,0.21285681455022284,-2.2320448165580293,0.41940403960410516,0.8724505635080375,Downregulated
Feature0190,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,1236591.4411400536,1718170.996773385,1.3894411198490486,0.47450469894895814,0.5731270009122599,0.8929340317679025,Upregulated
Feature0189,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,602768.454971708,202288.7280941793,0.33559939380648923,-1.5751879850487251,0.27896384296299,0.8724505635080375,Downregulated
Feature0188,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0188,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2309329.98598859,2774557.4270735965,1.2014555927077046,0.26478332565101514,0.6938133510321289,0.9233562380758966,Upregulated
Feature0187,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0187,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,2448739.85411934,782372.301699833,0.319499966639455,-1.6461123143538887,0.35935903240569456,0.8724505635080375,Downregulated
Feature0186,NA,C9 H9 O P S,196.01126,NA,NA,Feature0186,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,782418.45343148,139879.15443150167,0.178777933748915,-2.48375941673074,0.4252664013409228,0.8724505635080375,Downregulated
Feature0185,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,373637.8447797793,103905.12484532916,0.2780904726248232,-1.8463737760652972,0.4770338480182264,0.8724505635080375,Downregulated
Feature0184,NA,C8 H11 N O7,233.05354,NA,NA,Feature0184,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,1910449.1249470664,2624685.361775204,1.3738577633402969,0.4582326484458979,0.6455708504561564,0.905539285949828,Upregulated
Feature0183,NA,C23 H32,308.25044,NA,NA,Feature0183,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,4668159.344575916,867762.809475789,0.185889714858185,-2.4274811456820418,0.22898962616919713,0.8724505635080375,Downregulated
Feature0182,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0182,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3379400.1096319067,2159024.57991675,0.6388780581982987,-0.6463875027147677,0.42917485636684893,0.8724505635080375,Downregulated
Feature0181,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0181,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,604036.716726511,742375.145816893,1.229023212098905,0.29751216360621296,0.7027381271830376,0.9272348854064458,Upregulated
Feature0180,(+)-castanospermine,C8 H15 N O4,189.10012,NA,NA,(+)-castanospermine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,3465401.601575374,2514872.3594002854,0.7257087773772086,-0.462537375486385,0.7974258424510869,0.9586929428349551,Downregulated
Feature0179,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0179,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,2486750.3706704634,236713.6467769765,0.09518995133924726,-3.393046905298224,0.2349637227574619,0.8724505635080375,Downregulated
Feature0178,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,2613676.0127161,878301.2078085777,0.33604058174595935,-1.5732926251324293,0.3093845770000032,0.8724505635080375,Downregulated
Feature0177,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0177,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,3080068.1950998623,2248495.5470830584,0.7300148583269136,-0.45400226676264727,0.6056028884394022,0.9031677924568101,Downregulated
Feature0176,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0176,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,653314.6621717049,2415454.431822471,3.6972297909145015,1.8864447129626158,0.26161872132535796,0.8724505635080375,Upregulated
Feature0175,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa-peak1,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,905285.77708945,526292.7958427718,0.5813554229636035,-0.78250764180829,0.53157409943743394,0.8826174436414305,Downregulated
Feature0174,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,4604199.89583015,3143716.8125570435,0.6827932938802656,-0.5504792060196547,0.46752446435805484,0.8724505635080375,Downregulated
Feature0173,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,2247325.5318491333,4021961.8717935034,1.7896659005534337,0.8396902865941325,0.04165466640841041,0.8724505635080375,Upregulated
Feature0172,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,3144086.456298603,4149746.3933501,1.3198575964846135,0.4003822811533543,0.31112156234538674,0.8724505635080375,Upregulated
Feature0171,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,1776002.07018824,1425178.08188695,0.8024642008079946,-0.3174910621150894,0.3713577520228985,0.8724505635080375,Downregulated
Feature0170,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0170,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1758049.7866986098,217997.83935424668,0.12399980990505305,-3.0115901859626915,0.054957758822590005,0.8724505635080375,Downregulated
Feature0169,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,1614965.976795579,1707032.5265857,1.0570083525677734,0.07998677706165021,0.8413285128348247,0.9745510918195973,Upregulated
Feature0168,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,2528475.98073181,1588826.8581763234,0.6283733245970854,-0.6703061575530717,0.34397336892294955,0.8724505635080375,Downregulated
Feature0167,NA,C9 H19 N O8,269.11107,NA,NA,Feature0167,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,833604.0210331697,524183.97213164734,0.6288165110839715,-0.6692889953788979,0.5552548024559422,0.8929340317679025,Downregulated
Feature0166,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,599406.9308009377,161651.81759307726,0.26968626701909393,-1.8906460364502493,0.1772911830485461,0.8724505635080375,Downregulated
Feature0165,NA,C14 H25 N3 O6,331.17443,NA,NA,Feature0165,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1678652.5911580266,2267718.59424403,1.3509159704567777,0.43393793907843525,0.5544510311639675,0.8929340317679025,Upregulated
Feature0164,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,4015817.7411628133,3986148.51567381,0.9926119093541301,-0.010698330698560144,0.9481382881769891,0.9882637829765163,Downregulated
Feature0163,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1972275.8228782683,1142276.1713497604,0.5791665435936661,-0.7879498294579488,0.3769772066205653,0.8724505635080375,Downregulated
Feature0162,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,2833215.5333194835,2353015.4143800763,0.8305105583065931,-0.26792958555613877,0.8593615946993345,0.9789760557739694,Downregulated
Feature0161,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,719361.755646027,115209.00180000033,0.1601544715100071,-2.642464016192465,0.423227290076415,0.8724505635080375,Downregulated
Feature0160,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0160,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,600321.7956295477,437248.0814370443,0.7283561660101135,-0.4572839943501003,0.4343121057123448,0.8724505635080375,Downregulated
Feature0159,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1025909.9494356364,307990.6442222107,0.30021216227763414,-1.7359456698867874,0.5203522418365311,0.8823277748748858,Downregulated
Feature0158,DL-Metanephrine,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,DL-Metanephrine,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,3780737.6255291635,3704659.145802967,0.9798773447772513,-0.029326922349482566,0.8688686332643276,0.9807974651872519,Downregulated
Feature0157,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,2555083.0287714666,3255610.594337663,1.2741701767331701,0.34955797518688275,0.3027057261496678,0.8724505635080375,Upregulated
Feature0156,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,1336374.3720004873,686313.6178668083,0.513563887669763,-0.9613843350117127,0.09474918300992818,0.8724505635080375,Downregulated
Feature0155,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0155,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,3502884.2873757696,1598701.2341250675,0.45639567367004147,-1.1316429789933693,0.6103002947740752,0.904145091526307,Downregulated
Feature0154,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,2642677.07766113,2805837.8253173935,1.0617407056789046,0.08643147960159245,0.8764079984477238,0.9807974651872519,Upregulated
Feature0153,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,1539507.029178072,199295.98132654832,0.12945441465957486,-2.9494839299670166,0.40434452233915114,0.8724505635080375,Downregulated
Feature0152,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3701547.226577527,3726300.043928897,1.0066871542725815,0.009615410153716964,0.9585704166561921,0.9882637829765163,Upregulated
Feature0151,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0151,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,820238.9708733667,1199609.4521541886,1.4625121394523346,0.5484485997080062,0.5677225312543629,0.8929340317679025,Upregulated
Feature0150,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,1097895.3019218517,768166.6180606873,0.6996720149143744,-0.5152493061811956,0.47100673847638513,0.8724505635080375,Downregulated
Feature0149,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1091696.6972279313,1608920.3865561297,1.4737796593518584,0.5595208472808837,0.5233647092802227,0.8826174436414305,Upregulated
Feature0148,NA,C13 H21 N O8,319.12681,NA,NA,Feature0148,13,21,8,1,0,0,1.6153846153846154,0.6153846153846154,-0.1538461538461542,64.6846153846154,4,-4,-1.25,-0.125,-5,Amino Sugar,259122.10396912252,88154.7195013881,0.34020532463680825,-1.5555223737361454,0.35583497911381246,0.8724505635080375,Downregulated
Feature0147,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0147,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2451684.9490099167,2649961.4138601986,1.0808735498133042,0.11219775366651785,0.8605984174776704,0.9789760557739694,Upregulated
Feature0146,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0146,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3265200.589139283,4251742.392542443,1.302138192270514,0.3808825658028827,0.3005813493624967,0.8724505635080375,Upregulated
Feature0145,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0145,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,2894757.2353980266,1447350.5237834419,0.49999029489753827,-1.0000280032781612,0.1565680018411969,0.8724505635080375,Downregulated
Feature0144,Kynurenine,C10 H12 N2 O3,208.08476,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Kynurenine,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,4063315.3005508133,4057200.097424183,0.9984950212635969,-0.0021728608247506146,0.9917849522776587,0.9956526818674369,Downregulated
Feature0143,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,362851.87193100154,69455.45579632849,0.1914154539887171,-2.385220783909573,0.4138680501955993,0.8724505635080375,Downregulated
Feature0142,NA,C14 H26 N4 O5,330.19042,NA,NA,Feature0142,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,1462814.4233861647,1933556.626182707,1.3218058253123146,0.40251025896811793,0.6442282673266075,0.9054136314946792,Upregulated
Feature0141,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,1236459.187404742,3033098.8847164134,2.4530521634787776,1.294577912734485,0.027792765449196226,0.8724505635080375,Upregulated
Feature0140,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,1608910.6077535693,3245699.8235344533,2.017327630194595,1.012445408230583,0.15462552235111002,0.8724505635080375,Upregulated
Feature0139,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0139,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3604053.03199508,2288060.40655593,0.6348575856802359,-0.6554950990278984,0.3166944795348201,0.8724505635080375,Downregulated
Feature0138,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,2586175.895266507,1121908.3526304667,0.43380976316572367,-1.2048655727386952,0.10774254865751905,0.8724505635080375,Downregulated
Feature0137,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0137,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2657614.3730012733,2201975.5286263423,0.8285534391280504,-0.27133334508247475,0.7285555716388025,0.930298368021698,Downregulated
Feature0136,NA,C9 H17 N3 O2,199.13218,NA,NA,Feature0136,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,238847.328348697,144129.29598490134,0.603436919229361,-0.7287251293279773,0.5489509792488514,0.8906171704145945,Downregulated
Feature0135,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,1627536.1807596467,117675.1487548951,0.0723026315150614,-3.7898080335438316,0.4235872494812874,0.8724505635080375,Downregulated
Feature0134,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,3563361.9399631964,3375603.6779710334,0.9473086750221892,-0.07809349880006769,0.8645502830211678,0.9789760557739694,Downregulated
Feature0133,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3650319.40633219,2800817.58199713,0.7672801391403082,-0.3821746833135441,0.5040426758810542,0.8751236754042836,Downregulated
Feature0132,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,1119337.328775907,2657551.173277913,2.3742183030598802,1.2474525930515512,0.1929444448413699,0.8724505635080375,Upregulated
Feature0131,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0131,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,320459.22495588864,144502.12399200103,0.4509220291969807,-1.1490501022397024,0.24504501812549137,0.8724505635080375,Downregulated
Feature0130,Nipecotic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Nipecotic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,2082688.7148619934,2165224.91584155,1.0396296385487573,0.05606966895141325,0.8803558521143812,0.9808471485893633,Upregulated
Feature0129,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,3992195.2959242803,3673148.16645683,0.9200822841023905,-0.12016520593719629,0.523746240243245,0.8826174436414305,Downregulated
Feature0128,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,3240285.4383101333,4009386.5506707667,1.2373559758864126,0.3072606100677308,0.4183238178712649,0.8724505635080375,Upregulated
Feature0127,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,1260964.0374626396,2269031.700223074,1.799442040225752,0.8475496340072748,0.512994255217182,0.8786777232941418,Upregulated
Feature0126,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,10580555.595924435,514436.0022008329,0.04862088739451362,-4.3622799651044835,0.37119555316806585,0.8724505635080375,Downregulated
Feature0125,Methyl picolinate,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Methyl picolinate,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1906605.4317292103,379890.442103208,0.19924963801171144,-2.327350991696374,0.22539951120880092,0.8724505635080375,Downregulated
Feature0124,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,600760.8457162759,1369342.8526422745,2.279347701179881,1.188621016093277,0.45208755848094023,0.8724505635080375,Upregulated
Feature0123,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0123,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1798350.6798559034,968355.7007161414,0.5384687822920794,-0.8930653878855811,0.2391356420952691,0.8724505635080375,Downregulated
Feature0122,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0122,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,2079524.6812144667,1695157.3948982877,0.8151657973630282,-0.2948345745537958,0.6410351129166951,0.9050396416750427,Downregulated
Feature0121,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid-peak1,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,2806651.4561962667,3503624.03240396,1.2483288670094683,0.31999805623671423,0.3151912077826286,0.8724505635080375,Upregulated
Feature0120,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0120,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,500571.2989642054,818332.8959345969,1.6347978752036159,0.7091122733579243,0.4844330857775718,0.8724505635080375,Upregulated
Feature0119,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0119,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,602176.4205759357,326425.718938327,0.5420765539542809,-0.8834314864610036,0.6298442993949463,0.9043347628664763,Downregulated
Feature0118,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2838866.5427543623,1573045.5606081411,0.5541104299612197,-0.851754571896187,0.387352255515215,0.8724505635080375,Downregulated
Feature0117,NA,C9 H19 N O8,269.11113,NA,NA,Feature0117,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,546801.1098981163,306848.0013861688,0.56116930970265,-0.8334919846296813,0.20324809290047785,0.8724505635080375,Downregulated
Feature0116,Val-pro,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Val-pro,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,6265398.63182004,1297578.0751007828,0.2071022374395751,-2.271584955015357,0.506320618084399,0.8752113541173183,Downregulated
Feature0115,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0115,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2565254.0112818233,1619311.4231430455,0.6312479840286449,-0.6637212195597589,0.45886564427287396,0.8724505635080375,Downregulated
Feature0114,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,2892009.0776452534,3708827.19760714,1.282439680523742,0.3588909703502349,0.049039363566772506,0.8724505635080375,Upregulated
Feature0113,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,1892383.7096893666,3574684.78795624,1.8889851828956095,0.9176113853436132,0.01748621870196251,0.8724505635080375,Upregulated
Feature0112,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0112,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,1830610.0117776066,529286.3445359414,0.2891311317706495,-1.790204137635743,0.08588317516282647,0.8724505635080375,Downregulated
Feature0111,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,1465905.3533186517,3747283.736429403,2.5562930976041236,1.3540532612526688,0.08476577168500575,0.8724505635080375,Upregulated
Feature0110,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,832645.591714668,394958.167093414,0.47434126959115486,-1.0760027007597415,0.0506393568621971,0.8724505635080375,Downregulated
Feature0109,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1782522.9255125737,784320.1259380693,0.44000563174385765,-1.1844061055989308,0.30187017708634484,0.8724505635080375,Downregulated
Feature0108,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak1",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3053609.1972983335,3520744.2421931066,1.152978005603359,0.20536499216608178,0.3286683714342301,0.8724505635080375,Upregulated
Feature0107,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0107,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2781872.975199097,1939569.070159288,0.6972169784353558,-0.520320392884689,0.4528797298964955,0.8724505635080375,Downregulated
Feature0106,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,1639370.7172705368,3078482.0945684835,1.8778437739170972,0.9090770438381984,0.26238655220601526,0.8724505635080375,Upregulated
Feature0105,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0105,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3889335.3232749165,1798756.3816134622,0.46248426327480163,-1.1125238182998312,0.3003085850471198,0.8724505635080375,Downregulated
Feature0104,NA,C14 H27 N O10,369.16362,NA,NA,Feature0104,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1501344.6604167,1779539.3386453532,1.1852970111149828,0.24524861420537256,0.27256575760538376,0.8724505635080375,Upregulated
Feature0103,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0103,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,452403.1124638973,481166.1240615477,1.063578279647547,0.08892621994949529,0.9186972489736954,0.9838470257338569,Upregulated
Feature0102,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,729244.2762073356,147011.15784558983,0.2015938453575085,-2.3104765007307893,0.3633824546039931,0.8724505635080375,Downregulated
Feature0101,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,723633.8851822374,2170077.2160473336,2.9988606952821577,1.5844145069037476,0.26604934215990866,0.8724505635080375,Upregulated
Feature0100,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0100,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,2727911.9065937134,3077261.7584972465,1.1280649316640723,0.1738501119686919,0.3451739464525281,0.8724505635080375,Upregulated
Feature0099,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0099,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5893884.7614995595,1898038.814791573,0.322035277511714,-1.6347093571578395,0.23058509876252906,0.8724505635080375,Downregulated
Feature0098,NA,C20 H30 N6 O8,482.21265,NA,NA,Feature0098,20,30,8,6,0,0,1.5,0.4,0.20000000000000015,54.599999999999994,9,1,-0.8333333333333334,-0.1,-5,Protein,231995.3077074715,45341.400812292966,0.1954410253394652,-2.355194757359274,0.4128178667282935,0.8724505635080375,Downregulated
Feature0097,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,2306862.5529596275,1424952.3027882962,0.6177014321725107,-0.695018419229577,0.5462984299011037,0.8890580920144323,Downregulated
Feature0096,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak1,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,628211.6641962854,139766.40863887232,0.22248298878322348,-2.1682330641400522,0.41400329659529306,0.8724505635080375,Downregulated
Feature0095,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,3271477.13501399,3362778.32525926,1.0279082464823277,0.03971149191244454,0.91533439368785,0.9838470257338569,Upregulated
Feature0094,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,456956.5096295648,133720.39626860298,0.29263265420379814,-1.7728373294118698,0.44865842444760956,0.8724505635080375,Downregulated
Feature0093,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0093,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2207460.934608441,2236954.7007332025,1.013360945900496,0.019148134761156097,0.9821453872725066,0.9951332564369114,Upregulated
Feature0092,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0092,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,1290561.9239696932,649074.151795578,0.5029391769122272,-0.9915441570292682,0.059688126530028786,0.8724505635080375,Downregulated
Feature0091,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,3173189.165444717,2742232.4756139503,0.8641881503555529,-0.21058264588575695,0.532424005356927,0.8826174436414305,Downregulated
Feature0090,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0090,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,1241585.9779736106,2210074.394025009,1.780041360995447,0.8319107640061404,0.4086152021355727,0.8724505635080375,Upregulated
Feature0089,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,2094436.0975136433,3319536.827165717,1.5849310614472414,0.6644200899096862,0.03472265209296961,0.8724505635080375,Upregulated
Feature0088,NA,C10 H15 N O5,229.09499,NA,NA,Feature0088,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,398878.5402360379,134297.20661438443,0.3366869687572401,-1.5705202111828205,0.46242084088829927,0.8724505635080375,Downregulated
Feature0087,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0087,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2333312.6365339803,2252317.8726479863,0.9652876504340594,-0.05096917321552089,0.9525794364844342,0.9882637829765163,Downregulated
Feature0086,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0086,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,2781903.1082040765,362733.425977554,0.13039038811517958,-2.939090571404748,0.1537861509412684,0.8724505635080375,Downregulated
Feature0085,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0085,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,511903.6350002817,618963.1496892207,1.209139977466423,0.2739812694894427,0.7663027739033512,0.9489158618364597,Upregulated
Feature0084,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,1737979.0979477086,206966.45880721134,0.11908455001076108,-3.069941844311014,0.41534730255515123,0.8724505635080375,Downregulated
Feature0083,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,2118003.57274184,3074206.676337363,1.4514643487393555,0.5375091365332314,0.30497819551680694,0.8724505635080375,Upregulated
Feature0082,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0082,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,1930687.02304305,1491962.68376625,0.7727625793095635,-0.3719028608995434,0.38561937947504193,0.8724505635080375,Downregulated
Feature0081,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,2421335.6348317633,3356809.7702454166,1.3863463296688527,0.471287708904314,0.16504953592694593,0.8724505635080375,Upregulated
Feature0080,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak1,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,2916515.1680220766,3512437.05732044,1.20432668954796,0.26822679530357424,0.13940586724017226,0.8724505635080375,Upregulated
Feature0079,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0079,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,1561092.4392569368,2768406.686110247,1.7733778067799615,0.82649992591679,0.3373183473257225,0.8724505635080375,Upregulated
Feature0078,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0078,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1652651.05598962,1291835.3317438134,0.7816745870593067,-0.35535995966072736,0.19309143507066856,0.8724505635080375,Downregulated
Feature0077,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,5221758.750753209,2703453.6044801665,0.5177285534476691,-0.9497322078622118,0.572317734211364,0.8929340317679025,Downregulated
Feature0076,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,2872394.2699092603,1444337.2591028765,0.5028339160238275,-0.9918461324217595,0.5156868342074256,0.8801268903348092,Downregulated
Feature0075,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0075,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1857176.7367067332,1462137.6574023804,0.7872905300306196,-0.34503197009852493,0.47941637450190017,0.8724505635080375,Downregulated
Feature0074,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0074,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,3089730.259468387,1349571.351346485,0.43679261230353805,-1.1949796394610586,0.20748238837966587,0.8724505635080375,Downregulated
Feature0073,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0073,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,2789562.61724058,465691.00398708496,0.16694050927874277,-2.582594017692937,0.09315712399778339,0.8724505635080375,Downregulated
Feature0072,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455-peak1,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,2778839.883245753,3107445.1381064435,1.1182526768965442,0.1612462119000763,0.4684492306908432,0.8724505635080375,Upregulated
Feature0071,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,872399.9609071877,2080777.8818578927,2.385119182827727,1.2540613585488052,0.352248591961673,0.8724505635080375,Upregulated
Feature0070,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0070,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,1564652.8523853135,1383568.1477120756,0.8842652513002011,-0.17744889796945917,0.6410891045028142,0.9050396416750427,Downregulated
Feature0069,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0069,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,2309112.0189237767,1947981.5007434767,0.8436063234608191,-0.24535818563606415,0.7650253515860852,0.9486064407934096,Downregulated
Feature0068,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0068,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,986538.1828845727,832855.9944711826,0.844220739673721,-0.24430782297520715,0.6830712263590955,0.9233562380758966,Downregulated
Feature0067,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0067,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1968331.4475591532,844342.5492819346,0.42896360281647133,-1.2210728533719384,0.22007265615643834,0.8724505635080375,Downregulated
Feature0066,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,1861994.5147204127,279670.221529932,0.15019927251070653,-2.735050269703205,0.4433917474506194,0.8724505635080375,Downregulated
Feature0065,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,817000.783577687,253610.34391199306,0.3104162798980691,-1.6877238726963768,0.1088637823305215,0.8724505635080375,Downregulated
Feature0064,Ala-Tyr,C12 H16 N2 O4,252.11102,NA,NA,Ala-Tyr,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,2654011.3343438134,1348444.7034196283,0.5080779746379728,-0.976878170742503,0.23240363520344537,0.8724505635080375,Downregulated
Feature0063,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,1390793.4363201407,2022386.6471244625,1.4541243827519317,0.5401506796456995,0.5858394904619575,0.9001845658902912,Upregulated
Feature0062,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,2757270.40236291,1877316.5128982866,0.6808605029414142,-0.554568850731964,0.32799796558506583,0.8724505635080375,Downregulated
Feature0061,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,1643489.7161110668,1191163.8324003099,0.7247771742794472,-0.46439057420573754,0.5324882098002018,0.8826174436414305,Downregulated
Feature0060,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0060,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,2585608.41901143,944911.5027062476,0.36545035039277945,-1.452252678060201,0.14233943506750982,0.8724505635080375,Downregulated
Feature0059,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1048213.4006909876,2455863.678745501,2.34290429518129,1.2282980230498068,0.23167404355765703,0.8724505635080375,Upregulated
Feature0058,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,624004.781731671,136134.559249897,0.21816268598473076,-2.1965237271774143,0.4135202962929763,0.8724505635080375,Downregulated
Feature0057,NA,C12 H22 N4 O3,270.16923,NA,NA,Feature0057,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,456329.84497642406,805744.3145927277,1.7657059328090974,0.8202450912286986,0.530859500340088,0.8826174436414305,Upregulated
Feature0056,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,221474.1428515744,1962267.9679318697,8.860031887546011,3.1473118910965137,0.21944863452518493,0.8724505635080375,Upregulated
Feature0055,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0055,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,1597326.4880071736,693330.788363299,0.4340570281460112,-1.2040434927280992,0.32670623260488085,0.8724505635080375,Downregulated
Feature0054,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0054,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1151270.3524971586,365656.17559037067,0.3176110414006975,-1.654667027818507,0.12406132126159673,0.8724505635080375,Downregulated
Feature0053,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0053,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,1510358.9667604633,202976.89842298583,0.13438983903167512,-2.8955040321633656,0.10154993510277713,0.8724505635080375,Downregulated
Feature0052,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0052,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,613577.570464529,103764.07532587853,0.16911321456441203,-2.563938698050946,0.41578394568868876,0.8724505635080375,Downregulated
Feature0051,NA,C15 H33 N O,243.2562,NA,NA,Feature0051,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,12315253.774191331,1033164.3425129234,0.08389306152002256,-3.575304694063055,0.43170034610912067,0.8724505635080375,Downregulated
Feature0050,N-feruloylglycine,C12 H13 N O5,251.07936,NA,NA,N-feruloylglycine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,2138201.2420757567,3165053.99569116,1.4802413979605302,0.565832469936356,0.1176842786097866,0.8724505635080375,Upregulated
Feature0049,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,1396324.6951062947,2181890.1717429548,1.562595132342667,0.6439440251545926,0.6306241810604587,0.9043347628664763,Upregulated
Feature0048,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0048,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,886146.9507728074,101605.38092320727,0.11465974219580327,-3.1245691545307532,0.37171837895481735,0.8724505635080375,Downregulated
Feature0047,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0047,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2166446.32633839,2301120.272949652,1.0621635278815702,0.08700589674656835,0.8812570012709628,0.9808471485893633,Upregulated
Feature0046,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,2029992.308292469,2340056.07925305,1.1527413526120163,0.20506884329002362,0.7409224319368111,0.9351636436381646,Upregulated
Feature0045,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0045,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2563077.1952319234,3013702.5973413265,1.1758142138472063,0.2336601231541839,0.49976174116218386,0.8747804400244787,Upregulated
Feature0044,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,1049880.0809352817,1587517.77994329,1.5120943894173664,0.596548199674085,0.1539398365399646,0.8724505635080375,Upregulated
Feature0043,NA,C12 H17 N O4,239.11576,NA,NA,Feature0043,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,2199203.039485093,2760547.4983394435,1.255249037390281,0.32797361865023006,0.11877590473213961,0.8724505635080375,Upregulated
Feature0042,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,2359721.04661567,2173012.0543548195,0.9208766678041754,-0.11892014450106612,0.8171331244723745,0.9660274597293932,Downregulated
Feature0041,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0041,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1167626.4339417745,1779471.1399203776,1.5240072408373666,0.6078697573557392,0.5679492202019886,0.8929340317679025,Upregulated
Feature0040,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0040,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,1659462.541338165,574904.4519910454,0.3464401501509346,-1.5293219561997933,0.2267373814224457,0.8724505635080375,Downregulated
Feature0039,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0039,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,690901.69633842865,369683.50441092264,0.5350739567873898,-0.9021897833430267,0.34423901722778977,0.8724505635080375,Downregulated
Feature0038,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0038,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2405969.5189639335,2109470.22973039,0.8767651514715685,-0.1897376378278436,0.7700633811554165,0.9502143902366301,Downregulated
Feature0037,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,1225739.7903616023,278695.462342056,0.22736918923047994,-2.1368913268313454,0.1013736203075899,0.8724505635080375,Downregulated
Feature0036,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak1,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,757127.198920996,668557.1943293974,0.883018329393235,-0.1794847097313268,0.9071099956410333,0.983565624317811,Downregulated
Feature0035,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0035,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2598258.98421284,3157531.8852955033,1.2152490973689827,0.2812520625595116,0.2342626481140643,0.8724505635080375,Upregulated
Feature0034,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0034,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,1901949.7949917032,724372.5774015847,0.38085788558090966,-1.3926753281798732,0.10647175007972244,0.8724505635080375,Downregulated
Feature0033,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3342160.581555354,2041722.2282024033,0.6108989015878583,-0.7109944484701443,0.6417114411558137,0.9051283774504151,Downregulated
Feature0032,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,844205.4692499964,131498.91259430267,0.15576647792998558,-2.6825433064668296,0.4273018255962706,0.8724505635080375,Downregulated
Feature0031,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0031,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1538318.85301502,822422.2385685873,0.5346240390649085,-0.9034033858884647,0.12616596747329248,0.8724505635080375,Downregulated
Feature0030,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0030,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,553305.1797208106,1332916.8547523906,2.4090084524872157,1.26843945556891,0.5765869353674824,0.8952688070692164,Upregulated
Feature0029,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,1689166.3099656512,210265.38216793168,0.12447879224645876,-3.0060281271088574,0.44066776566486254,0.8724505635080375,Downregulated
Feature0028,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0028,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,1710614.879881101,870564.3659331714,0.508918971869157,-0.9744921206849029,0.19290207969378195,0.8724505635080375,Downregulated
Feature0027,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1282134.882910362,910587.8667915172,0.7102122241027735,-0.4936779027899841,0.35509490167276603,0.8724505635080375,Downregulated
Feature0026,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0026,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2656598.94553262,2963274.1607079734,1.1154390336904498,0.15761166266668292,0.5731061292580106,0.8929340317679025,Upregulated
Feature0025,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0025,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,1961017.0620494431,991859.1815811826,0.5057881447214939,-0.9833948731332541,0.3936669460993662,0.8724505635080375,Downregulated
Feature0024,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0024,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,793678.1151226154,1181738.4876881116,1.4889392376726234,0.5742848799797509,0.1668702782360293,0.8724505635080375,Upregulated
Feature0023,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1610739.87613282,1541125.7008549122,0.9567812430117254,-0.06373898804283233,0.8963357351898875,0.983565624317811,Downregulated
Feature0022,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0022,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,490119.38696198433,101563.00221356664,0.20722094435624575,-2.2707582675780587,0.21002745351531577,0.8724505635080375,Downregulated
Feature0021,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0021,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,2950123.81512811,978932.5721701193,0.33182762267474825,-1.591494107818583,0.08080693966827189,0.8724505635080375,Downregulated
Feature0020,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,851016.8246595907,126395.31841574066,0.1485227021995707,-2.751244626168013,0.42810458200948054,0.8724505635080375,Downregulated
Feature0019,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,2489278.7457692535,793469.3409446717,0.31875471651908893,-1.649481405626902,0.12170529204396403,0.8724505635080375,Downregulated
Feature0018,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0018,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1778286.3157540322,1541758.1510899842,0.8669909549611785,-0.20591115253681652,0.8391555035147001,0.9729838623914456,Downregulated
Feature0017,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,1297590.8087131183,2254855.7385427165,1.7377248076987866,0.7971996299064957,0.20345597177775376,0.8724505635080375,Upregulated
Feature0016,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0016,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,356760.606270951,195252.569104842,0.5472929624874345,-0.8696147895017556,0.41569084749090307,0.8724505635080375,Downregulated
Feature0015,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0015,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2353403.3490456133,1462839.6665615777,0.6215847645304022,-0.6859769521549411,0.3505938094743123,0.8724505635080375,Downregulated
Feature0014,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1974703.88191991,1384183.115168865,0.7009573069877647,-0.5126015178022602,0.42630280344696975,0.8724505635080375,Downregulated
Feature0013,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,2343052.4566716966,2935001.8771092067,1.252640276470111,0.3249721721517,0.3715093000512002,0.8724505635080375,Upregulated
Feature0012,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,314893.725904313,79688.15840914317,0.2530636587956601,-1.9824277507720474,0.4067221222880216,0.8724505635080375,Downregulated
Feature0011,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0011,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1115039.275212878,958003.9846331447,0.8591661351572097,-0.21899096562782475,0.8241562249352106,0.96885540946582,Downregulated
Feature0010,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0010,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,2136987.4913666826,1250227.8756260534,0.585042205757829,-0.7733873884116312,0.3555423162209528,0.8724505635080375,Downregulated
Feature0009,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,715530.2365514704,99326.17210220653,0.13881477962540537,-2.8487669148880896,0.4108245548674732,0.8724505635080375,Downregulated
Feature0008,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0008,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,1108640.9558928127,2096270.5453711548,1.8908471081000093,0.9190327132065242,0.2683995079377853,0.8724505635080375,Upregulated
Feature0007,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,2480396.8836755375,877387.601560803,0.3537287146807973,-1.4992847572562258,0.49281032542730324,0.8724505635080375,Downregulated
Feature0006,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak1,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,524615.1363644016,1818836.0363550645,3.4669911527136867,1.793684154985403,0.17212455459859097,0.8724505635080375,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,947992.847835285,1492931.7227901004,1.574834373697194,0.6552001074630774,0.44847069038260495,0.8724505635080375,Upregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,1603969.2095070132,2291835.19434413,1.428852362476793,0.514856856303426,0.05178296764364107,0.8724505635080375,Upregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,1231480.0567867716,1649187.274578926,1.3391912158789263,0.4213619700009887,0.6553545134294869,0.9089232543643583,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,359756.5255911334,68120.37246468294,0.18935131851396175,-2.4008626276817657,0.4252865330807683,0.8724505635080375,Downregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,338341.3584301317,452120.57131461136,1.3362852635350382,0.4182280200549133,0.6346743978002416,0.9043690984397965,Upregulated
